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CANCER AND THE OLDER PATIENT 
Cancer remains a leading cause of death, accounting for 13% and 20% of all deaths 
worldwide (Ferlay, Shin, et al., 2010) and in Europe (Ferlay, Parkin, & Steliarova-Foucher, 2010), 
respectively. These prevalences indicate that, for a certain number of patients, cancer will no longer 
be curable. Cancer that is advanced or untreated is characterised by progression and deterioration in 
function over time, which results in higher risk of symptom burden (Peppercorn et al., 2011).   
In the development of cancer, ageing is a fundamental risk factor (Anisimov, Sikora, & 
Pawelec, 2009). The International Agency for Research on Cancer (IARC) and the World Health 
Organisation (WHO) estimated that approximately 60% of all new cancer cases occur at the age of 65 
years and older in Europe (Ferlay et al., 2015). In 2012, the incidence of cancer in patients aged 65 
years and older was estimated at approximately 6.5 million cases worldwide (Ferlay et al., 2015). In 
men above 65 years, the most common cancer sites are prostate, lung and colorectal (Ferlay et al., 
2015). In women above 65 years, the most common cancer sites are breast, lung and colorectal (Ferlay 
et al., 2015). The number of cancer cases will continue to increase as a result of the growing aging in 
the west (Davies & Higginson, 2004), and this especially in the group of 65 years and older. Moreover, 
literature suggests that older patients do not always get cancer treatment for a variety of reasons 
such as changes in physiology related to the aging process, comorbidities and the reluctance of 
healthcare professionals to treat cancer in these patients (Krzyzanowska, Regan, Powell, Earle, & 
Weeks, 2009; Townsley et al., 2005). Consequently, this leads to a higher risk of advanced stage cancer 
in older people. Statistics indicate that the death rate of cancer is 13 times higher in persons aged 65 
years and older compared to persons younger than 65 years (Eurostat, 2016). For patients with 
advanced stage cancer, palliative care might be beneficial. 
 
PALLIATIVE CARE 
Palliative care is an important part of healthcare all over the world. In palliative care, the 
challenge lies on trying to achieve a dignified existence for patients in their time left to live. The 
concept of the palliative care was introduced by Cicely Saunders with the foundation of a hospice in 
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1967 (Saunders, 2006). The hospice movement was a reaction against the inadequacy to care for the 
dying. What started as offering a place to relieve the dying from pain, grew as a new concept of care 
(Saunders, 2006). Cicely Saunders promoted in her work the principles of dying with dignity, 
maintaining that death is a natural process which can be eased by sensitive and compassionate 
nursing care and effective pain management (Saunders, 2006). Cicely Saunders is also recognised for 
her introduction of the concept of total pain, in which she emphasised that pain has a physical, 
emotional, social, and spiritual dimension (Saunders, 2006). Building on the principles of Cicely 
Saunders, the World Health Organisation launched in 1990 the first definition of palliative care (World 
Health Organisation, 1990). In 2002, the World Health Organisation extended their definition: “An 
approach that improves the quality of life of patients and their families facing the problems associated 
with life-threatening illness, through the prevention and relief of suffering by means of early 
identification and impeccable assessment and treatment of pain and other problems, physical, 
psychosocial and spiritual” (World Health Organisation, 2002). The definition was extended following 
the recognition that today the diseases patients suffer and die from are no longer solely cancer. Also, 
it is widely recognised that palliative care is no longer seen as the last option when all treatments 
have failed. Palliative care should rather be introduced early in the course of an illness to improve 
quality of live at the end of life (Bakitas et al., 2009; Temel et al., 2010). The early integration allows 
patients to prepare for their death by reviewing their life and say goodbye, which brings them closure 
(Steinhauser et al., 2001). 
The early integration of palliative care inevitably means that it not only focuses on the 
terminal phase (also called the dying phase or end-of-life phase) (Bruera & Hui, 2010; Von Roenn & 
Temel, 2011). This is also recommended by the Belgian Health Care Knowledge Centre, a state 
scientific organisation, which calls for the recognition of the palliative patient based on his/her needs 
such as relieving patients of suffering rather than on prognosis (Keirse et al., 2009). A lot of research 
has been published on various aspects such as quality of care, needs, and preferences of patients in 
the terminal phase. Less research has focused on the palliative care in its broader sense. This can be 
explained by the difficulty for healthcare professionals to determine when to integrate palliative care 
in the course of treatment and their attitude/perception towards palliative care (Von Roenn, Voltz, & 
Serrie, 2013). Examples of attitudes/perceptions are physicians finding it difficult to talk about death, 
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seeing their role as curing people, finding palliative care not meaningful or believing that they provide 
sufficient symptom control (Beernaert et al., 2015; Von Roenn et al., 2013).   
Symptoms and symptom control 
Patients with advanced or untreated cancer experience multiple symptoms. This because 
cancer in itself can have a physical and functional burden, but also because the patient is confronted 
with deterioration over time and death which will impact his/her psychological, social, and existential 
well-being (World Health Organisation, 2002). Studies showed that adult patients with all types of 
advanced cancer suffer from diverse and often severe symptoms (Gilbertson-White, Aouizerat, Jahan, 
& Miaskowski, 2011; Moens, Higginson, Harding, 2014; Teunissen et al., 2007). The most prevalent 
symptoms were fatigue, pain, anorexia, and appetite loss occurring in more than 50% of the adults 
with advanced cancer (Moens et al., 2014; Teunissen et al., 2007). Moreover, as the number of 
symptoms and their severity increase, the quality of life for patients decreases (Gilbertson-White et 
al., 2011). To optimise quality of life in adults with advanced cancer, research indicated that adequate 
symptom control is required, and that a comprehensive symptom assessment is needed to achieve 
symptom control (Bakitas et al., 2009; Temel et al., 2010; World Health Organisation, 2002). Current 
research on symptoms in advanced cancer has mainly focused on adults younger than 65 year old. 
However, the care for older patients is more complex as a result of the ageing process (Depp & Jeste, 
2006). Moreover, advances in economy, technology, and medicine have led to patients living longer 
with a chronic disease (Ritchie & Zulman, 2013). Nevertheless, these patients will at some point 
require some form of care (Suzman, Beard, Boerma, & Chatterji, 2015). With increasing age, patients 
are at higher risk of multimorbidity (two or more chronic diseases) (Ritchie & Zulman, 2013). 
Consequently, aside from cancer being a leading cause of death, many older persons are often 
confronted with life-threatening non-cancer diseases as indicated in the extended definition of 
palliative care by the World Health Organisation. Sometimes a combination of life-threatening non-
cancer and advanced cancer diseases is present. All making the older patients more vulnerable for 
the experience of multiple symptoms and more challenging to care for. The care for older patients 
demands a different care focus than the younger patients. In addition, the healthcare system is 
increasingly confronted with older patients. In hospitals, it is estimated that approximately one third 
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of the hospitalised patients are 65 years and older and this proportion will rise in the following years 
and decade (Deschodt et al., 2015). The overall consumption of the healthcare system by older 
patients is three to five times higher than in younger patients (Casey, Whithouse, Antolín, Duval, & 
Leibfritz, 2003). Insight in the care for older palliative cancer patients is needed to assure quality of 
care for these patients. Research on palliative care for complex older patient population is lacking. 
Therefore, several domains should be considered for further research in this population.  
First, research is needed in symptoms in older palliative cancer patients to provide insight, 
to increase the knowledge of healthcare professionals, and to identify areas of care which need further 
attention. Both symptom frequency and intensity in this vulnerable population need to be evaluated 
because a symptom could be prevalent but not burdensome for patients and the other way around. 
Given the fact that cancer, palliative and older patients experience multiple symptoms (Eckerblad et 
al., 2015; Gilbertson-White et al., 2011), it is believed that symptoms in these populations might be 
interrelated due to a shared underlying aetiology, a single ‘trigger’ symptom causing or negatively 
influencing other symptoms or a side-effect of treatment (Miaskowski, Dodd, & Lee, 2004; Williams, 
2007). According to Kim, McGuire, Tulman, and Barsevick (2005): “A symptom cluster consists of two 
or more symptoms that are related to each other and that occur together. Symptom clusters are 
composed of stable groups of symptoms, are relatively independent of other clusters, and may reveal 
specific underlying dimensions of symptoms. Relationships among symptoms within a cluster should 
be stronger than relationships among symptoms across different clusters. Symptoms in a cluster may 
or may not share the same aetiology.” Knowledge on symptom clustering may help healthcare 
professionals to be alert to the occurrence of other symptoms within the cluster alongside an already 
identified symptom, and to adapt treatment according to its possible influence on other symptoms 
within the cluster.  
Second, it is essential that symptom assessment should be performed comprehensively and 
allow identification of symptoms on multiple domains (World Health Organisation, 2002). A valid and 
reliable instrument should be used for symptoms assessment to avoid measurement bias (Polit & 
Beck, 2008). One comprehensive assessment is the most suitable in terms of feasibility (minimal 
burden for patients). In addition, the instrument should best be population- and disease specific to 
be able to capture those symptoms characteristic for the target population. No such instrument is 
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available. Over the past years, many instruments have been developed to assess symptoms in 
palliative, oncologic or older populations. Moreover, the current instruments merely cover a limited 
number of symptoms and domains (Katz, Downs, Cash, & Grotz, 1970; Nekolaichuk, Watanabe, & 
Beaumont, 2008; Yesavage et al., 1982).  
Third, in symptom assessment, patients’ self-reported symptoms are seen as the gold 
standard. However, patients are not always able to report their symptoms because of a variety of 
reasons that are particularly relevant for older adult patients in palliative care (Kaye, Baluch, & Scott, 
2010). Older palliative cancer patients could, for instance, not be able to report their symptoms if they 
experience cognitive problems, confusion, and weakness (Kaye et al., 2010; Nekolaichuk et al., 1999). 
For those patients, symptoms can only be assessed indirectly or estimated by a formal (nurse and 
physician) or informal (proxy) caregiver. The validity and reliability of those assessments in older 
palliative cancer patients are unclear. Studies on the agreement of symptom assessment among the 
patient, the healthcare provider and the proxy have been performed in different settings and other 
populations (Higginson & Gao, 2008; Laugsand et al., 2010; Pautex, Berger, Chatelain, Herrmann, & 
Zulian, 2003; Yip, Wilber, Myrtle, & Grazman, 2001). Overall, healthcare professionals and proxies have 
a tendency to under- and overreport symptoms, respectively. Lower agreement has been observed 
for more subjective symptoms, such as depression, and less prevalent symptoms, such as poor sleep 
(Laugsand et al., 2010; Pautex et al., 2003). Underreporting may result in undertreatment and 
overreporting may lead to unnecessary interventions, such as high doses of medication (Kaye et al., 
2010; Winn & Dentino, 2005). This may reduce the quality of life of the patient and lead to discomfort.  
Forth, symptom control is an essential part of palliative care. Multiple international and 
national guidelines have been published to treat symptoms in palliative care patients (Larkin et al., 
2008; Radbruch, Elsner, Trottenberg, Strasser, & Fearon, 2010; Radbruch et al., 2008; Rayner, Price, 
Hotopf, & Higginson, 2011; Ripamonti et al., 2001). Moreover, these guidelines are often developed 
for a large population and are not focused on the older person.  Despite the availability of guidelines, 
Laugsand et al. (2009) concluded that 30% to 50% of the younger cancer patients experiencing 
moderate to severe symptoms did not receive any treatment to improve comfort (Laugsand, Kaasa, 
de, Hanks, & Klepstad, 2009).  
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Role of the nurse in the assessment and management of symptoms 
Nurses play an essential role in both the assessment and the control of symptoms in older 
palliative cancer patients, because nurses are most often involved in the observation of patients. In 
clinical practice, symptom assessment is rarely systematically performed using a standardised 
instrument (Kaasa et al., 2008). If symptoms are not identified through systematic assessment, the 
question rises how nurses identify problems in patients, and more specifically in older palliative cancer 
patients. Research indicates that nurses base their care on intuition, theoretical knowledge, clinical 
experience, and ‘knowing the patient’ (Tanner, 2006). However, it remains unclear how nurses in the 
care for older palliative cancer patients identify patient problems, and make clinical decisions to assist 
in problem resolution. 
 
DEFINING THE TARGET POPULATION 
This thesis focuses on the older palliative cancer patient. A clear definition of the target 
population is needed to understand to whom the findings are applicable.  
Defining the older patient 
The older patient in this thesis was defined as the patient aged 65 years and older. The choice 
to include patients aged 65 years and older was made to increase comparability with other research. 
Much research still sets the age limit of being older at the age of 65 years. It could be argued that the 
group between 65 years and 75 years should not be seen as the older person, because the population 
is ageing and persons at the age of 65 years might still have a long time to live. Also, persons of older 
age are increasingly fit and healthy due to advances in technology, and life-style (Mathers, Stevens, 
Boerma, White, & Tobias, 2015). Consequently, not all older patients are geriatric patients. An older 
patient can be defined as a geriatric patient when confronted with a complex interplay of 
comorbidities, polypharmacy, functional decline, psychosocial problems and cognitive impairment as 
a result of the ageing process (Depp & Jeste, 2006; Marengoni et al., 2011; Pallis et al., 2010). 
Nevertheless, the likelihood of being a geriatric patient increases in palliative cancer patient aged 65 
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years and older due to the impact of the life-threatening illness and it’s treatments (Mohile et al., 
2009; Pal, Vani, & Hurria, 2010).  
Defining the palliative patient 
There is a lack of a universal definition on what a palliative patient constitutes of. In research, 
this leads to heterogeneity between studies and difficulties to compare studies (Van Mechelen et al., 
2013). In accordance with previous research (Borgsteede et al., 2006; Van Mechelen et al., 2013), the 
findings of our systematic review indicate that the palliative patient was defined differently across 
studies: advanced cancer, patients referred to a palliative team, and patients referred to a palliative 
unit (Chapter II). Consequently, we needed a clear and comprehensive definition of the older palliative 
patient to ensure the validity of our findings. Our aim was to obtain a definition which builds on the 
palliative care model of the World Health Organisation and is applicable for the older patient. The 
concept of palliative care described by the World Health Organisation recommends to offer palliative 
care to patients with life-threatening illness not only at the end of life, but alongside (curative) 
treatment (Davies & Higginson, 2004). In this concept, there is an early focus on symptom 
management which gradually increases when death approaches (Figure 1). 
 
Figure 1. Concept of palliative care (Murray, Kendall, Boyd, & Sheikh, 2005)  
We wanted to focus on this broader concept of palliative care and not solely focus on the patients 
in the terminal phase. Therefore, we purposefully did not want to recruit patient through palliative 
care support teams or palliative care units because literature indicates that older people are 
compared to younger patients less often referred to palliative care and referral to palliative care still 
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remains equated with terminal care (Beernaert et al., 2015; Burt & Raine, 2006; Gardiner, Cobb, Gott, 
& Ingleton, 2011). We also wanted to define the palliative patient without a prognostication of time 
until death to comply with the recommendation to identify palliative patients based on their needs 
rather than prognosis (Davies & Higginson, 2004; Keirse et al., 2009). In compliance with these 
principles, a set of criteria was developed based on definitions reported in the literature (Desmedt 
et al., 2011; Pastrana et al., 2008; Van Lancker et al., 2014; Van Mechelen et al., 2013; World Health 
Organisation, 2002) by a panel of experts (n = 7) with clinical expertise in oncology, palliative care 
and/or geriatric care. This resulted in the following criteria to define the older palliative cancer 
patient: “A patients with cancer who is no longer curable as a result of a lack of treatment options 
or for whom curative treatment is not/no longer recommended because the harm of treatment 
outweighs the benefit of treatment, a weak general condition, multipathology and/or preference of 
the patient to discontinue treatment. In contrast to healing, stabilisation of the cancer is possible.” 
The terminal phase was defined as: “The last phase of life characterised by global organ failure 
which is clinically apparent by physical (e.g. respiratory) and mental (e.g. agitation) changes.”  
 
OUTLINE AND RESEARCH QUESTIONS 
Over the last years, due to the ageing population, more attention has been given to the care 
for older palliative cancer patients. However, in research and in clinical practice, the focus on this 
population remains in its infancy. Still more attention is given to younger populations. The first step 
before developing an intervention to improve care for older palliative cancer patients, is to analyse 
the current practice and identify the problem areas (van Meijel, Gamel, van Swieten‐Duijfjes, & 
Grypdonck, 2004). Therefore, the general objective of this doctoral thesis was to gain insight into the 
symptoms older palliative cancer patients experience and the interventions and nursing care that 
these patients received. This objective leads to seven research questions.
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RESEARCH QUESTIONS 
1. Which symptoms do older palliative cancer patients experience and what is the frequency 
and intensity of these symptoms?  
2. What is the content validity and test-retest reliability of a new instrument to assess 
symptoms in older palliative cancer patients? 
3. Which interventions do older palliative cancer patients receive? 
4. How do symptoms cluster in older palliative cancer patients? 
5. What is the difference in symptoms between older palliative patients with a cancer and a 
non-cancer diagnosis? 
6. What is the level of agreement in symptom assessment between the patient, nurse and proxy 
of the patient? 
7. How do nurses provide care for hospitalised older palliative cancer patients?   
    
The first part focuses on symptoms in older palliative cancer patients. In Chapter II, the 
literature on the prevalence of symptoms in older palliative cancer patients is reviewed (RQ1). This 
first step indicated a gap in studies on the prevalence of symptoms, and mainly on non-physical 
symptoms in the target population. Also, evidence was based on small sample sizes, and few studies 
used a validated instrument to collect data on symptoms in older palliative cancer patients. The lack 
of a comprehensive instrument to assess symptoms in multiple domains (physical, psychological, 
functional, social, existential) stresses the need for the development and validation of a new 
instrument. Chapter III outlines the development and validation of a new instrument specifically 
developed for the assessment of symptoms in older palliative cancer patients (RQ2). In Chapter IV, 
the frequency and intensity of symptoms (RQ 1) and interventions (RQ 3) of a sample of 400 older 
palliative cancer patients are presented. Symptoms in older palliative cancer patients very likely occur 
together. Therefore, a cluster analysis of symptoms (RQ 4) is presented in Chapter V. For some time, 
palliative care has focused on the care of patients with cancer (Zheng et al., 2013). Currently, more 
attention is devoted to introducing palliative care early in the trajectory of patients facing chronic 
illnesses other than cancer (Zheng et al., 2013). Therefore, we also performed an explorative study on 
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the difference in symptoms between older palliative patients with a cancer and a non-cancer 
diagnosis (RQ 5). Results of these differences are presented in Chapter VI. 
The second part focuses on nursing care for older palliative cancer patients. In Chapter VII, 
we looked at the level of agreement in symptom assessment between patients, nurses and proxies of 
patients (RQ 6). Disagreements were observed between the different symptom assessments. Hence, 
it remains unclear how nurses identify older palliative cancer patients’ problems, and make clinical 
decisions to assist them in a solution for the problem of patients. Results of the study on how nurses 
care for older palliative cancer patients (RQ 7) are presented in Chapter VIII.  
The third part provides a general discussion on the findings of this doctoral thesis. A 
reflection is provided on the relevance of the findings for nursing practice, education, policy and 
research.  
This doctoral thesis is composed of different chapters each representing a stand-alone 
research paper which has been published, accepted for publication or submitted to a peer-reviewed 
science citation indexed journal.
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ABSTRACT 
Context Symptom control is an essential part of palliative care and important to achieve optimal 
quality of life. Studies showed that patients with all types of advanced cancer suffer from diverse and 
often severe symptoms. Research focusing on older persons is scarce, because older persons are 
often excluded from studies. Consequently, it is unclear which symptoms older palliative care patients 
with cancer experience and what the prevalence of these symptoms is.  
To date, no systematic review has been performed on the prevalence of symptoms in older cancer 
patients receiving palliative care. 
Objectives The objective of this systematic review was to search and synthesize the prevalence figures 
of symptoms in older palliative care patients with cancer. 
Methods A systematic search through multiple databases and other sources was conducted from 
2002 until April 2012. The methodological quality was evaluated. All steps were performed by two 
independent reviewers. A meta-analysis was performed to pool the prevalences of symptoms.   
Results Seventeen studies were included in this systematic review. Thirty-two symptoms were 
identified. The prevalence of these symptoms ranged between 3.5% and 77.8%. The most prevalent 
symptoms were fatigue, excretory symptoms, urinary incontinence, asthenia, pain, constipation and 
anxiety and occurred in at least 50% of the patients. 
Conclusion There is a high degree of uncertainty about the reported prevalence because of small 
sample sizes, high heterogeneity among the studies, and the extent of instruments validation. 
Research based on rigorous methods is needed to allow more conclusive results.  
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BACKGROUND 
In 2008, the estimated incidence of cancer was 12.7 million cases internationally (Ferlay, Shin, 
et al., 2010) of which 3.2 million cases were in Europe (Ferlay, Parkin, et al., 2010). Because ageing is 
a fundamental risk factor for cancer development (Anisimov et al., 2009), the number of cancer cases 
will continue to increase as a result of the growing aging in the west (Davies & Higginson, 2004). 
Cancer remains a leading cause of death, accounting for 13% and 20% of all deaths worldwide (Ferlay, 
Shin, et al., 2010) and in Europe (Ferlay, Parkin, et al., 2010), respectively. These prevalences indicate 
that, for a certain number of patients, the focus of treatment will eventually shift from cure to care. 
Therefore, many authors have recommended the integration of palliative care with cancer care and 
that this is done in the early stage of illness (Bruera & Hui, 2010; Von Roenn & Temel, 2011).  
Symptom control is an essential part of palliative care and important to achieve optimal 
quality of life (Anisimov et al., 2009). Studies showed that patients with all types of advanced cancer 
suffer from diverse and often severe symptoms. Two systematic reviews (Gilbertson-White et al., 2011; 
Teunissen et al., 2007) of patients of all ages identified between 11 and 56 different symptoms. 
Teunissen et al. (2007) reported that the most prevalent symptoms were fatigue, pain, lack of energy, 
weakness and appetite loss occurring in more than 50% of the patients with advanced cancer. 
Moreover, as the number of symptoms and their severity increases, the quality of life for patients 
decreases (Gilbertson-White et al., 2011). Despite the high prevalence of symptoms, many patients 
remain untreated (Laugsand et al., 2009). Research focusing on older persons is scarce, because older 
persons are often excluded from studies (Bugeja, Kumar, & Banerjee, 1997; McMurdo, Witham, & 
Gillespie, 2005). Despite the fact that a majority of older people are ageing well, the incidence of frail 
older person with complex and multiple chronic pathologies and disability increases (Depp & Jeste, 
2006). Therefore, results from studies in younger persons cannot always be extrapolated to the older 
person (Bell, May, & Stewart, 1987). Consequently, it is unclear which symptoms older palliative 
patients with cancer experience. To date, no systematic review has been performed on the prevalence 
of symptoms in older cancer patients receiving palliative care. 
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AIM 
The aim of this systematic review was to search and synthesize the prevalence figures of 
symptoms in older palliative patients with cancer. The following questions were addressed: (1) which 
symptoms do older palliative patients with cancer experience? and (2) what is the point prevalence 
of the identified symptoms in older palliative cancer patients? 
METHODS 
Review protocol 
The review protocol, which details the predefined criteria for this review, is available from 
the authors and the Joanna Briggs Institute (JBI) (Van Lancker, Velghe, Verbrugghe, Bekkering, & 
Beeckman, 2012).  
Search strategy 
Multiple steps were undertaken to identify all relevant literature. First, an initial limited search 
of Pubmed and CINAHL was carried out to define the appropriate index terms and key words. Second, 
a subsequent search was undertaken across the following electronic databases: Pubmed, Embase, 
CINAHL, Web of Science, and the Cochrane Library. The concepts, using identified index terms and 
key words, were combined as follows: “palliative” AND “symptoms” AND “prevalence” AND “cancer” 
AND “older person”. Third, Google Scholar was searched to identify grey literature. Fourth, a hand 
search through the tables of content of relevant journals (Journal of Pain and Symptom Management, 
Palliative and Supportive care, Journal of Palliative Medicine, Support Care Cancer, Critical Review in 
Oncology, and International Journal of Palliative Nursing), conference proceedings (Congresses of the 
European Association for Palliative Care and Flemish Congresses on Palliative Care), and reference 
lists of all retrieved full-text articles was carried out to identify additional studies.  
Articles written in English, French, German and Dutch and published between 2002 and April 
2012 were considered for inclusion. A time period of 10 years was adopted because of change over 
time in treatment options and its influence on symptoms. 
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Study inclusion criteria were having a quantitative design, reporting on prevalence of 
symptoms in adults older than 65 years, and reporting on palliative patients or patients with incurable 
or advanced cancer. Studies only reporting on the prevalence of symptoms in terminal patients were 
excluded from this review. 
The title and abstract of all identified records were screened by two independent reviewers (A.V.L. 
and M.V.). Full texts of all potentially relevant records were further checked for inclusion. Differences 
in assessment were discussed between the two reviewers to reach consensus. In case of disagreement, 
a third reviewer (A.V.) was consulted. The interrater reliability for study selection was tested using the 
overall agreement and Cohen’s kappa.        
Methodological quality 
The methodological quality of the papers selected for retrieval was evaluated independently 
by two reviewers (A.V.L. and A.V.). Standardized critical appraisal instruments from the Joanna Briggs 
Institute Meta-Analysis of Statistics Assessment and Review Instrument (JBI-MAStARI) were used to 
explore the presence of potential bias. Three checklists were used depending on study design: (1) 
Randomized Controlled Trials/Pseudo-randomized Trial, (2) Comparable Cohort Study/Case Control 
Study, and (3) Descriptive/Case series. The checklist for Comparable Cohort Study/Case Control Study 
was used for quasi-experimental studies. The items were rated as + (present) or – (not present). 
Differences in assessment were discussed between the two reviewers to reach consensus. In case of 
disagreement, a third reviewer (M.V.) was consulted. No study was excluded based on evaluation of 
the methodological quality. 
Data collection and synthesis 
Data from the included studies was extracted by two independent reviewers (A.V.L. and A.V.). 
A standardized form and detailed instruction guide were used to extract data, which included study 
design, setting, sample characteristics, symptom description and collection, and results. Subsequently, 
study characteristics and results were tabulated.  
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Data pooling 
Prevalence figures were combined using meta-analysis, if the heterogeneity was acceptable. 
Data were pooled using either the random- or fixed effect model depending on the heterogeneity of 
the included studies. Heterogeneity was determined using the Cochran’s Q test at a significance level 
of .10. I² was calculated to quantify the heterogeneity; acceptable heterogeneity was defined as I² 
<70% (Higgins, Thompson, Deeks, & Altman, 2003). In studies with a high heterogeneity (I² >70%), a 
random effect model was used.  
Logit transformation of the prevalence figures was applied, because logits are more likely to 
have a normal distribution, which is essential for pooling data. The final pooled logit was back 
transformed, resulting in pooled prevalence and 95% confidence intervals (CIs). Following formulae 
were used: logit event rate = log [event rate/(1 – event rate)], logit event rate SE = √1/(event rate x 
total) + 1/[(1 – event rate) x total)] and event rate = (e^logit event rate)/(e^logit event rate + 1) with 
e = 2.718. Subgroup-analyses were performed based on the type of cancer, but only if there were at 
least three studies in a subgroup. The Comprehensive Meta-Analysis, version 2 software (BioStat 
Software, Englewood, NJ), was used to perform the analyses. Microsoft Office Excel 2010 was used to 
develop the forest plots. 
RESULTS 
Search strategy 
The electronic database search identified 7881 records: Pubmed (n=2293), Embase (n=3018) 
CINAHL (n=691), Web of Science (n=1332), and the Cochrane Library (n=460) (Figure 1). Google 
scholar yielded 136 records. The hand search resulted in 393 records from relevant journals and two 
records from conference proceedings. No additional record was added after checking the reference 
lists of the included studies. This resulted 8325 records, of which 2266 were duplicates. Based on title 
and/or abstract screening, 293 records potentially met the inclusion criteria. Based on the review of 
the full texts, 276 records were excluded. Reasons for exclusion are reported in Figure 1. The 
systematic review included 17 studies (Table 1) (Altundag et al., 2007; Biesma et al., 2011; Comella, 
Gambardella, Frasci, Avallone, & Costanzo, 2008; Feliu et al., 2006; Genz, Jenetzky, Hauer, Oster, & 
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Pfisterer, 2010; Kudoh et al., 2006; Langer et al., 2002; LeCaer et al., 2011; Li, Chen, Dai, Li, & Bao, 2009; 
Lloyd-Williams, 2002; Maestu et al., 2003; Maestu et al., 2007; Paillaud, Caillet, Campillo, & Bories, 
2006; Su, Yeh, Chen, Wu, & Lai, 2011; Teunissen, de Haes, Voest, & de Graeff, 2006; Tredan et al., 
2007; Yoshimura et al., 2009).  
There was almost perfect agreement between the reviewers: an overall agreement of 9.0% 
and a Cohen’s kappa of 0.93. 
Methodological quality 
In general, the included studies had multiple methodological limitations (Table 2-4). The 
most common methodological problems were the absence of valid and reliable measurement 
instruments to identify the prevalence of symptoms and the absence of a representative sample.  
Definition of a palliative patient 
Palliative patients were defined differently across the included studies. Most of the studies 
(n = 13) did not define the patients as being in a palliative phase, but included patients with advanced 
cancer (Altundag et al., 2007; Biesma et al., 2011; Comella et al., 2008; Feliu et al., 2006; Kudoh et al., 
2006; Langer et al., 2002; LeCaer et al., 2011; Li et al., 2009; Maestu et al., 2003; Maestu et al., 2007; 
Trédan et al., 2007; Yoshimura et al., 2009). Four studies included cancer patients referred to a 
palliative/hospice care unit (n=3) (Genz et al., 2010; Lloyd-Williams, 2002; Paillaud et al., 2006) or 
palliative care team (n=1) (Teunissen et al., 2006). None of the studies gave a clear description on 
when patients were seen as being in a palliative phase. 
Study characteristics 
Participants were older persons based in the community (n=3) (Feliu et al., 2006; Langer et 
al., 2002; Lloyd-Williams, 2002), hospital (n=3) (Li et al., 2009; Su et al., 2011; Teunissen et al., 2006), 
palliative care unit (n=2) (Genz et al., 2010; Paillaud et al., 2006) or cancer center (n=1) (Altundag et 
al., 2007). The setting was not reported in eight studies (Biesma et al., 2011; Comella et al., 2008; 
Kudoh et al., 2006; LeCaer et al., 2011; Maestu et al., 2003; Maestu et al., 2007; Tredan et al., 2007; 
Yoshimura et al., 2009).   
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Figure 1: Flow chart included studies 
Potentially relevant records 
identified                            
7794 
Additional potentially relevant 
records (hand searching) 
 identified                             
  531 
Duplicates   2266 
Records excluded based on  
title and/or abstract 
identified:                             
5766 
Records retrieved for more  
detailed evaluation                             
293 
Records excluded based on  
full evaluation   
Reasons 
   Age   95 
   No prevalence   19 
   No symptoms 109 
   No cancer     8 
   Terminal patients only     8 
   Not palliative   14 
   No baseline symptoms     1  
   No original study   11 
   Insufficient data                   7 
   Other                                           4 
276 
Additional from reference lists              
0 
  0 
Final included studies   17 
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In most studies the primary diagnosis was non-small cell lung cancer stage III or IV (n=10) (Altundag 
et al., 2007; Biesma et al., 2011; Comella et al., 2008; Kudoh et al., 2006; Langer et al., 2002; LeCaer et 
al., 2011; Li et al., 2009; Maestu et al., 2003; Maestu et al., 2007; Yoshimura et al., 2009). Other studies 
included patients with advanced colorectal cancer (Feliu et al., 2006), ovarian epithelial cancer stage 
III and IV (Tredan et al., 2007) or multiple other cancers (n=4) (Genz et al., 2010; Lloyd-Williams, 2002; 
Paillaud et al., 2006; Teunissen et al., 2006). One study did not report on the cancer type (Su et al., 
2011). Terminal patients were included in three studies, but did not comprise the total sample (Lloyd-
Williams, 2002; Paillaud et al., 2006; Teunissen et al., 2006). However, the number of terminal patients 
was not reported. In eight studies, it was unclear if terminal patients were included (Altundag et al., 
2007; Comella et al., 2008; Langer et al., 2002; Li et al., 2009; Maestu et al., 2007; Su et al., 2011; 
Yoshimura et al., 2009). The data-collection method was not described in eleven studies (Altundag et 
al., 2007; Biesma et al., 2011; Comella et al., 2008; Genz et al., 2010; Langer et al., 2002; LeCaer et al., 
2011; Li et al., 2009; Maestu et al., 2003; Maestu et al., 2007; Yoshimura et al., 2009), 10 of which 
symptom prevalence was reported as a baseline characteristic (Altundag et al., 2007; Biesma et al., 
2011; Comella et al., 2008; Langer et al., 2002; LeCaer et al., 2011; Li et al., 2009; Maestu et al., 2003; 
Maestu et al., 2007; Yoshimura et al., 2009). The other studies used validated instruments (n=2) (Feliu 
et al., 2006; Lloyd-Williams, 2002), a questionnaire with unknown validity (n=2) (Su et al., 2011; 
Teunissen et al., 2006) or subjective assessment (n=2) (Paillaud et al., 2006; Tredan et al., 2007). The 
prevalence of symptoms was calculated based on samples of 30 to 182 older patients with a 
combined maximum of 652 patients.   
  
Table 1: Characteristics of the included studies 
Study Study design and Setting Patient characteristics Measurement Instrument Symptom prevalence in the 
Subgroup of Palliative Elderly  
Altundag et 
al. (2007)  
Quasi-experimental study 
(matched control 2:1) 
Cancer center  
Sample sizea: 138 
Number of elderlya: 46  
Age: group ≥ 80 yrs: median age 82 yrs 
Primary diagnosis: advanced NSCLC (stage III and IV) 
Metastasis: NR 
Terminal patients: NR 
NRb ≥ 10% weight loss (6 months): 
4.3% 
No data on weight loss for 8.7% of 
the patients 
Biesma et al. 
(2011)  
Randomized controlled trial 
Setting NR 
Sample sizea: 182 
Number of elderlya: 182  
Age: all ≥ 70 yrs - median age 74 yrs 
Primary diagnosis: inoperable NSCLC (stage III and 
IV) 
Metastasis: NR 
Terminal patients: survival > 5.6 months 
NRb > 10% weight loss: 8% 
Comella et al. 
(2008)  
Randomized controlled trial 
Setting NR 
Sample sizea: 259 
Number of elderlya: 145 
Age: group > 70 yrs: median age 74 yrs 
Primary diagnosis: locally advanced NSCLC (stage III 
and IV) 
Metastasis: > 1 metastatic site 
Terminal patients: NR 
NRb > 5% weight loss: 25% 
Feliu et al. 
(2006)  
Quasi experimental study (no 
control group) 
Ambulatory patients 
Sample sizea: 50 
Number of elderlya: 50 
Age: all > 70 yrs - mean age 76 yrs 
Primary diagnosis: advanced colorectal cancer 
Metastasis: liver, lung, lymph node and other sites 
Terminal patients: LE > 3 months 
Memorial pain assessment 
card for pain (score ≥ 20) 
VAS♯  (1-100) for asthenia 
and anorexia (score ≥ 20) 
Asthenia: 56% 
Pain: 40% 
Anorexia: 28% 
Genz et al. 
(2007)  
Case control study 
Special care unit for palliative 
geriatric patients 
Sample sizea: 217  
Number of elderlya: 101 (116 non-oncological) 
Age: all > 75 yrs - mean age 76.8 (8.7) yrs - median 
age 78 yrs 
NR Urinary incontinence: 71% 
Fecal incontinence: 44% 
Pain: 86% 
Constipation: 51% 
  
Study Study design and Setting Patient characteristics Measurement Instrument Symptom prevalence in the 
Subgroup of Palliative Elderly  
Primary diagnosis: palliative patients with different 
type of cancer  
Metastasis: NR 
Terminal patients: NR 
Agitation: 38% 
Dyspnea: 20% 
Anorexia: 29% 
Diarrhea: 24% 
Vomiting: 26% 
Nausea: 30% 
Confusion: 22% 
Dysphagia: 17% 
Malnutrition: 46% 
Kudoh et al. 
(2006)  
Randomized controlled trial 
Setting NR♯  
Sample sizea: 180  
Number of elderlya: 180  
Age: all ≥ 70 yrs - median age 76 yrs 
Primary diagnosis: NSCLC (stage IIIb and IV) 
Metastasis: NR 
Terminal patients: LE ≥ 3 months 
NRb > 10% weight loss: 13.4% 
Langer et al. 
(2002)  
Randomized controlled trial 
Academic and community care 
centers and practices 
Sample sizea: 574  
Number of elderlya: 86  
Age: group ≥ 70 yrs - median/mean age NR 
Primary diagnosis: NSCL (stage III and IV) 
Metastasis: lung, pleura, mediastinum, 
supraclavicular, lymph node, liver, bone, other 
Terminal patients: NR 
NRb ≥ 5% weight loss: 34.0% 
Cough: 37% 
Dyspnea: 41% 
Hoarseness: 3.5%  
Pain: 26%  
Respiratory symptoms: 21% 
Decreased appetite: 30% 
LeCaer et al. 
(2011)  
Randomized controlled trial 
Setting NR 
Sample sizea:99  
Number of elderlya: 99 
Age: mean age 75.9 yrs 
Primary diagnosis: NSCLC (stage IIIb and IV) 
Metastasis: NR 
Terminal patients: LE ≥ 3 months 
NRb > 5% weight loss: 37.3% 
Li et al. 
(2009)  
Retrospective cohort study  
Hospital 
Sample sizea:109  
Number of elderlya: 109 
Age: all > 70 yrs - median age 74 yrs 
Primary diagnosis: unresectable locally advanced 
NSCLC (stage IIIb and IV) 
NRb > 5% weight loss (3 months): 
34.9%  
 
  
Study Study design and Setting Patient characteristics Measurement Instrument Symptom prevalence in the 
Subgroup of Palliative Elderly  
Metastasis: present 
Terminal patients: NR 
Lloyd-William 
et al. (2002)  
Cross-sectional study 
Community 
Sample sizea:184 
Number of elderlya: 44 (> 70 yrs) 
Age: median age 64 yrs 
Primary diagnosis: hospice patients with different 
type of cancer  
Metastasis: NR 
Terminal patients: survival range 6 days to 17 
months 
Edinburgh Postnatal 
Depression Scale (score ≥ 
13) 
Depression: 16.28% 
Maestu et al. 
(2003)  
Quasi-experimental study (no 
control group) 
Setting NR 
Sample sizea:88 
Number of elderlya: 88 
Age: all > 65 yrs - median age 74 yrs 
Primary diagnosis: advanced NSCLC (stage IIIa/b and 
IV) 
Metastasis: NR 
Terminal patients: LE > 12 weeks 
NRb > 10% weight loss: 21.6% 
Asthenia: 75.6% 
Dyspnea: 73.1% 
Pain: 57.7% 
Anorexia: 52.6% 
Maestu et al. 
(2007)  
Quasi-experimental study (no 
control group)  
Setting NR 
Sample sizea:59 
Number of elderlya: 59 
Age: all ≥ 70 yrs - median age 74 yrs 
Primary diagnosis: advanced NSCLC (stage IIIb and 
IV) 
Metastasis: NR 
Terminal patients: NR 
NRb > 10% weight loss: 16.9% 
 
Paillaud et al. 
(2006)  
Cohort study 
Palliative care unit 
Sample sizea:83 
Number of elderlya: 45 
Age: group > 70 yrs - median/mean age NR 
Primary diagnosis: incurable cancer 
Metastasis: NR 
Terminal patients: survival range 4 days to 184 days 
Self-report > 10% weight loss: 71% 
 
Su et al. 
(2011)  
Cross-sectional study 
Hospital 
Sample sizea:200 
Number of elderlya: 75 
Age: group ≥ 65 yrs - mean age 74.01 yrs 
Translated ICD-10 (Chinese) Fatigue: 92% 
  
Study Study design and Setting Patient characteristics Measurement Instrument Symptom prevalence in the 
Subgroup of Palliative Elderly  
Primary diagnosis: advanced cancer, type NR 
Metastasis: NR 
Terminal patients: NR 
Teunissen et 
al. (2006)  
Cross-sectional study 
Hospital 
Sample sizea:203 
Number of elderlya: 40 
Age: group ≥ 70 yrs - median age 77 yrs 
Primary diagnosis: advanced cancer  
Metastasis: bone, lymph node, lung, liver, brain, 
viscera, other 
Terminal patients: unclear: survival of included 
patients ranged between 1 days and 759 days 
Standardized list Pain: 90% 
Excretory problems: 78% 
Anorexia: 60% 
Constipation: 55% 
Fatigue: 53% 
Anxiety: 50% 
Depressed mood: 48% 
Nausea: 43%  
Sleeplessness: 30% 
Dry mouth: 25% 
Confusion: 25% 
Dyspnea in rest: 23% 
Vomiting: 23%  
Diarrhea: 20% 
Urinary tract problems: 20% 
Drowsiness: 18% 
Sore mouth: 18% 
> 10% weight loss: 18% 
Dysphagia: 15% 
Restlessness: 10%  
Bed sores: 10% 
Delirium: 10% 
Coughing: 3% 
Trédan et al. 
(2007)  
Quasi-experimental study (no 
control group) 
Setting NR 
Sample sizea:155 
Number of elderlya: 155 
Age: all ≥ 70 yrs - median age 75.5 yrs 
Primary diagnosis: ovarian epithelial carcinoma 
(stage III and IV) 
Metastasis: NR 
Terminal patients: LE ≥ 3 months 
Evaluated as present or 
absent by investigator 
Depression: 15.5% 
  
Study Study design and Setting Patient characteristics Measurement Instrument Symptom prevalence in the 
Subgroup of Palliative Elderly  
Yoshimura et 
al. (2009)  
Quasi-experimental study (no 
control group) 
Setting NR 
Sample sizea:30 
Number of elderlya: 30 
Age: all ≥ 70 yrs - median age 75 yrs 
Primary diagnosis: NSCLC♯  (stage IIIb and IV) 
Metastasis: NR 
Terminal patients: NR 
NRb > 10 % weight loss: 16.6% 
NSCLC: non-small cell lung cancer; NR: not reported; LE: life expectancy; VAS: visual analogue scale  
a Reported as number of patients 
b Symptom(s) reported in study as baseline characteristics 
 
  
Table 2: Quality assessment of randomized controlled trial studies  
Study Random 
assignment 
Blinding of 
patient 
Blinding of 
assessor 
Allocation 
concealment 
Intention-to-
treat analysis 
Comparable 
groups at 
baseline 
Identical 
treatment 
other than 
intervention 
Outcome 
measurement 
identical 
between 
groups 
Reliable 
measurement 
of outcome 
Appropriate 
statistical 
analysis 
Biesma   - - - - + + + + - + 
Comella  - - - - + + + + - + 
Kudoh - - - - + + + + - + 
Langer   - - - - - + - - - + 
LeCaer  - - - - + + - - - + 
+ Present; - Not present 
 
Table 3: Quality assessment of quasi-experimental, comparable cohort and case-control studies 
Study Representative 
sample 
Patient at 
similar course 
in illness 
Minimized bias 
in selection of 
cases/control 
Dealt with 
confounding 
factors 
Objective 
measurement of 
outcome 
Reliable 
measurement 
of outcome 
Sufficient 
follow-up 
Withdrawals 
described and 
included in 
analysis 
Appropriate 
statistical 
analysis 
Altundag   - + + - - - + - + 
Feliu   - + NA - + + + + + 
Genz   + + + - - - NA NA + 
Li   - + - + - - + + + 
Maestu   - + NA + - - - + + 
Maestu   - + NA + - - + + + 
Paillaud  + + - - - - + + + 
Trédan  - + NA - - - + + + 
Yoshimura  - + NA - - - + + + 
+ Present; - Not present; NA: Not Applicable 
 
  
Table 4: Quality assessment of cross-sectional studies  
Study (Pseudo)-
random 
sample 
Clear inclusion 
criteria 
Dealt with 
confounding 
factors 
Objective 
measurement 
of outcome 
Reliable 
measurement of 
outcome 
If comparisons, 
sufficient 
description of 
groups 
Sufficient 
follow-up 
Withdrawals 
described and 
included in 
analysis 
Appropriate 
statistical 
analysis 
Lloyed-
Williams  
+ - - + - - NA - - 
Su  - + - - + - NA - - 
Teunissen  - - + + - + NA - + 
+ Present; - Not present; NA: Not Applicable 
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Symptom prevalence 
Thirty-two symptoms were identified across 16 studies (Table 5). Sixteen symptoms could 
be meta-analysed because they were reported in more than one study. Weight loss, pain, anorexia 
and dyspnea were the symptoms reported by at least four studies.   
The seven most prevalent symptoms, occurring in at least 50.0% of the patients, were 
fatigue, with a pooled prevalence of 77.8% (95% CI, 26.1–92.7; I², 0.0%); excretory symptoms, with an 
occurrence of 77.5%; urinary incontinence, with an occurrence of 71.0%; asthenia, with a pooled 
prevalence of 66.7% (95% CI, 45.5–82.7; I², 0.0%); pain, with a pooled prevalence of 66.3% (95% CI, 
35.8–83.9; I², 16.6%); constipation, with a pooled prevalence of 52.5 (95% CI, 44.2–60.6; I², 0.0%); and 
anxiety, with an occurrence of 50.0%. The pooled prevalences of these symptoms are displayed in 
forest plots (Figure 2). Wide confidence intervals were found for the pooled prevalence of eight 
symptoms (fatigue, asthenia, pain, anorexia, dyspnea, agitation, weight loss >10% and cough). For 
one symptom (weight loss >10%), subgroup analyses could be done based on the cancer type. 
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Table 5: Prevalence of symptoms 
Symptom Number of 
studies 
Number of 
elderly 
subjects 
Pooled 
prevalence 
(%) 
95% CI I² (%) 
Fatigue 2 109 77.8a 26.1 - 92.7 0.0a 
Excretory problems 1 40 77.5b 62.1 - 87.9 - 
Urinary incontinence 1 101 71.0b 61.7 - 79.3 - 
Asthenia 2 128 66.7a 45.5 - 82.7 0.0a 
Pain 5 355 66.3a 35.8 - 83.9 16.6a 
Constipation 2 141 52.5 44.2 - 60.6 0.0 
Anxiety 1 40 50.0b 35.0 - 65.0 - 
Depressed mood 1 40 48.0b 32.7 - 62.7 - 
Malnutrition 1 101 46.0b 36.1 - 55.3 - 
Fecal incontinence 1 101 44.0b 34.2 - 53.4 - 
Anorexia 4 269 41.5a 26.8 - 57.9 3.5a 
Nausea 2 141 33.5 26.2 – 41.8 52.1 
Dyspnea 4 305 33.3a 13.0 - 62.5 19.0a 
Weight loss > 5% 4 439 32.1 27.9 - 36.7 42.6 
Decreased appetite 1 40 30.0b 21.5 - 40.7 - 
Sleeplessness 1 40 30.0b 17.9 - 53.4 - 
Dry mouth 1 40 25.0b 14.0 - 40.5 - 
Vomiting 2 141 24.9 18.4 - 32.6 0.0 
Confusion 2 141 22.7 16.5 - 30.4 0.0 
Diarrhea 2 141 22.7 16.6 - 30.4 0.0 
Agitation 2 141 21.7a 5.1 - 59.2 0.0ǂ 
Respiratory symptoms 1 86 21.0b 62.1 - 87.9 - 
Urinary problems 1 40 20.0b 10.3 - 35.2 - 
Weight loss > 10% 
Subgroup: NSCLC 
7 
5 
652 
567 
18.9a 
13.5 
9.4 - 34.1 
10.8 - 16.7 
8.3a 
65.6 
Drowsiness 1 40 18.0b 8.6 - 32.4 - 
Sore mouth 1 40 18.0b 8.6 - 32.4 - 
Dysphagia 2 141 16.3 11.1 - 23.4 0.0 
Depression  2 198 15.7 11.2 - 21.4 0.0 
Cough 2 141 12.6b 0.7 - 75.5 0.0a 
Bed sore 1 40 10.0b 3.8 - 23.8 - 
Delirium 1 40 10.0b 3.8 - 23.8 - 
Hoarseness  1 86 3.5b 1.1 - 10.3 - 
NSCLC = non-small-cell lung cancer 
a Random effect model  
b No pooled prevalence, only one study 
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Figure 2. Forest plots of symptoms occurring in at least 50% of the patients.  
Logit transformation of the prevalence figures was applied. The final pooled logit was back transformed, 
resulting in pooled prevalence and 95% CIs.
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DISCUSSION 
The purpose of this systematic review and meta-analysis was to identify the prevalence of 
symptoms in older cancer patients receiving palliative care. A rigorous method was applied to 
maximally reduce the risk of  bias. In addition, the inter-rater reliability for screening of records was 
high between reviewers. 
Thirty-two symptoms were identified. The most prevalent symptoms were fatigue, excretory 
symptoms, urinary incontinence, asthenia, pain, constipation and anxiety and occurred in at least 50% 
of the patients. None of the studies assessed nor reported prevalences on social and spiritual 
symptoms.  
The results of the meta-analysis should be considered with caution. First, only two studies 
reported the use of valid and reliable instruments to collect symptom data. An unknown risk of 
instrument bias is likely to have occurred, and therefore, prevalence could have been estimated 
incorrectly. Many validated instruments exist to assess single symptoms in the older or cancer 
population. However, an instrument to assess multiple symptoms in older palliative cancer patients 
is lacking. Therefore, the development and validation of an instrument that assesses symptoms on 
physical, psychological, social and spiritual level in older palliative cancer patients is recommended 
(Polit & Beck, 2008).  
Second, it should be noted that the 95% confidence intervals of the prevalences are wide. 
The wide confidence interval in the individual studies could be explained by the small sample size 
(between 30 and 182 patients) and the inclusion of different cancer types in one sample (Higgins & 
Green, 2011). A pooled prevalence with a wide confidence interval is related to the number of studies 
included in the meta-analysis and the heterogeneity among the included studies (Higgins & Green, 
2011). In this review, few studies were included in the meta-analysis, and heterogeneity among studies 
was obvious. Moreover, even the size of combined samples remained rather small, ranging between 
109 and 652 patients. Therefore, it is recommended to conduct more research on the prevalence of 
symptoms in an older palliative care cancer population with an appropriate sample size. The required 
sample size to estimate a prevalence of 50%, seen as worst case scenario, with a precision of 5% and 
a confidence limit of 95%, is on average 400 participants. 
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Third, there is no clear and internationally accepted definition regarding the palliative patient 
(Van Mechelen et al., 2013). In this review, no study provided a definition of palliative care, and 
therefore, it is unclear when patients were seen as being in the palliative phase. Most of the studies 
(n=12) included patients with advanced cancer. These studies reported a median overall survival 
between 29 weeks (Maestu et al., 2007) and 25.9 months (Tredan et al., 2007). In research, patients 
with advanced cancer are often referred to as palliative patients (Higginson & Costantini, 2008; 
Minton, Strasser, Radbruch, & Stone, 2012). This is in line with the recommendation to offer palliative 
care in the early course of illness (Bruera & Hui, 2010). The remaining studies included incurable 
cancer patients (n=1) and palliative cancer patients (n=4). Consequently, the heterogeneity among 
patients in the studies included in the meta-analysis is likely.  
Fourth, the majority of the symptoms were identified in the studies of Genz et al. (2007) and 
Teunissen et al. (2006). These two studies focused on older patients referred to a specialized geriatric 
palliative care unit and a palliative care team, respectively. No study included patients not referred to 
a specialized palliative care unit or palliative care team. Therefore, results could be less representative 
to daily practice as literature has revealed that older patients are significantly less often referred to a 
palliative care unit or team (Burt & Raine, 2006). More research is needed on the prevalence of 
symptoms in older palliative cancer patients hospitalized on a general ward, in long-term care 
facilities, and not referred to a palliative care team. 
Teunissen et al. (2007) conducted a systematic review on symptom prevalence in advanced 
cancer patients of all ages. Comparison between this systematic review and the systematic review of 
Teunissen et al. (2007) is difficult because the prevalences in the review of Teunissen at al. (2007) are 
based on at least five studies compared with few studies in this review. Moreover, Teunissen et al. 
(2007) regrouped different symptoms, which complicates the comparison. Therefore, comparison 
should be interpreted with caution. Twenty of the 32 symptoms identified in this review were also 
reported in the review of Teunissen et al. (2007). Five symptoms had a higher prevalence (>5% 
difference) in older patients compared to a younger population: constipation, anxiety, depressed 
mood, confusion and diarrhea. Six symptoms had a lower prevalence (>5% difference) in older 
patients compared to a younger population: weight loss, decreased appetite, sleeplessness 
(compared with insomnia), dry mouth, cough and hoarseness. The nine remaining symptoms were 
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equally prevalent (<5% difference) in older and younger patients: fatigue, pain, nausea, dyspnoea, 
vomiting, urinary problems, drowsiness, sore mouth, and dysphagia. In both reviews fatigue, pain and 
depressed mood were among the most prevalent symptoms and a sore mouth, hoarseness and 
confusion were among the least prevalent symptoms. 
The current systematic review also indicates that older palliative cancer patients suffer from 
a variety of symptoms as the prevalence of most symptoms was high. To optimize care for palliative 
patients, international and national organizations have already published different guidelines on the 
control of multiple symptoms (Caraceni et al., 2012; Rayner et al., 2011; Vanden Eynde & Delaruelle, 
2010). However, these guidelines are often developed for a large population and are not focused on 
the older person. The care for older patients is complex as these patients are often confronted with 
multiple chronic pathologies, comorbidities and polypharmacy, disability, frailty, and psychosocial 
problems (Depp & Jeste, 2006). Therefore, when implementing these guidelines, healthcare facilities 
should take the complexity of care for older patients into account. 
  
CONCLUSION 
Thirty-two symptoms were identified in this systematic review. The most prevalent 
symptoms were fatigue, excretory symptoms, urinary incontinence, asthenia, pain, constipation and 
anxiety and occurred in at least 50% of the patients. There is a high degree of uncertainty about the 
identified prevalences due to small sample sizes, high heterogeneity between the studies and the 
extent of instruments validation. Further rigorous research is needed to be able to make more precise 
conclusions. First, valid and reliable instruments should be developed and used to assess symptom 
prevalence. Second, results should be based on larger sample sizes. 
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ABSTRACT 
Purpose To develop and validate an instrument to collect data on symptoms (frequency/intensity) in 
older palliative cancer patients. 
Methods A four-phase instrument development and validation study was performed. A preliminary 
version of the instrument was developed through a literature review. Face- and content validity were 
assessed in a Delphi-procedure with eleven experts. Cognitive interviewing with 24 older cancer 
patients was performed to enhance content validity of the instrument. Test-retest was performed to 
assess the stability. 
Results An 40-item instrument was developed. The Assessment Symptoms Palliative Elderly(ASPE) 
collects data on frequency and intensity of 24 physical, 10 psychological, 3 functional, 1 spiritual and 
2 social symptoms. Content validity was excellent (I-CVI 81.8%-100.0% and S-CVI 92.9%). Cognitive 
interviewing allowed to improve the content validity. Test-retest showed  substantial to almost perfect 
agreement for 87.5% of the items. No item had poor or fair agreement. 
Conclusion This study resulted in the development of the ASPE which reflects good properties for 
face- and content validity and reliability. Cognitive interviewing has a valuable contribution in the 
validation process. The instrument can be used to gain insight in symptoms in older palliative cancer 
patients.  
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BACKGROUND 
In approximately 60% of the older patients with cancer, the focus on ‘cure’ will eventually 
shift to palliative ‘care’ (Ferlay et al., 2010). The World Health Organization (2002) define palliative 
care as “an approach that improves the quality of life of patients and their families facing the problems 
associated with life-threatening illness, through the prevention and relief of suffering by means of 
early identification and impeccable assessment and treatment of pain and other problems, physical, 
psychosocial and spiritual.” This definition points out that symptom assessment in different domains 
and appropriate interventions to control these symptoms are essential parts of palliative care (World 
Health Organisation, 2002). 
Literature revealed that adults in a palliative stage of cancer suffer from a variety of 
symptoms and that the prevalence of some symptoms is high (Gilbertson-White, Aouizerat, Jahan, & 
Miaskowski, 2011; Teunissen et al., 2007). Moreover, as the number of symptoms and their severity 
increases, the quality of life of patients decreases (Gilbertson-White et al., 2011; Teunissen et al., 2007). 
Research demonstrated that cancer patients experience different symptoms compared to non-cancer 
patients (Krouse et al., 2007). Literature also indicates that older patients experience different 
symptoms than younger patients (Teunissen, de Haes, Voest, & de Graeff, 2006; Cataldo et al., 2013; 
Walsh, Donnelly, & Rybicki, 2000). This is mainly due to the complex interplay of symptoms related 
to the ageing process and the expression of health problems through specific symptoms such as 
incontinence, disorientation, and the presence of airway mucus (Depp & Jeste, 2006). The 
physiological changes related to the ageing process in older people make them more vulnerable for 
comorbidities, polypharmacy, psychosocial problems, and functional and cognitive decline (Depp & 
Jeste, 2006). As a result, holistic care which is not solely focused on the physical aspects of care is 
essential. Symptom assessment should be performed comprehensively and allow identification of 
symptoms on multiple domains (World Health Organisation, 2002). A valid and reliable instrument 
should be used for symptoms assessment (Strasser, 2006). The use of validated instruments in 
research is required to avoid measurement bias (Polit & Beck, 2008). 
Over the past years, many instruments have been developed to assess symptoms in 
palliative, oncologic and older populations. Nevertheless, the current instruments merely cover a 
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limited number of symptoms and domains (Katz et al., 1970; Nekolaichuk et al., 2008; Yesavage et al., 
1982). In 2014, a systematic review was performed on the prevalence of symptoms in older palliative 
cancer patients (Van Lancker et al., 2014). The authors reported that the available data were merely 
based on small sample sizes, seldom being collected using validated instruments (Van Lancker et al., 
2014). The findings indicate the need for a validated instrument to collect data on symptoms in older 
palliative cancer patient. The authors judge one comprehensive assessment which is population- and 
disease specific and includes symptoms on multiple domains as the most suitable in terms of 
feasibility (minimal burden for patients) and provision of valid and reliable results.  
 
AIM 
The aim of this study was to develop and validate (face- and content validity and test-retest 
reliability) an instrument to collect data on frequency and intensity of symptoms in the older palliative 
cancer patient. 
 
METHODS 
Design 
A five phase instrument development and validation study was performed: 
(1) Instrument development 
(2) Delphi-procedure to evaluate the face- and content validity of the instrument 
(3) Cognitive interviewing to evaluate the content validity of the instrument 
(4) Test-retest to evaluate the reliability of the instrument  
(5) Evaluation of the applicability and acceptability of the instrument  
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Procedure 
PHASE I INSTRUMENT DEVELOPMENT 
The Assessment Symptom Palliative Elderly (ASPE) instrument was developed based on a 
review of the literature on available symptom assessment instruments in the target population.  A 
literature search revealed that no validated instrument existed to assess and collect data on symptoms 
in the physical, psychological, functional, social and/or spiritual domains in older palliative cancer 
patients. Consequently, a broader systematic search was performed to identify instruments for the 
assessment of symptoms in the different domains, developed and validated in palliative and/or cancer 
patients of all ages. Following keywords were used: symptoms AND (instrument OR scale OR tool OR 
questionnaire) AND (cancer OR palliative). The literature search was performed in August 2011.  
  A matrix was developed to make an inventory of all the symptoms being reported in the 
available symptom assessment instrument.  
PHASE II DELPHI-PROCEDURE 
Face- and content validity of the initial instrument were assessed by a panel of experts. The 
experts were healthcare professionals with clinical and/or research expertise in oncology, palliative 
care, geriatric care and/or nursing. Thirteen experts were invited to participate in an anonymous 
Delphi procedure. The experts independently evaluated relevance and clarity of all items, domains, 
and the answer categories (Polit & Beck, 2008). A 4-point scale (1=not relevant; 2=somewhat relevant; 
3=quite relevant; 4=very relevant) and a dichotomous scale (1=clear; 2=not clear) were used to assess 
relevance and clarity of the wording, respectively (Polit & Beck, 2006). Experts could write comments, 
such as additional items or suggestions in re-wording. The Item-Content Validity Index (I-CVI) was 
calculated to evaluate the extent of expert agreement on relevance of the items, domains and answer 
options (Polit & Beck, 2008). Lynn (1986) recommends an I-CVI ≥ 80.0% in a panel of 10 or more 
experts. Items with an I-CVI < 80.0% were eliminated. If an item obtained an I-CVI ≥ 80% but was 
evaluated as unclear, the item was revised per experts’ comment. All modifications were presented 
to the expert panel in a second and third round. The content validity of the instrument was calculated 
after the third round by the Scale-Content Validity Index (S-CVI), which is defined as “the proportion 
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of experts who score items as relevant” (Grant & Davis, 1997). In other words, the S-CVI provides 
information on the proportion of items scored as quite to very relevant by all experts (Polit & Beck, 
2006). The S-CVI was computed by averaging the I-CVIs. Polit and Beck (2008) recommended a S-CVI 
≥ 90.0%.   
Face-validity of the instrument was enhanced through preliminary feedback on the (1) clarity 
of wording, (2) ambiguity of items, and (3) layout of the instruments. This was obtained through a 
pilot evaluation in hospitalized older patients (Polit & Beck, 2008). Feedback provided by the patients 
was discussed within the research team to allow refinement of the instrument.  
PHASE III COGNITIVE INTERVIEWING 
The third phase included cognitive interviewing, which allowed a more in-depth evaluation 
of the content validity of the instrument. Cognitive interviewing is based on the theories of cognitive 
psychology and is useful for instrument development when there is a probability of response errors 
such as interpretation, language, and recall problems (Drennan, 2003; Willis, Royston, & Bercini, 1991). 
The aim of cognitive interviewing is to obtain a more in-depth understanding of how respondents 
perceive and interpret items, and to identify problems that may arise when completing the instrument 
(Drennan, 2003; Willis, Royston, & Bercini, 1991). In our study, verbal probing was used and consisted 
of asking the participants to define the meaning of the symptoms, and based on the answer further 
probes were used (Willis et al., 1991). First, participants were asked to complete the ASPE instrument. 
Second, the researcher conducted a face-to-face semi-structured interview with the participants. The 
researcher initiated the interview by asking which symptom bothered the patient most. Verbal 
probing was used to request more in-depth information about the interpretation of the items (Willis 
et al., 1991). Questions such as what does the symptom mean to you, can you tell me about a specific 
situation, how often did you experience the symptom and with what severity, what did you feel then, 
were used. Patients were only invited to talk about the symptoms which they experienced during the 
last week. The interviews were performed by the primary researcher (mean time of 15 minutes per 
interview) and were tape recorded. 
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PHASE IV TEST-RETEST 
The fourth phase included measurement of the stability of the instrument. The instrument 
was completed twice with a 30-minute interval. Only test-retest reliability of the items measuring 
frequency of the symptoms was assessed because of ethical implications. To be able to measure the 
stability of the intensity of the symptoms a very large number of patients should be required and 
patients indicated that a second interview would be too burdensome for them.   
PHASE V APPLICABILITY AND ACCEPTABILITY OF THE INSTRUMENT 
Time to complete the instrument and need for assistance were recorded during the test-
retest. Additional information on the applicability and acceptability of the instrument was obtained 
during the cognitive interviewing and test-rest. 
Sample 
PHASE III COGNITIVE INTERVIEWING 
A purposive sample of older cancer patients including a diversity in age groups (65-74 years, 
75-84 years and ≥ 85 years), educational level, and cancer types was invited to conduct the cognitive 
interviews. Participants were eligible if they (1) were 65 years or older, (2) had a diagnose of cancer, 
(3) were able to interact with the interviewer, and (4) were able to provide written informed consent. 
There is no universal consensus regarding sample size in cognitive interviewing (Beatty & 
Willis, 2007). In this study, all items were presented to at least five participants.   
PHASE IV TEST-RETEST PROCEDURE 
A convenience sample (n=20) of older palliative cancer patients were invited to participate. 
Participants were eligible if they (1) were 65 years or older, (2) had a diagnose of cancer, (3); were a 
palliative patient, (4) were able to interact with the interviewer, and (5) were able to provide written 
informed consent. The criteria for defining the palliative patient was operationalised by a panel of 
experts (n = 7) in geriatric, oncologic and/or palliative care. The criteria were based on definitions 
provided in the literature (Desmedt et al., 2011; Pastrana et al., 2008; Van Lancker et al., 2014; Van 
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Mechelen et al., 2013; World Health Organisation, 2002). This resulted in the following criteria: “A 
patients with cancer who is no longer curable as a result of a lack of treatment options or for whom 
curative treatment is not/no longer recommended because the harm of treatment outweighs the 
benefit of treatment, a weak general condition, multipathology and/or preference of the patient to 
discontinue treatment. In contrast to healing, stabilisation of the cancer is possible.”  
Setting 
The study was performed in oncological wards and geriatric wards of a teaching hospital 
and three general hospital in Ghent, Belgium.  
Data Analysis 
PHASE III COGNITIVE INTERVIEWING 
The analysis was based on the analysis described by Knafl et al. (2007). An item-by-item 
review was used to identify the interpretations and problems regarding formulation of items. 
Interpretations, language and recall problems were transcribed verbatim and tabulated in a matrix. 
The matrix consisted of all symptoms (rows), and interpretations and problems per patient (columns). 
Interpretation of and problems with items were discussed within the research team until consensus 
was reached on the retention, deletion and revision of items by means of researcher triangulation. 
After ten interviews, a preliminary analysis was performed, which allowed us to modify the instrument. 
The modified version was re-evaluated and adjusted after an additional five interviews. Another nine 
interview were conducted to confirm the final version of the ASPE instrument. 
PHASE IV TEST-RETEST PROCEDURE 
The stability of the instrument was evaluated using the proportion of observed agreement 
(Po), weighted Cohen’s kappa coefficient and intra-class correlation (Bartko, 1991). The proportion of 
observed agreement is the ratio of exact agreement between the two measurement in function of 
the total number of assessments (Bartko, 1991). Cohen’s kappa coefficient is a measure of agreement 
corrected for chance (Landis & Koch, 1977). Weighted linear Cohen’s kappa (kw) was used because of 
the ordinal nature of the variables (Landis & Koch, 1977). The strength of agreement was interpreted 
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according to Landis and Koch (1977): 0.00-0.20: poor, 0.21-0.40: fair, 0.41-0.60: moderate, 0.61-0.80: 
substantial, 0.81-1.00: almost perfect. SPSS version 20.0 (SPSS Incorporated, Chicago, IL, USA) was 
used for data analysis. 
Ethical Approval 
Ethical approval was obtained by the ethics review committee of the teaching hospital 
(B670201213540, B670201214585 and B670201317036) for phase II and III and IV. Additional approval 
was obtained from the ethics review committee of the general hospitals for phase III and IV. The 
participants received oral and written information before deciding to participate and giving written 
informed consent. 
RESULTS 
Phase I Instrument development 
The literature review revealed seven instruments validated in a palliative and/or oncological 
population. An expert in geriatrics and palliative care proposed one additional instrument Symptom 
Assessment To Improve Symptom Control For Institutionalized Elderly (SATISFIE) developed and 
validated within a master thesis (De Roo, Uyttersprot, & Van Den Noortgate, 2009). The eight 
instruments were: the Memorial Symptom Assessment Scale (Portenoy et al., 1994), the Edmonton 
Symptom Assessment System (Bruera, Kuehn, Miller, Selmser, & Macmillan, 1991), the Rotterdam 
Symptom Checklist (de Haes, van Knippenberg, & Neijt, 1990), the European Organisation for 
Research and Treatment of Cancer Quality of Life Questionnaire Core 30 items (EORTC-QLQ-C30) 
(Aaronson et al., 1993), the Hospice Quality of Life Index (McMillan & Weitzner, 1998), the McGill 
Quality of Life (Cohen, Mount, Strobel, & Bui, 1995), the Functional Assessment of Chronic Illness 
Therapy – Spiritual well-being (Peterman, Fitchett, Brady, Hernandez, & Cella, 2002), and the SATISFY 
(De Roo et al., 2009). Table 1 provides an overview of the study population for whom the instruments 
were developed and indicated whether these instruments were validated in an older palliative cancer 
population.  
  
 
Table 1 Overview of Instruments. 
Instrument Study Population Items and Measurement Validated Further Validated in Different Population 
Older 
Patients 
Cancer 
Patients 
Palliative 
Patients 
Memorial Symptom 
Assessment Scale 
(Portenoy et al., 1994) 
In and outpatients 
with cancer 
Items 
27 physical items  
7 psychological items 
Measured 
Intensity: Likert 
Frequency: Likert 
Content validity 
Developed based on a literature review 
of symptoms in cancer patients. Changes 
were made based on content analysis of 
the instruments administered to 218 
patients  
Construct validity: 
Factor analysis: 3 factors: psychological 
symptoms, relatively prevalent physical 
symptoms, and relatively low frequent 
physical symptoms 
Internal consistency (in symptom 
groups) α≥0.45 
No Original 
population  
Yes 
Edmonton Symptom 
Assessment System 
(Bruera et al., 1991; 
Bruera & MacDonalds, 
1993) 
Cancer patients on a 
palliative care unit  
Items 
6 physical items  
3 psychological items  
Measured 
Intensity: VASa 
Construct validity 
Compared with STASb: r=0.08 (p<0.001) 
Stability 
Test-retest (one hour): r>0.8 
Yes Original 
population 
Original 
population 
Rotterdam Symptom 
Checklist (de Haes et 
al., 1990) 
Cancer patients Items 
23 physical items 
7 psychological items 
8 functional items  
overall score on well-being 
Measured 
Frequency: Likert 
Content validity 
Developed based on factor leading and 
distribution of answer resulting from 
secondary analysis of three studies, and 
opinion of oncological experts 
Construct validity 
Factor analysis: 4 factors: psychological 
distress, pain, gastro-intestinal 
symptoms, and fatigue and lack of 
energy; psychical component compared 
Yes, specific 
for non-
Hodgkin’s 
lymphoma 
Original 
population 
No 
  
 
Instrument Study Population Items and Measurement Validated Further Validated in Different Population 
Older 
Patients 
Cancer 
Patients 
Palliative 
Patients 
with MOS-20b r>0.53 (p<0.001), 
psychological component compared 
with personality characteristics: r>0.6  
Internal consistency 
α > 0.81 
EORTC-QLQ-C30 
(Aaronson et al., 1993)  
Lung cancer patients Items 
11 physical items 
5 psychological items 
7 functional items 
1 cognitive item 
2 social items 
Measured 
Frequency: Likert 
Construct validity 
In 96% of the cases convergent 
coefficient was higher than discriminant 
coefficient 
Internal consistency 
α > 0.53 
No Original 
population 
Yes 
Hospice Quality of Life 
Index (McMillan & 
Weitzner, 1998) 
Cancer patients in a 
hospice 
Items 
7 physical items 
7 psychological items 
3 functional items 
11 social/spiritual items 
Measured 
Frequency: VAS 
Content validity 
Developed based on literature review on 
quality of life. I-CVIc: 0.40 – 1.0, item with 
low I-CVI were revised 
Construct validity 
Factor analysis: 3 factors: psycho-
physiological wellbeing, functional 
wellbeing, and social/spiritual wellbeing; 
compared with ECOG PSb: r=0.26 
(p<0.001); discriminate between hospice 
patients with cancer and healthy 
persons: lambda: 0.34 (p<0.001) 
Internal consistency 
α=0.88 
No Original 
population 
Original 
population 
McGill Quality of Life 
(Cohen et al., 1995; 
Cohen et al., 1997) 
Palliative patients with 
advanced disease 
Items 
3 physical items 
4 psychological items 
Content validity 
Developed based on literature review, 
existing instruments and informal 
No No Original 
population 
  
 
Instrument Study Population Items and Measurement Validated Further Validated in Different Population 
Older 
Patients 
Cancer 
Patients 
Palliative 
Patients 
2 support items 
6 existential items 
Measured 
Frequency and intensity: VAS 
patients interview. Changes were made 
based on the preliminary findings. 
Construct validity: 
Factor analysis: 4 factors: psychological 
symptoms, existential wellbeing, support 
and psychical symptoms; compared with 
the Spitzer Index: r>0.40 (p≥0.03) 
Internal consistency 
α=0.83 
Functional 
Assessment of 
Chronic Illness 
Therapy – Spiritual 
well-being (Peterman 
et al., 2002) 
Cancer patients Items 
7 physical items 
6 emotional items 
7 functional items 
7 social/family items 
12 spiritual items 
Measured 
Intensity: Likert 
Content validity 
Developed based on Facit-G and input 
of patients and psychological and 
religious/spiritual experts.  
Construct validity 
Factor analysis: 2 factors: 
meaning/peace, and faith; compared to 
Facit-Gb:r=0.58 (p<0.001), MCSDSb: 
r=0.27 (p<0.001), POMS TMDSb:r=-0.54 
(p<0.001); compared to measures of 
religion and spirituality: r≥0.25 
(p<0.0005) 
Internal consistency 
α=0.87 
Yes Original 
population 
No 
Symptom Assessment 
To Improve Symptom 
control For 
Institutionalised 
Elderly (De Roo et al., 
2011; De Roo et al., 
2009) 
Older palliative 
patients 
Items 
6 psychical items 
4 psychological items 
Measured 
Intensity: VAS 
Content validity 
Developed based on existing 
instruments and expert opinion (decided 
on a top 10). 
Construct validity 
Factor analysis: 3 factors: which these 
were was not reported 
Original 
population 
No Original 
population 
  
 
Instrument Study Population Items and Measurement Validated Further Validated in Different Population 
Older 
Patients 
Cancer 
Patients 
Palliative 
Patients 
Stability 
Test-retest (one day): r>0.62 (p<0.001) 
Equivalence 
Intra-rater reliability: r>0.30 (p<0.05) 
a Visual Analogue Scale 
b STAS: Support Team Assessment Schedule; MOS-20: Medical Outcome Study instrument; ECOG PS: Easterm Cooperative Oncology Group Performance Status; Facit-G:  
Functional Assessment of Chronic Illness Therapy-General; MCSDS: Marlowe–Crowne Social Desirability Scale; POMS TMDS: Profile of Mood States Total Mood Disturbance Score 
c Item Content Validity Index 
 
 
 
Table 2 Process of Instrument Development and Validation. 
 Development Delphi-procedure I-CVI
a 
(range) 
S-CVIb Pilot Study 
 
Cognitive 
Interviewing 
Test-retest  Final 
Instrument Delphi Round 1 Delphi Round 2 Delphi Round 3 
Symptom 34 items 
physical 
13 items 
psychological 
7 items 
functional 
2 items  
social 
2 items 
spiritual 
29 items retained 
13 items re-
worded 
16 items 
removed 
1 item added 
8 items retained 
4 items re-
worded 
2 items removed 
1 item added 
4 items retained 
1 item removed 
 
89.8% - 
100.0% 
92.9% 5 items re-
worded 
5 items 
removed 
4 items spit 
into 8 items 
 
No changes 24 items 
physical 
10 items 
psychological 
3 items 
functional 
2 items  
social 
1 items 
spiritual 
Instrument 
 
   41 symptom 
items 
81.8% - 
100.0% 
92.4% 36 symptom 
items 
40 symptom 
items 
40 symptom 
items 
40 symptom 
items 
a Item-Content Validity Index: the extent of expert agreement on relevance of the items. 
b Scale-Content Validity Index: the proportion of experts who score items as relevant. 
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Only the reliability of the French version of the Edmonton Symptom Assessment System was tested 
in an older palliative cancer population by Pautex et al. (2003). Validity of this instrument in the target 
population was not investigated. 
The matrix was build listing all the symptoms included in the eight instruments. Duplicates 
were removed, which resulted in 58-items covering five domains: (1) physical, (2) psychological, (3), 
functional, (4) social, and (5) existential domain. 
Phase II Delphi procedure 
Eleven experts (85%) agreed to participate in the Delphi-procedure. The process of retention, 
re-wording, removal and addition of items throughout the three Delphi rounds are presented in Table 
2. Based on expert’s comments, changes were made to the answer categories. The symptom weight 
loss received a separate dichotomized answer option of ‘yes or ‘no’. The preliminary instrument 
included 41-items. The I-CVI ranged between 81.8 and 100.0% and the S-CVI was 92.9%.  
Preliminary feedback was obtained from 10 hospitalized older patients. Based on their 
feedback changes were made to the instrument.   
Phase III Cognitive interviewing 
A total of 28 participants were asked to participate; four of them refused to participate. Ten 
men and 14 women participated. Age ranged between 65 and 95 years, with a mean age of 76 years 
(SD=7.0). Demographic details are provided in Table 3.  
In total, thirty items were retained without modifications. Changes made to the remaining 
items are outlined in Table 4. The most important findings were: (1) difficulties with the recall period, 
(2) differences in interpretation of items, and (3) difficulties in deciding an answer category in the 
Likert scales.  
Sometimes patients experienced difficulties with the recall period of one week. However, 
when they were given time to think about last week the recall period of one week seemed acceptable 
for patients. The time to think allowed them to resort to events that happened the past week.
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Table 3 Demographic Characteristics of Participants Included in Cognitive Interviewing (N=24) and 
Test-retest (N=20). 
 Cognitive Interviewing Test-retest 
 Mean (SD) N (%) Mean (SD) N (%) 
Age (years) 
65 – 74 
75 – 84 
≥ 85 
Gender 
Male  
Female 
Type of cancer 
Prostate cancer 
Breast cancer 
Renal cancer 
Ovarian cancer 
Other type of cancer 
Metastasis 
Yes 
No 
Palliative 
Yes 
No 
Cognitive levela,b 
Normal 
Deficit 
76 (7.0)  
13 (54.2) 
9 (37.5) 
2 (8.3) 
 
10 (41.7) 
14 (58.3) 
 
7 (29.2) 
5 (20.8) 
4 (16.7) 
3 (12.5) 
5 (20.8) 
 
15 (62.5) 
9 (37.5) 
 
10 (41.7) 
14 (58.3) 
 
15 (65.2) 
8 (34.8) 
74 (5.1)  
9 (45.0) 
11 (55.0) 
0 (0.0) 
 
11 (55.0) 
9 (45.0) 
 
3 (15.0) 
2 (10.0) 
0 (0.0) 
2 (10.0) 
13.0 (65.0) 
 
16 (80.0) 
4 (20.0) 
 
20 (100.0) 
0 (0.0) 
 
5 (25.0) 
15 (75.0) 
a One missing 
b Clock drawing test (Shulman, et al. 1993): A score of ≥ 2 represents a cognitive deficit, while a score of 0 or 1 is considered 
to be normal. 
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These events were used as point of reference to recall the presence of symptoms. For example one 
patients said:  
“Yes, I experienced physiological pain last week because on Friday I normally 
had to visit my mentally disabled daughter, but I was too tired to do so. It’s the 
only thing that gives me a lot of pain (started to cry)…” (female, age 77) 
Following the analysis of the first round, it was apparent that in the items, fatigue, pain and 
loss of energy, patients talked about a physical and/or a psychological dimension. For example, for 
fatigue one patient stated: “I can sleep while I stand.” (female, age 74). While another patient stated: 
“I don’t have the courage any more, knowing I will not heal makes me tired and devastated.” (female, 
age 82)  Consequently, the three items were split up into six items.  
Ten items were interpreted differently by the patients than being originally meant (Table 4). 
For change in taste of food, one patient stated:  
“Yes, my taste of food has changed. When you eat at home, it tastes differently 
from here (hospital). They cook differently.” (male, age 75)  
Originally, the symptoms needed to capture the change in taste of food due to the cancer or 
cancer-related treatment. Therefore, additional information was provided between brackets.  
Some participants experienced difficulties to decide in which category of frequency 
(1=never; 2=rarely; 3=sometimes; 4=often; 5=always) and intensity (1=not; 2=somewhat; 
3=moderate; 4=very serious) their answer could fit in. However, when patients were given the 
possibility to talk about the experience of these symptoms, it helped them to determine the frequency 
and intensity category. The final instrument is presented in Figure 1.   
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Table 4 Changes Made to the Items Through the Different Rounds. 
Items  Changes Made 
First round  
Fatigue  
 
Pain 
 
Loss of energy   
 
Changes in taste of food 
Loneliness 
To perform activities of daily living 
Physical fatigue 
Psychological fatigue 
Physical pain 
Psychological pain 
Loss of energy (physical) 
Loss of strength of will 
Changes in taste of food (due to illness) 
Loneliness (feeling; different from physically being alone) 
To move (inside house or inside room  hospital) 
To move (outside house or outside room hospital) 
Second round  
Physical fatigue 
 
Psychological fatigue 
 
Physical pain 
Psychological pain 
Loss of energy (physical) 
Loss of strength of will 
 
To move without aid of another person (inside 
house or inside room  hospital) 
To move (outside house or outside room 
hospital) 
Physical fatigue (being physically tired; having difficulties 
with physical efforts) 
Psychological fatigue (being mentally tired; being 
drained; being tired of ‘it’) 
Physical pain (pain at a body part or organ) 
Psychological pain (mentally suffering) 
Loss of energy (having physically no energy to do 
something) 
Loss of strength of will (not wanting anymore; wanting 
but not able to do something) 
To move without aid of another person (inside house or 
inside room  hospital) 
To move without aid of another person (outside house or 
outside room hospital) 
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Phase IV Test-retest procedure 
A total of 20 participants participated. Eleven men and nine women participated. Age ranged 
between 65 and 84 years, with a mean age of 74 years (SD=5.1). Demographic details are provided 
in Table 3. 
Observed agreement and weighted kappa of all items are presented in Table 5. The majority 
of the items showed substantial (27.5%) to almost perfect agreement (60.0%). Only five items showed 
moderate agreement. For seven items the lower boundary of the 95% confidence was <0.41. The 
mean observed agreement 0.87 and 85% of the items had an observed agreement >0.80. One item, 
loss of energy, had a poor observed agreement (Po=0.50). 
Phase V Applicability and acceptability of the instrument 
The average time to complete the ASPE was 21.75 minutes (SD=8.04). The instrument was 
administered to all patients by the means of a structured interview with the patient due to the weak 
condition of the patient, problems with writing, and vision problems. Generally, the patients expressed 
a preference for an interview instead of self-completing the instrument. 
In addition, the results of the cognitive interviewing indicated that healthcare professionals 
should allow to patients to recall events and prompt patients to talk about their burden in order to 
determine the frequency and intensity of symptoms.  
Also, during the cognitive interviewing and test-retest it became obvious that completing 
the instrument by a structured interview allowed patients to speak about their experience and burden. 
Some patients even expressed feeling of relief and gratitude to be able to talk about it.
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Table 5 Test-retest Reliability 
 
Observed 
Agreement 
(Po) 
Weighted 
Kappa (Kw) 
95% CI 
Lack of appetite 0.90 0.76 0.46 1.00 
Physical fatigue 0.65 0.79 0.64 0.93 
Psychological fatigue 0.80 0.69 0.40 0.99 
Brooding  0.70 0.69 0.45 0.94 
Physical pain 0.80 0.78 0.56 1.00 
Psychological pain 0.90 0.91 0.78 1.00 
Depressed mood 0.70 0.64 0.33 0.94 
Loss of strength 0.80 0.58 0.23 0.93 
Lack of energy 0.50 0.53 0.25 0.80 
Nervousness 0.75 0.69 0.41 0.97 
Nausea 0.80 0.79 0.62 0.96 
Sleeplessness 0.70 0.80 0.65 0.94 
Vomiting 0.90 0.83 0.61 1.00 
Dizziness 1.00 1.00 1.00 1.00 
Tension 0.80 0.60 0.22 0.99 
Heartburn/belching 0.80 0.53 0.15 0.91 
Tingling hands or feet 1.00 1.00 1.00 1.00 
Difficulties concentrating 0.95 0.94 0.82 1.00 
Sore mouth/pain when swallowing 0.90 0.92 0.82 1.00 
Shortness of breath 0.85 0.84 0.66 1.00 
Dry mouth 0.85 0.81 0.59 1.00 
Cough 0.90 0.93 0.84 1.00 
Urinary incontinence 0.85 0.77 0.50 1.00 
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Observed 
Agreement 
(Po) 
Weighted 
Kappa (Kw) 
95% CI 
Faecal incontinence 0.90 0.53 0.11 0.95 
Itching 0.90 0.84 0.67 1.00 
Changes in food tasting 0.95 0.96 0.87 1.00 
Airway mucus 0.85 0.96 0.87 1.00 
Confusion 1.00 1.00 1.00 1.00 
Anger 0.95 0.96 0.87 1.00 
Loneliness 0.90 0.84 0.61 1.00 
Anxiety 0.80 0.71 0.41 1.00 
Constipation 0.95 0.96 0.90 1.00 
Diarrhoea 0.95 0.95 0.85 1.00 
Difficulties with self-care 0.95 0.95 0.85 1.00 
Difficulties moving inside  0.95 0.97 0.92 1.00 
Difficulties moving outside 0.95 0.97 0.92 1.00 
Experience life as not meaningful 1.00 1.00 1.00 1.00 
Not feeling supported  1.00 1.00 1.00 1.00 
Not satisfied with social life 1.00 1.00 1.00 1.00 
Weight loss 0.95 0.88 0.64 1.00 
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DISCUSSION 
The aim of this study was to develop an instrument to assess the frequency and intensity of 
symptoms in older palliative cancer patients. The ASPE instrument was specifically designed to collect 
data on a broad range of symptoms, more specially on a physical, psychological, functional, social 
and spiritual domain. This instrument differs from previously developed instrument because (1) the 
list of symptoms and domains which can be assessed is more extensive, (2) symptoms are grouped 
in one instrument and measured consistently and (2) the instrument is population- and disease 
specific.  
The face- and content validity were established through a rigorous process of a literature 
review, a three round Delphi-procedure, and additional cognitive interviewing for the ASPE 
instrument. Stability of the instrument was determined by test-retest reliability. Applicability and 
acceptability of the instrument was evaluated. 
The Delphi-procedure is a widely used and recognised method despite the fact that its 
validity has been criticised (Landeta, 2006). The selection of experts and anonymity are important 
aspects to validity (Keeney, Hasson, & McKenna, 2001). In this study, a purposive sample of experts 
in Flanders was contacted to ensure diversity in profession and domains of expertise. The response 
rate was high (85%) and all experts participated in the three Delphi rounds, which promoted the 
trustworthiness of the obtained results (Polit & Beck, 2008). True anonymity was not possible. 
However, individual experts responses were provided independently of other experts. Consequently, 
answers were provided without feeling pressured by potentially more influential participants (Couper, 
1984). An I-CVI of 81.8% and a S-CVI of 92.9% indicate an excellent content validity of the instrument.  
The ASPE instrument was further validated through cognitive interviews. The use of cognitive 
interviewing in the development and validation of instruments has increased over the last years 
(Drennan, 2003; Beatty & Willis, 2007). Cognitive interviews have proved to be beneficial in refining 
instruments (Murtagh, Addington-Hall, & Higginson, 2007; Lasch et al., 2012). Murtagh et al. (2007) 
pointed out that specific issues arise through the cognitive interviews, which had not been identified 
by ‘standard validation procedures’. This concurred with findings in the current study. For example, 
based on the interviews with patients it was clear that three symptoms had a physical and a 
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psychological dimension. The difference in dimension had not been identified through standard 
validation procedures and was probably related to the patients input. Patient input was particularly 
valuable because a patient could interpret the item of pain as psychological suffering. In contrast, the 
healthcare team could interpret it as physical pain and would give the patient some analgesics. 
However, analgesics will not be effective for mental suffering. In addition, the cognitive interviewing 
revealed important information about the applicability and acceptability of the instrument. It seems 
important that when assessing symptoms in older palliative cancer patients, healthcare professionals 
may be required to pay attention to the need for patient to receive time to recall events and to be 
prompt to talk about their burden in order to correctly evaluate the frequency and intensity of 
symptoms.  
The test-retest reliability demonstrated satisfactory stability of the instrument, which 
indicates that the report of symptoms is not influenced by external factors (Polit & Beck, 2008). 
However, caution is needed as only the stability of the frequency part was evaluated because 
subjecting the target population twice to the instrument was experienced as burdensome.  
The ASPE instrument is a self-report instrument, which allows to assess symptoms as 
perceived by the patients. In contrast, there is a high probability that participants will give socially 
desirable answers, which can be due to multiple reasons such as not wanting to be a burden to others 
or being ashamed of experiencing certain symptoms (Polit & Beck, 2008). In addition, recall bias 
cannot be ruled out. Patients were asked about the frequency and intensity of the symptoms which 
they experienced during the last week. Despite the fact that symptoms change over time, this short 
time frame was chosen because it was assumed that patients would be able to recall better what they 
experienced for the last week instead of a longer period. A limitation of the ASPE instrument is that 
it is not usable in older patients with a severe cognitive deficit. The competing of the ASPE relies on 
the self-report of patients and its accuracy is questionable in patients with severe cognitive 
impairment (Davies, Male, Reimer, & Turner, 2004). 
The instrument was designed to collect data on the frequency and intensity of symptoms in 
older palliative cancer patients. Using this instrument in research can provide insight in frequency and 
intensity of symptoms in older palliative cancer patients and can improve comparability between 
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studies. The ASPE instrument could also be used by healthcare professionals to gain insight in 
symptoms that patients experience. This may help them to optimize and evaluate symptom 
management in patients. The assessment of both frequency and intensity of symptoms could allow 
healthcare professionals to prioritize the management of symptoms reported as highly prevalent and 
with severe intensity. The use of the ASPE instrument during the test-retest revealed that the time 
needed to fill in the instrument was approximately 21 minutes. Moreover, patients expressed a 
preference of data collection by the means of a structured interview. This could be seen as a barrier 
to implement the instrument in daily practice (Kaasa et al., 2008). Despite this fact, results indicate 
that prompting patients to talk about symptoms may be essential to determine the frequency and 
intensity of symptoms. Also, patient expressed relief and gratitude to be able to talk about their 
experience and burden when completing the instrument. This is possibly related to the openness of 
the researcher and the absence of time constraints. Nevertheless, the instrument could be used as a 
narrative intervention to reduce burden, in which patients are allowed to tell their story (Green, 2006). 
This narrative intervention could be performed during the daily nursing activities.  
 
CONCLUSION 
The instrument was developed through a rigorous process including a literature review, 
Delphi-procedure, cognitive interviewing and test-retest. These steps led to a well-designed, content 
validated and reliable instrument. Cognitive interviewing had a valuable contribution to conceptual 
clarification. The instrument is an 40-items instrument consists of 24 physical, 10 psychological, and 
3 functional symptoms, and 2 items in the social and 1 item in the spiritual domain. Both frequency 
and intensity are measured. The instrument can be used to collect data on frequency and intensity of 
symptoms in older palliative cancer patients.
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Figure 1 The Final Instrument. 
The instrument was translated to English for publication, only the Dutch version was validated. Also, the lay-out 
of the instrument was adapted for publication purpose.   
THE ASPE INSTRUMENT 
In this document 40 symptoms are presented. We would like to ask you what you felt last 
week. 
 Last week, did you experience ….? How bothersome was this for you? 
 Never Rarely Some-
times 
Often   Always Not Some-
what 
Moder-
ate 
Very  N/Aa 
Lack of appetite           
Physical fatigue 
(feeling physically 
tired; having 
difficulties with 
physical efforts) 
          
Psychological fatigue 
(being mentally 
exhausted; being 
drained) 
          
Brooding           
Physical pain (pain in 
the part of a body or 
organ) 
          
Psychological pain 
(mentally suffering) 
          
Depressed mood           
Lack of energy 
(having physically no 
energy to do 
something) 
          
Loss of strength (not 
willing anymore; 
willing but not able 
to do something) 
          
Nervousness           
Nausea           
Sleeplessness           
Vomiting           
Dizziness           
Tension           
Heartburn/belching           
Tingling hands or 
feet 
          
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Difficulties with 
concentrating 
          
 Last week, did you experience ….? How bothersome was this for you? 
 Never Rarely Some-
times 
Often   Always Not Some-
what 
Moder-
ate 
Very  N/Aa 
Sore mouth/pain 
when swallowing 
          
Shortness of breath 
(difficulties when 
breathing) 
          
Dry mouth           
Cough           
Urinary incontinence           
Faecal incontinence           
Itching           
Changes in food 
tasting (due to 
illness) 
          
Airway mucus           
Confusion           
Anger           
Loneliness (feeling; 
different from being 
psychically alone) 
          
Anxiety           
Constipation           
Diarrhoea           
 a Not Applicable 
 
 Last week, did you have difficulties to …?  How bothersome was this for you? 
 Never Rarely Some-
times 
Often   Always Not Some-
what 
Moder-
ate 
Very  N/Aa 
Take care of oneself 
(e.g. bathing) 
          
Move without 
support of another 
person (inside house 
or inside room  
hospital) 
          
Move without 
support of another 
person (outside 
house or outside 
room of hospital) 
          
a Not Applicable 
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 Last week, did you ….? How strongly did you experience this? 
 Never Rarely Some-
times 
Often   Always Not Some-
what 
Moder-
ate 
Very  N/Aa 
Experience your life 
as being meaningful 
          
Felt supported by 
family and/or friends 
          
Felt satisfied with 
your social life           
a Not Applicable 
 
 Last six months, did you …? 
 Yes No 
Lost weight (> 10%)     
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ABSTRACT 
Aim To increase the knowledge of the frequency and intensity of symptoms and treatment 
interventions in older palliative cancer patients. 
Background Research on symptoms and treatment modalities in older palliative cancer patients is 
scarce. Insight in these aspects is needed to enable healthcare professionals to alleviate the burden. 
Design A cross-sectional study. 
Methods Four hundred hospitalized older palliative cancer patients participated in the study between 
March 2013 and February 2015. A two-part instrument was used to assess 40 symptoms in multiple 
domains and collect data on treatment modalities in older palliative cancer patients. 
Results Patients reported an average of 13.85 (SD 5.78) symptoms. Dry mouth (77.0%), physical 
fatigue (69.3%), lack of energy (65.8%), lack of appetite (58.0%), and difficulty  moving outside (55.8%) 
were the most prevalent. Psychological pain (92.4%), psychological fatigue (90.1%), lack of willpower 
(89.4%), lack of energy (87.3%), physical fatigue (85.1%) were reported as intensive. On average, 5.15 
(SD 1.7) disciplines were consulted per patient. Few patients were referred to a palliative support 
team, spiritual consultant, or psychologist. Patients received a variety of interventions to increase life 
expectancy and alleviate symptoms and side effects of treatment. The occurrence of symptoms was 
associated with different clinical and treatment variables such as having a geriatric risk profile.  
Conclusions Older patients receiving palliative cancer care are confronted with multiple symptoms. 
Psychological symptoms are more often reported as intensive. Greater attention should be given to 
the early referral of patients to palliative care teams, assessment and management of multiple 
symptoms, particularly psychological symptoms. 
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INTRODUCTION 
Palliative care is an essential part of cancer care (World Health Organisation, 2002). Cancer 
that is advanced or untreated is characterized by progression and deterioration in function over time, 
which results in higher risk of symptom burden (Peppercorn et al., 2011). The cancer in itself can have 
physical and functional burden, but the disease will also have an impact on the psychological, social 
and existential well-being of the patient (World Health Organisation, 2002). Therefore, symptom 
assessment is essential in palliative care, especially in older patients who are often confronted with a 
complex interplay of multiple problems and symptoms in different domains (Depp & Jeste, 2006). In 
addition, the literature suggests that older patients do not always get cancer treatment for a variety 
of reasons such as changes in physiology related to the aging process, comorbidities and the 
reluctance of healthcare professionals to treat cancer in these patients (Krzyzanowska et al., 2009; 
Townsley et al., 2005). Consequently, this leads to a higher risk of advance stage of cancer in older 
people.  
Research on the frequency and intensity of symptoms in older patients receiving palliative 
cancer care is scarce. Available studies are small and focus primarily on the prevalence of physical and 
a few psychological symptoms (Van Lancker et al., 2014). Having greater insight into the frequency 
and intensity of symptoms enables healthcare professionals to alleviate the burden and therefore the 
negative impact of symptoms on well-being.  
Symptom control is an essential part of palliative care. Multiple international and national 
guidelines have been published to treat symptoms in palliative care patients are available (Larkin et 
al., 2008; Radbruch et al., 2008) Despite the availability of guidelines, Laugsand et al. (2009) concluded 
that 30% to 50% of the patients experiencing moderate to severe symptoms did not receive any 
treatment to improve comfort.  
Although there is some information available in the field of symptoms prevalence, 
assessment and treatment, the information is gathered in a heterogeneous population other than the 
older palliative cancer patient. Moreover there is little transformation of the limited  available 
evidence into clinical practice.  
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AIM 
The aim of this study was to increase the knowledge of: (1) the frequency and intensity of 
symptoms; (2) treatment interventions in older patients receiving palliative cancer care; and (3) the 
association between symptoms and demographic-, clinical- and treatment variables.  
METHOD 
Design and Setting 
A multi-centre cross-sectional study in a convenience sample of acute care hospitals (n = 7) 
in Flanders, Belgium was performed. Hospitals were chosen based on proximity. Geriatric and internal 
wards of one teaching hospital and six general hospitals participated in the study.   
Sample 
A convenience sample of older patients receiving palliative cancer care were invited to 
participate. Participants were eligible if they: (1) were 65 years of age or older; (2) had a current 
diagnosis of cancer; (3) were a palliative patient;  (4) were able to interact with the interviewer; and 
(5) provided informed consent. Patients in a terminal phase were excluded. A panel of experts (n = 7) 
with clinical expertise in oncology, palliative care and/or geriatric care were consulted to find a 
consensus about how to define the criteria for a palliative patient and the terminal phase of cancer. 
The criteria were based on definitions provided in the literature (Desmedt et al., 2011; Pastrana et al., 
2008; Van Lancker et al., 2014; Van Mechelen et al., 2013; World Health Organisation, 2002). This 
resulted in the following: “A patients with cancer who is no longer curable as a result of a lack of 
treatment options or for whom curative treatment is not/no longer recommended because the harm 
of treatment outweighs the benefit of treatment, a weak general condition, multipathology and/or 
preference of the patient to discontinue treatment. In contrast to healing, stabilisation of the cancer 
is possible.” The terminal phase was defined as: “The last phase of life characterised by global organ 
failure which is clinically apparent by physical (e.g. respiratory) and mental (e.g. agitation) changes.” 
An a priori sample size calculation was conducted. A prevalence of 50%, of the studied 
population having a symptom, is considered as worst-case scenario in sample size estimation at least 
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if the prevalence of the symptom (e.g. pain, anxiety) is unknown or if at least one symptom has a 
prevalence of 50% (Fleiss, Levin, & Paik, 2013). A sample size of 400 patients was calculated for a two-
sided 95% confidence interval with a width equal to 0.10 (Fleiss et al., 2013).  
Instrument 
A validated two-part 82-item instrument was used for data collection: (1) the Assessment 
Symptoms Palliative Elderly (ASPE), and (2) the Symptom Intervention Palliative Elderly (SIPE) ((Van 
Lancker, Beeckman, et al., 2016a). The ASPE was used to collect data on the frequency and intensity 
of 24 physical, 10 psychological, 3 functional symptoms, plus 2 items in the social and 1 item in the 
spiritual domain. All items, except the item “weight loss,” were rated on (1) a 5-point Likert scale to 
assess frequency (1 = never to 5 = always) and (2) a 4-point Likert scale to assess intensity (1 = not 
to 4 = very serious). A dichotomised answer category (yes or no) was used for weight loss. The SIPE 
was used to collect data on the presence or absence of medical and paramedical interventions. 
Interventions were focused on prolonging the life of the patient and on alleviating symptoms and 
side effects of treatments as a result of cancer or other comorbidities. In addition, a complete list of 
the prescribed medications was collected. 
The two-part instrument was developed by reviewing the international literature and face- 
and content validity were obtained through a three-round Delphi-procedure with a panel of experts 
(Van Lancker, Beeckman, et al., 2016a). The ASPE instrument was further validated using cognitive 
interviewing with older cancer patients. The test-retest reliability of the ASPE showed a mean 
observed agreement of 0.85, and a weighted kappa > 0.60 for 87.5% of the items and a weighted 
kappa between 0.52 and 0.60 for the remaining five items (Van Lancker, Beeckman, et al., 2016a). The 
SIPE was not further validated because it was developed for the purpose of this study and all 
information was collected by the same researcher.    
Demographic and clinical variables were collected using a standardized form and included: 
age, gender, living status, and living arrangements. Clinical variables were: cognitive screening 
assessed by the Clock Drawing Test (CDT) (Shulman, Gold, Cohen, & Zucchero, 1993), expected 
prognosis, cancer type, presence or absence of metastasis, presence or absence of co-morbidities, 
Flemish Triage Risk Screening Tool (fTRST) (Deschodt et al., 2011), and G8 (Bellera et al., 2012). The 
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CDT is a quick cognitive screening tool in which the participant is scored from 0 to 5 based on his/her 
ability to draw a clock and set the hands at ten past ten. A score of ≥ 2 represents a possible cognitive 
deficit (Shulman et al., 1993). The fRTRST and G8 are two screening tools used in clinical practice to 
identify older patients with a geriatric risk profile. The fTRST is a multidimensional screening tools 
containing five items (0 = absent, 1 = present) (Deschodt et al., 2011). The final sum score ranges 
from 0 to 5 in which a score of > 2 indicates having a geriatric risk profile (Deschodt et al., 2011). The 
G8 is a screening tool containing eight items (Bellera et al., 2012). The total sum score ranges from 0 
to 17 in which a score of ≤ 14 indicates having a geriatric risk profile (Bellera et al., 2012). 
Data Collection 
Patients hospitalized between March 2013 and February 2015 who met study criteria were 
asked to participate. The ASPE was completed  during a structured interview with the researcher. 
Instructions and guidance provided by the interviewer were reduced to a minimum and were 
standardized to improve validity of the results. The SIPE was completed based on the medical and 
paramedical record of the patient. In case of incomplete, absent or dubious information, additional 
information was  obtained from the attending medical doctor or nurse. 
Ethical Approval 
Ethical approval was obtained from the ethics review committee of the teaching hospital and 
general hospitals (B670201317036). The participants received oral and written information before 
deciding to participate and giving written informed consent. 
DATA ANALYSIS 
Descriptive data are presented in frequencies for categorical variables, and means with 
standard deviation for ordinal variables with at least five response options and continuous variables. 
Median values were used because of the non-normal distribution of the data. The answer options of 
the frequency of symptoms were recoded to allow prevalence calculation of the symptoms. The 
answers categories “never” and “rarely” were recoded to 0, and “sometimes,” “often” and “always” 
were recoded to 1.  
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The association between the outcome variables (symptoms) and the explanatory variables 
were tested at univariate level using binary logistic regression analysis. The choice of which symptom 
to include as outcome variable was based on the prevalence and intensity of the symptoms. This 
resulted in the selection of: lack of energy, physical fatigue, physical pain, sum of psychological 
symptoms, and functional dependence. Lack of energy, physical fatigue, and physical pain were 
selected because they are the three most prevalent and bothersome physical symptoms. An 
agglomerative hierarchical cluster analysis revealed that all psychological symptoms, except for anger 
and lack of willpower, were clustered (Van Lancker, Beeckman, Verhaeghe, Van Den Noortgate, & Van 
Hecke, 2016), which indicates a connection between the psychological symptoms (Beckstead, 2002). 
The internal consistency of these items was analysed using a Cronbach’s alpha of 0.76. A Cronbach’s 
alpha of > 0.70 is acceptable and means that the items measure the same construct (Bland & Altman, 
1997). Functional dependence was defined as requiring help for at least one of the following activities: 
self-care, moving inside, and moving outside. The explanatory variables were patient demographics 
(e.g. age), clinical variables (e.g. cancer type), team variables (e.g. presence of dietician), and therapy 
variables (e.g. receiving chemotherapy). Simultaneous multivariate logistic regression analyses were 
conducted subsequently to the univariate analysis. All clinically relevant variables with a p <. 10 at 
univariate level were entered in the model at the same time (Wampold & Freund, 1987). Different 
models for each outcome variable were built. The results of the multivariate regression models are 
presented by odds ratios (OR) with its 95% confidence intervals (CI). Prior to the inclusion in the 
model, multicollinearity was tested between the explanatory variables using the Fischer exact test. A 
correlation was observed between the fTRST and G8 (p=0.012) and therefore these variables were 
entered separately in the model. A p-value of < .05 was considered statistically significant. Data were 
analysed using SPSS, version 22 (SPSS, Inc., Chicago, IL, USA). 
 
RESULTS 
Demographics 
A total of 449 patients were asked to participate, with 49 refusals, resulting in a final sample 
of 400 older patients receiving palliative cancer care. Just over half the participants were men (52.3%). 
CHAPTER IV 
 
90 
 
The mean age was 75.7 years (SD 6.8) and ranged from 65 to 93. A geriatric risk profile was detected 
for 72.5% of the patients according to the fTRST, and 95.5% according to the G8. Approximately half 
of the patients (52.2%) were at risk of cognitive impairment. Demographic and clinical details are 
provided in Table 1. 
Symptoms  
On average, patients reported 13.85 symptoms (SD 5.78; range 1-31) of which dry mouth 
(77.0%), physical fatigue (69.3%), lack of energy (65.8%), lack of appetite (58.0%), difficulties with 
moving outside (55.8%), shortness of breath (53.3%), difficulties with self-care (52.0%), brooding 
(51.8%), physical pain (49.3%), and psychological fatigue (46.0%) were the most prevalent  (Table 2). 
Almost 30% of the patients reported experiencing life as not meaningful and were not satisfied with 
their social life.  
The following symptoms were moderate to severe in more than 80% of the patients 
reporting the symptom: psychological pain (92.4%), psychological fatigue (90.1%), lack of willpower 
(89.4%), lack of energy (87.3%), physical fatigue (85.1%), physical pain (83.5%), depressed mood 
(81.3%), and 
brooding (80.5%). 
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Table 1. Demographic  and Clinical Characteristics of  Patients (N = 400) 
 Mean (SD) N (%) 
Demographic variables 
Age (years) 
Gender 
Male 
Female 
Marital status 
Married 
Widow/widower 
Unmarried 
Divorced 
Living arrangements 
Alone 
Living with partner 
Living with others 
Clinical variables 
Cancer type 
Lung cancer 
Gynaecological cancer 
Gastro-intestinal cancer 
Breast cancer 
Prostate cancer 
Other type of cancer 
Metastasis 
Yes 
No 
Expected prognosis 
Months 
Years 
Number of co-morbidities 
Clock drawing testa 
Normal 
Risk of cognitive deficit 
fTRSTb 
Normal 
Geriatric risk profile 
G8 
Normal 
Geriatric risk profile 
 
75.7 (6.8) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.0 (1.6) 
 
 
 
209 (52.2) 
191 (47.8) 
 
236 (59.0) 
111 (27.8) 
22 (5.5) 
31 (7.7) 
 
125 (31.3) 
229 (57.3) 
46 (11.4) 
 
 
95 (23.7) 
48 12.0) 
42 (10.5) 
41 (10.3) 
36 (9.0) 
138 (34.5) 
 
300 (75.0) 
100 (25.0) 
 
304 (77.4) 
89 (22.6) 
 
 
191 (47.8) 
209 (52.2) 
 
110 (27.5) 
290 (72.5) 
 
18 (4.5) 
382 (95.5) 
a Clock Drawing Test (CDT) (Shulman et al. 1993). Seven missing values, these missing values were considered to 
be missing ad random 
b fTRST: Flemish Triage Risk Screening Tool.  
 
  
 
Table 2. Frequency and Intensity of Symptoms 
 Symptom 
Prevalence 
Symptom Frequency Symptom Intensitya 
Symptom  
 
N (%) 
Never 
 
N (%) 
Rarely 
 
N (%) 
Sometimes 
 
N (%) 
Often 
 
N (%) 
Always 
 
N (%) 
Mean (SD) Not 
 
N (%) 
Somewhat 
 
N (%) 
Moderate 
 
N (%) 
Very 
serious 
N (%) 
Physical            
Dry mouth 308 (77.0) 85 (21.3) 7 (1.8) 104 (26.0) 101 (25.3) 103 (25.8) 3.3 (1.4) 79 (25.1) 41 (13.0) 80 (25.4) 115 (36.5) 
Physical fatigue 277 (69.3) 119 (29.8) 4 (1.0) 56 (14.0) 71 (17.8) 150 (37.5) 3.3 (1.7) 29 (10.3) 12 (4.3) 64 (22.7) 177 (62.8) 
Lack of energy 263 (65.8) 134 (33.5) 3 (0.8) 38 (9.5) 78 (19.5) 147 (36.8) 3.3 (1.7) 18 (6.7) 13 (4.9) 55 (20.6) 181 (67.8) 
Lack of appetite 232 (58.0) 157 (39.3) 11 (2.8) 51 (12.8) 58 (14.5) 123 (30.8) 3.0 (1.7) 58 (23.8) 19 (7.8) 52 (21.3) 115 (47.1) 
Shortness of breath 213 (53.3) 176 (44.0) 11 (2.8) 98 (24.5) 62 (15.5) 53 (13.3) 2.5 (1.5) 27 (12.1) 24 (10.7) 65 (29.0) 108 (48.2) 
Physical pain 197 (49.3) 188 (47.0) 15 (3.8) 54 (13.5) 53 (15.8) 80 (20.0) 2.6 (1.6) 4 (1.9) 22 (10.4) 56 (26.4) 130 (61.3) 
Weight lossb 165 (41.3) - - - - - - - - - - 
Sleeplessness 163 (40.8) 210 (52.5) 27 (6.8) 55 (13.8) 57 (14.3) 51 (12.8) 2.3 (1.5) 25 (6.3) 24 (6.0) 38 (9.5) 103 (25.8) 
Constipation 151 (37.8) 239 (59.8) 10 (2.5) 70 (17.5) 50 (12.8) 30 (7.5) 2.1 (1.4) 29 (24.5) 10 (6.9) 41 (15.7) 81 (52.9) 
Cough 148 (37.0) 207 (51.8) 45 (11.3) 82 (20.5) 54 (13.5) 12 (3.0) 2.1 (1.2) 58 (30.1) 21 (10.9) 43 (22.3) 71 (36.8) 
Difficult concentrating 146 (36.5) 250(62.5) 4 (1.0) 59 (14.8) 44 (11.0) 43 (10.8) 2.1 (1.5) 22 (5.5) 17 (4.3) 36 (9.0) 75 (18.8) 
Changes in food tasting 140 (35.0) 257 (64.3) 9 (0.8) 18 (4.5) 19 (4.8) 103 (25.8) 2.3 (1.8) 25 (17.5) 17 (11.9) 26 (18.2) 75 (52.4) 
Airway mucus 132 (33.0) 244 (61.0) 24 (6.0) 62 (15.5) 44 (11.0) 26 (6.5) 2.0 (1.3) 42 (26.9) 14 (9.0) 34 (21.8) 66 (42.3) 
Tingling hand/feet 129 (32.3) 260 (65.0) 11 (2.8) 36 (9.0) 24 (6.0) 69 (17.3) 2.1 (1.6) 21 (14.7) 29 (11.3) 36 (24.0) 55 (50.0) 
Dizziness 120 (30.0) 260 (65.0) 20 (5.0) 86 (21.5) 28 (7.0) 6 (1.5) 1.8 (1.1) 17 (12.1) 22 (15.7) 36 (25.7) 65 (46.4) 
Urinary incontinence 106 (26.5) 272 (68.0) 22 (5.5) 66 (16.5) 26 (6.5) 14 (3.5) 1.7 (1.2) 16 (12.5) 7 (5.5) 22 (17.2) 83 (64.8) 
Nausea 105 (26.3) 275 (68.8) 20 (5.0) 50 (12.5) 44 (11.0) 11 (2.8) 1.7 (1.2) 8 (6.3) 14 (11.1) 31 (24.6) 73 (57.9) 
Diarrhoea 70 (17.5) 300 (75.0) 30 (7.5) 32 (8.0) 28 (7.0) 10 (2.5) 1.6 (1.1) 25 (6.3) 7 (1.8) 16 (4.0) 54 (13.5) 
Sore mouth/pain 
when swallowing 
69 (17.3) 318 (79.5) 13 (3.3) 25 (6.3) 17 (4.3) 27 (6.8) 1.6 (1.2)  8 (9.8) 14 (17.1) 17 (20.7) 43 (52.4) 
Heartburn/belching 68 (17.0) 314 (78.5) 18 (4.5) 39 (9.8) 21 (5.3) 8 (2.0) 1.5 (1.0) 16 (18.6) 12 (14.0) 24 (27.9) 34 (39.5) 
Itching 58 (14.5) 335 (83.8) 7 (1.8) 29 (7.3) 22 (5.5) 7 (1.8) 1.4 (1.0) 13 (20.0) 11 (16.9) 13 (20.0) 28 (43.1) 
Vomiting 48 (12.0) 330 (82.5) 22 (5.5) 23 (5.8) 20 (5.0) 5 (1.3) 1.4 (0.9) 7 (10.1) 4 (5.8) 9 (13.0) 49 (71.0) 
Confusion 47 (11.8) 345 (86.3) 8 (2.0) 35 (8.8) 11 (2.8) 1 (0.3) 1.3 (0.8) 11 (19.6) 8 (14.3) 8 (14.3) 29 (51.8) 
Fecal incontinence 38 (9.5) 350 (87.5) 12 (3.0) 23 (5.8) 12 (3.0) 3 (0.8) 1.3 (0.8) 4 (8.0) 2 (4.0) 7 (14.0) 37 (74.0) 
  
 
 
 Symptom 
Prevalence 
Symptom Frequency Symptom Intensitya 
Symptom  
 
N (%) 
Never 
 
N (%) 
Rarely 
 
N (%) 
Sometimes 
 
N (%) 
Often 
 
N (%) 
Always 
 
N (%) 
Mean (SD) Not 
 
N (%) 
Somewhat 
 
N (%) 
Moderate 
 
N (%) 
Very 
serious 
N (%) 
Psychological            
Brooding 207 (51.8) 185 (46.3) 8 (2.0) 90 (22.5) 85 (21.3) 32 (8.0) 2.4 (1.4) 22 (10.2) 15 (7.0) 57 (26.5) 121 (56.3) 
Psychological fatigue 184 (46.0) 208 (52.0) 8 (2.0) 77 (19.3) 59 (14.8) 48 (12.0) 2.3 (1.5) 5 (2.6) 7 (3.6) 52 (27.1) 128 (66.7) 
Nervousness 156 (39.0) 231 (57.8) 13 (3.3) 62 (15.5) 38 (9.5) 56 (14.0) 2.2 (1.5) 35 (20.7) 16 (9.5) 45 (26.6) 73 (43.2) 
Depressed mood 145 (36.3) 241 (60.3) 14 (3.5) 93 (23.3) 39 (9.8) 13 (3.3) 1.9 (1.2) 7 (4.4) 11 (6.9) 36 (22.5) 106 (66.3) 
Tension 133 (33.3) 253 (63.3) 14 (3.5) 72 (18.0) 32 (8.0) 29 (7.3) 1.9 (1.3) 10 (6.8) 10 (6.8) 54 (36.7) 73 (49.7) 
Lack of willpower 118 (29.5) 277 (69.3) 5 (1.3) 67 (16.8) 31 (7.8) 20 (5.0) 1.8 (1.3) 10 (8.1) 7 (5.7) 37 (30.1) 69 (56.1) 
Psychological pain 114 (28.5) 281 (70.3) 5 (1.3) 43 (10.8) 53 (13.3) 18 (4.5) 1.8 (1.3) 1 (0.8) 4 (3.4) 22 (18.5) 92 (77.3) 
Loneliness 103 (25.8) 286 (71.5) 11 (2.8) 54 (13.5) 32 (8.0) 17 (4.3) 1.7 (1.2) 11 (9.6) 14 (12.3) 25 (21.9) 64 (56.1) 
Fear 89 (22.3) 295 (73.8) 16 (4.0) 44 (11.0) 33 (8.3) 12 (3.0) 1.6 (1.1) 3 (2.9) 9 (8.6) 20 (19.0) 73 (69.5) 
Anger 78 (19.5) 312 (78.0) 10 (2.5) 54 (13.5) 20 (5.0) 4 (1.0) 1.5 (1.0) 8 (9.0) 5 (5.6) 25 (28.1) 51 (57.3) 
Functional            
Difficulties with self-
care 
208 (52.0) 182 (45.5) 10 (2.5) 18 (4.5) 19 (4.8) 171 (42.8) 3.0 (1.9) 100 (45.5) 22 (10.0) 35 (15.9) 63 (28.6) 
Difficulties with 
moving inside 
138 (34.5) 261 (65.3) 1 (0.3) 10 (2.5) 22 (5.5) 106 (26.5) 2.3 (1.8) 19 (13.7) 8 (5.8) 14 (10.1) 98 (70.5) 
Difficulties with 
moving outside 
223 (55.8) 175 (43.8) 2 (0.5) 15 (3.8) 16 (4.0) 192 (48.0) 3.1 (1.9) 56 (24.8) 14 (6.2) 24 (10.6) 132 (58.4) 
Social            
Not satisfied with 
social life 
108 (27.0) 254 (63.5) 38 (9.5) 33 (8.3) 25 (6.3) 50 (12.5) 2.0 (1.4) 0 (0.0) 3 (2.1) 28 (19.2) 115 (78.7) 
Not feeling supported 29 (7.3) 362 (90.5) 9 (2.3) 9 (2.3) 7 (1.8) 13 (3.3) 1.3 (0.9) 1 (2.6) 2 (5.3) 6 (15.8) 29 (76.3) 
Existential            
Experience life as not 
meaningful 
113 (28.3) 213 (53.3) 50 (12.5) 60 (15.0) 24 (6.0) 53 (13.3) 2.1 (1.4) 0 (0.0) 7 (3.7) 26 (13.9) 154 (82.4) 
a Intensity of symptoms was only reported for those symptoms which were rated as rarely to always present by the patient.  
b The item weight loss was a dichotomous variable: yes/no.  
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Treatment Interventions 
Multiple disciplines were involved in the care of the patients: nurse (100.0%), oncologist 
(92.8%), geriatrician (13.8%), dietician (44.3%), social worker (40.8%), physical therapist (31.3%), and 
oncology support team (OST) (32.8%). Few patients were referred to a palliative support team (PST) 
(26.3%), or were followed up by a spiritual consultant (16.0%) or psychologist (17.5%). On average 
5.15 (SD 1.7) disciplines were consulted per patient.  
Patients received a variety of interventions to increase life expectancy and to alleviate symptoms 
and side effects of treatments as a result of cancer or other comorbidities. These interventions are 
reported in Table 3. Two-thirds of the patients received analgesics (67.9%) and 41.3% received 
corticosteroids. About one third of the patients received an anxiolytic, laxative, anti-emetic, sleeping 
pill, or palliative chemotherapy. Less than 20% received an antidepressant and 10% received palliative 
radiotherapy. 
Physical Symptoms 
The three most prevalent and burdensome physical symptoms were lack of energy, physical 
fatigue, and physical pain. 
Lack of energy was associated with a geriatric risk profile (fTRST ≥ 2) (OR 1.85; 95% CI 1.15-
2.98), receiving chemotherapy in the period of symptom assessment (OR 0.58; 95% CI 0.37-0.90), 
receiving oxygen (OR 2.30; 95% CI 1.16-4.56), and taking non-opioids (e.g. paracetamol) (OR 0.58; 
95% CI 0.37-0.90) in the multivariate analysis (Table 4). The percent of variance for the presence of 
lack of energy explained by the variables in the model was 12.4%. 
Physical fatigue was associated with a geriatric risk profile (G8 ≥ 14) (OR 2.68; 95% CI 1.01-
7.15) in the multivariate analysis. The percent of variance explained by the variable in the model was 
4.7%.
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Table 3. Treatment Interventions 
 Number of Patients Receiving the 
Intervention  
Interventions Yes (%) No (%) 
Surgery (cancer related) 165 (41.4) 234 (58.6) 
Radiotherapy 
Total 
In the past 
In period of symptom assessment 
 
146 (36.6) 
107 (73.3) 
39 (26.7) 
 
253 (63.4) 
- 
- 
Chemotherapy 
Total 
In the past 
In period of symptom assessment 
 
277 (69.4) 
123 (44.4) 
154 (55.6) 
 
122 (30.6) 
- 
- 
Hormone therapy 50 (12.5) 349 (87.5) 
Immunotherapy 7 (1.8) 392 (98.2) 
Nuclear medicine 2 (0.5) 397 (99.5) 
Stenting  26 (6.5) 373 (93.5) 
Draining 27 (6.8) 372 (93.2) 
Oxygen 65 (16.3) 334 (83.7) 
Analgesics 
Total 
Non-opioid (e.g. paracetamol) 
NSAID (e.g. ibuprofen)  
Weak opioid (e.g. tramadol) 
Strong opioid (e.g. morphine) 
Adjuvant analgesics  
 
271 (67.9) 
186 (46.6) 
28 (7.0) 
60 (15.0) 
109 (27.3) 
41 (10.3) 
 
128 (32.1) 
213 (53.4) 
371 (93.0) 
339 (85.0) 
290 (72.7) 
358 (89.7) 
Steroids 165 (41.4) 234 (58.6) 
Antidepressant 75 (18.8) 324 (81.2) 
Anxiolytic 94 (23.6) 305 (76.4) 
Laxative  139 (34.8) 260 (65.2) 
Antiemetic 135 (33.8) 264 (66.2) 
Sleeping medication 136 (34.1) 263 (65.9) 
1 missing data which gives a total of 399 participants 
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Physical pain was associated with age (OR 0.96; 95% CI 0.93-0.99), taking non-opioids (OR 
2.23; 95% CI 1.43-3.46), taking NSAIDS (OR 2.66; 95% CI 1.02-6.95), taking weak opioids (OR 2.50; 
95% CI 1.33-4.70), and taking strong opioids (OR 2.51; 95% CI 1.51-4.49) in the multivariate model. 
The explained variance for the presence of physical pain was 22.1%.  
Psychological Symptoms 
In a multivariate model with psychological distress as outcome variable, having metastasis 
(B-2.52; 95% CI -4.83--0.20, p = .033), taking an antidepressant (B 5.06; 95% CI 2.54-7.59; p < .001), 
taking an anxiolytic (B 3.42; 95% CI 1.06-5.79; p = .005), and being followed up by a social worker (B 
2.05; 95% CI 0.01-4.09; p = .049) were found to be independently associated (Table 4). The percent 
of variance for the presence of psychological symptoms explained by the variables in the model was 
19.7%. 
Functional Dependence 
Functional dependence was present in 67.0% of the participants. Patients with functional 
dependence had significantly more symptoms (M 15.60; SD 5.46) compared to functionally 
independent patients (M 10.28; SD 4.67) (two tailed t(398)=-9.59; p < 0.001). In the multivariate 
analysis, the presence of functional dependence was associated with being older than 75 years of age 
(OR 1.71; 95% CI 1.01-2.90), having a geriatric risk profile (fTRST ≥ 2) (OR 4.14; 95% CI 2.37-7.20), 
having an expected life-expectancy of months (OR 2.22; 95% CI 1.21-4.07), being followed  by a 
physical therapist (OR 3.08; 95% 1.61-5.92), and receiving palliative chemotherapy (OR 0.41; 95% CI 
0.22-0.77) or palliative radiotherapy (OR 2.71; 95% CI 1.03-7.11) in the period of symptom assessment. 
The explained variance for the presence of functional dependence was 38.7%. 
  
Table 4. Multivariate Analysis of Five Dependent Variables and Several Covariates 
 Lack of energy  Physical fatigue  Physical pain  Psychological 
symptoms 
 Functional 
dependence 
 
 OR (95% CI) p-
value 
OR (95% CI) p-
value 
OR (95% CI) p-
value 
OR (95% CI) p-
value 
OR (95% CI) p-
value 
Demographics variables 
Gender 
Male 
Female 
Agec 
Clinical variables 
fTRSTd 
No risk profile 
Geriatric risk profile 
G8d 
No risk profile 
Geriatric risk profile 
Cognitive status 
Normal 
Deficit 
Cancer typee 
Lung cancer 
Gynaecological cancer 
Gastro-intestinal cancer 
Breast cancer 
Prostate cancer 
Metastasise 
Prognosis 
Years 
Months 
Comorbidityc 
Multidisciplinary team 
Psychologiste 
Physical therapiste 
 
 
-b 
- 
- 
 
 
a 
1.84 (1.15-2.98) 
 
- 
- 
 
- 
- 
 
- 
0.31 (0.09-1.04) 
- 
- 
1.39 (0.35-5.49) 
- 
 
- 
- 
- 
 
- 
- 
 
 
 
 
 
 
 
 
.012 
 
 
 
 
 
 
 
 
.057 
 
 
.637 
 
 
 
 
 
 
 
 
 
 
a 
1.39 (0.89-2.16) 
- 
 
 
- 
- 
 
a 
2.68 (1.01-7.15) 
 
- 
- 
 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
 
- 
1.39 (0.85-2.27) 
 
 
 
.144 
 
 
 
 
 
 
 
.049 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
.193 
 
 
- 
- 
0.96 (0.93-0.99) 
 
 
a 
1.54 (0.93-2.54) 
 
- 
- 
 
a 
0.67 (0.43-1.04) 
 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
 
- 
- 
 
 
 
 
.020 
 
 
 
.093 
 
 
 
 
 
.076 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- 
- 
- 
 
 
a 
1.70 (-0.63-4.03) 
 
- 
- 
 
- 
1.89 (-0.63-4.03) 
 
- 
- 
- 
- 
- 
-2.52 (-4.83- -0.20) 
 
- 
- 
- 
 
0.83 (-1.77-3.45) 
- 
 
 
 
 
 
 
 
 
.151 
 
 
 
 
 
.061 
 
 
 
 
 
 
.033 
 
 
 
 
 
.533 
 
 
 
- 
- 
1.71 (1.01-2.90) 
 
 
- 
4.14 (2.37-7.20) 
 
- 
- 
 
a 
1.55 (0.92-2.61) 
 
- 
- 
- 
- 
- 
- 
 
- 
2.22 (1.21-4.07) 
- 
 
- 
3.08 (1.61-5.92) 
 
 
 
 
.045 
 
 
 
.000 
 
 
 
 
 
.098 
 
 
 
 
 
 
 
 
 
.010 
 
 
 
.001 
  
 Lack of energy  Physical fatigue  Physical pain  Psychological 
symptoms 
 Functional 
dependence 
 
 OR (95% CI) p-
value 
OR (95% CI) p-
value 
OR (95% CI) p-
value 
OR (95% CI) p-
value 
OR (95% CI) p-
value 
Dieticiane 
Social workere 
Palliative support teame 
Medical interventions 
Chemotherapy activee 
Radiotherapy activee 
Hormonal therapye 
Oxygene 
Non-opioide 
NSAIDe 
Weak opioide 
Strong opioide  
Steroidse 
Antidepressante 
Anxiolytice 
Antiemetice 
Laxativee 
Sleeping medicatione 
- 
- 
- 
 
0.58 (0.37-0.90) 
0.57 (0.28-1.17) 
- 
2.30 (1.16-4.56) 
0.58 (0.37-0.90) 
- 
- 
- 
1.38 (0.88-2.19) 
- 
- 
- 
- 
- 
 
 
 
 
.016 
.126 
 
.018 
.015 
 
 
 
.159 
- 
- 
- 
 
0.66 (0.42-1.03) 
- 
- 
- 
- 
- 
 
 
1.56 (0.99-2.45) 
- 
- 
- 
- 
- 
 
 
 
 
.065 
 
 
 
 
 
 
 
.055 
 
 
- 
- 
- 
 
- 
1.62 (0.74-3.53) 
- 
- 
2.23 (1.43-3.46) 
2.66 (1.02-6.95) 
2.50 (1.33-4.70) 
2.51 (1.51-4.49) 
- 
- 
- 
- 
1.40 (0.87-2.24) 
1.30 (0.81-2.06) 
 
 
 
 
 
.227 
 
 
.000 
.046 
.005 
.000 
 
 
 
 
.168 
.277 
- 
2.05 (0.01-4.09) 
0.28 (-0.63-4.03) 
 
- 
- 
- 
- 
1.55 (-0.41-3.52) 
- 
- 
0.99 (-1.14-3.13) 
- 
5.06 (2.54-7.59) 
3.42 (1.05-5.79) 
- 
- 
1.43 (-0.63-3.50) 
 
.049 
.810 
 
 
 
 
 
.121 
 
 
.361 
 
.000 
.005 
 
 
.173 
- 
1.50 (0.84-2.68) 
1.20 (0.63-2.27) 
 
0.41 (0.22-0.77) 
2.71 (1.03-7.11) 
- 
2.00 (0.91-4.37) 
- 
- 
- 
1.67 (0.89-3.14) 
- 
1.29 (0.62-2.68) 
- 
- 
- 
- 
 
.168 
.583 
 
.006 
.043 
 
 
 
 
 
.109 
 
.109 
 
A logistic regression analysis was performed for all models except for the model with psychological symptoms as dependent variable. This model was build using linear 
regression analysis. 
Abbreviations: OR, Odds Ratio; CI, confidence interval 
Nagelkerke R Square: lack of energy: 0.124; physical fatigue: 0.058; physical pain: 0.221; psychological symptoms: 0.197; functional dependence: 0.387  
a Reference category 
b Not included in the multivariate analysis because the p-value at univariate level was > .10 or clinically not relevant 
c Continuous variable 
d fTRST and G8 are correlated (Fished exact p=.012). G8 was also significant at univariate level and remained significant at multivariate level for lack of energy , lack of appetite, 
and difficulties with moving outside 
e ‘No’ is the reference category as opposed to ‘yes’. 
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DISCUSSION 
This study is the first to investigate the frequency and intensity of symptoms and the 
treatment practices in a large sample of hospitalized older patients receiving palliative cancer care. 
The results of this study indicate that these patients are confronted with multiple symptoms. Highest 
burden was reported for psychological symptoms. Functional dependence was reported by 67% of 
the patients and one third of the patients reported problems with their social life and the experience 
of life as meaningful. Prevalences reported in the current study are somewhat lower compared to 
figures reported in the meta-analysis on symptom prevalence in older palliative cancer patients (Van 
Lancker et al., 2014). Possible explanations for these discrepancies are the inclusion of small scale 
studies mainly focusing on physical symptoms and the high heterogeneity in populations in terms of 
setting and cancer type in the meta-analysis (Van Lancker et al., 2014). Teunissen et al. (2006) 
observed a trend to lower symptom prevalence in older patients. However, they used a small sample 
and included only those patients referred to a PST. In comparison to a systematic review on symptoms 
in a younger palliative cancer population (Teunissen et al., 2007), the prevalence in the present study 
seems to be higher. This may indicate that older patients receiving palliative cancer care experience 
a higher symptom burden.  
In general, a variety of interventions were provided. The study did not allow conclusions 
about the over- or under-treatment due to a lack of justification of interventions and available 
information on non-pharmaceutical interventions such as relaxation and education. Nevertheless, the 
data provides some indication that most attention is paid to physical pain. This can be assumed by 
the lower prevalence of pain compared to figures in the literature (Van Lancker et al., 2014) and the 
prescription of analgesics in two-thirds of the sample. Despite the fact that great attention is given 
to physical pain, 20% of the patients reporting physical pain did not receive analgesics.   
One-third of the patients received chemotherapy and 10% received radiotherapy in the 
period of symptom assessment. The multivariate analysis seems to indicate that the odds of being 
functionally dependent was 60% lower in patients receiving chemotherapy. This could be due to the 
fact that treatment decisions (such as chemotherapy) are often based on age, functionality, and 
comorbidity (Decoster et al., 2013). In contrast, the analysis seems to indicate that patients receiving 
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radiotherapy were 2.71 times more likely to be functionally dependent compared to patients not 
receiving radiotherapy. Radiotherapy is more likely to be given to patients in the more advanced 
stage of their illness and this is done to control symptoms, such as physical pain in patients with bone 
metastases (Chow, Harris, Fan, Tsao, & Sze, 2007). Radiotherapy is chosen because of its lower 
intrusiveness for patients compared chemotherapy in terms of toxicity and side effects (Chow et al., 
2007).  
The involvement of other providers such as a dietician, social worker, or physical therapist 
seems to indicate that in the medical and social aspects of  care are the main focus for these patients. 
Few patients were seen by a psychologist or spiritual consultant, despite the fact that psychological 
symptoms were reported as highly prevalent and bothersome. A possible reason could be that older 
cancer patients do not want to talk to these providers because they need to stay hopeful and use 
avoidance as coping strategy (Aarts et al., 2015). Other explanations might be a negative attitude and 
lack of knowledge  by healthcare professionals regarding the need of patients to be supported 
psychologically and spiritually (Dilworth, Higgins, Parker, Kelly, & Turner, 2014). The PST was 
consulted for a limited number of patients. Healthcare professionals informally reported to the 
primary researcher that the PST was not consulted because the patients were not yet in the end-of-
life stage. This is in line with the literature, which indicated that palliative care is often only provided 
in the terminal phase of illness (Bruera & Hui, 2010). In addition, the literature has reported that older 
people are less often referred to  palliative care  in comparison to those who are younger (Burt & 
Raine, 2006).  
Implication for Practice 
The results are important for clinical practice because they indicate a high prevalence of 
symptoms experienced by older patients receiving palliative cancer care. In particular, psychological 
symptoms were reported by the patients to be extremely bothersome. More efforts are needed to 
alleviate symptoms to achieve an improved quality of life in these patients. The focus should not 
solely be on physical aspects, further, not only focusing on physical pain, but rather, should be more 
holistic in the approach. Patients might benefit from being followed upon by a multidisciplinary team 
of professionals. Nevertheless, every nurse should be educated complexity and basic skills of geriatric 
  SYMPTOMS AND TREATMENT IN OLDER PALLIATIVE CANCER PATIENTS 
 
101 
 
and palliative care (Boltz et al., 2008; Gamondi, Larkin, & Payne, 2013; Parke & Brand, 2004). However, 
when the basic skills do not suffice, healthcare professional should consult or refer to specialised care 
(Baztán, Suárez-García, López-Arrieta, Rodríguez-Mañas, & Rodríguez-Artalejo, 2009; Fox et al., 2012; 
Higginson et al., 2002; Radbruch & Payne, 2004). Reflections and discussions within the care team 
and with the patient might be beneficial in identifying the need to refer patients to specialised 
geriatric and/or palliative or a psychologist or spiritual consultant.  
Symptom assessment is the first step in symptom management. The literature indicates that 
less symptoms are reported following one open-ended question compared to systematic assessment 
(Homsi et al., 2006). One could argue that symptoms which are not voluntarily reported by patients 
are less burdensome. However, studies examining the impact of systematic symptom assessment 
reported higher quality of life in the systematic assessment group (Velikova et al., 2004). It is 
recommended to educate healthcare professionals on how to systematically assess symptoms and to 
adapt care accordingly. Validated instruments could be used to improve this systematic assessment. 
Few patients were referred to a PST, despite the fact that it is widely recommended to 
integrate  palliative care early in the stage of life-threatening illnesses because in palliative care 
focusses on alleviating symptoms and improving the quality of life (Hall, Petkova, Tsouros, Costantini, 
& Higgison, 2011; Temel et al., 2010). It is recommended to encourage healthcare professionals to 
critically reflect on the benefits a referral to such care teams might have for patients, and more 
specifically older patients. 
Patients with a geriatric risk profile seem to be at a higher risk of experiencing symptoms. 
This is in line with the evidence that older people are at higher risk of symptom burden and functional 
decline due to the aging process (Depp & Jeste, 2006). The results need to be interpreted with caution 
because of the high false positives resulting from the use of these screening  instruments (Hamaker 
et al., 2012). Nevertheless, healthcare professionals should give special attention to those patients 
with a geriatric risk profile and their higher risk of experiencing symptoms. In line with this, the care 
for older patients is complex and requires specific knowledge. Educating healthcare professionals 
about the basic skills of symptom assessment and  symptom control in older people is recommended. 
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Strengths and Limitations  
 This study used a cross-sectional design to collect the data which does not allow for 
identification of causal relationships among variables. Therefore, the observed associations should be 
confirmed in high quality cohort studies. Also, the lack of justification of interventions and information 
on non-pharmaceutical interventions did not allow for evaluation of over- or under-treatment in the 
target population. Another limitation is that about 50% of the patients were at risk of cognitive 
impairment. Nevertheless, all patients were considered to be able to adequately interact with a 
researcher by the attending healthcare professionals and none of the patients had dementia. 
Therefore, the authors are of the opinion that valid results were obtained.  
Strengths of the present study are the use of a validated instrument to assess symptoms and 
use of a large sample size to evaluate the frequency and intensity of symptom. 
 
CONCLUSION 
The results of this study indicate that older patients receiving palliative cancer care are 
confronted with multiple symptoms and that psychological symptoms are more often reported as 
severely bothersome. It is recommended to sensitize healthcare professionals about the high 
occurrence and intensity of those symptoms in these patients. Current data suggests that more 
attention is given to the treatment of physical pain and that  few patients were seen by a psychologist, 
spiritual consultant, or palliative support team. Education healthcare professionals about the early 
referral to palliative care is recommended. They also need knowledge about basic skills of symptom 
assessment and symptom control and care of older people.  
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ABSTRACT 
Background Accurate detection of symptoms is essential in palliative care. Identification of clustering 
of symptom is valuable to develop target interventions. This area is largely understudied in older 
palliative cancer patients.  
Objectives To identify symptom clustering in older palliative cancer patients, and patient groups 
based on the clustering of symptoms, and to evaluate the difference in functional dependence and 
experiencing life as not meaningful between the identified patient groups.  
Design A cross-sectional study.  
Setting Geriatric and non-geriatric wards of seven acute care hospitals. Participants: 400 palliative 
cancer patients aged 65 years and older.  
Methods Symptoms were collected using a validated instrument which assesses physical, 
psychological, functional, social, and existential symptoms by means of a structured interview with a 
researcher. An agglomerative hierarchical clustering analysis was used to analyse the data.  
Results The cluster analysis revealed five groups of symptoms: (1) urological and gastrointestinal 
symptoms, and their treatment complications, (2) psychological and existential symptoms, (3) pain, 
constipation, sleeplessness and airway problems, (4) functionality problems, and (5) fatigue-related 
symptoms. Three patient groups were identified: (1) symptom-free group, (2) physical discomfort 
group, and (3) physical and psychological discomfort group. In the last group, significant more 
patients had a geriatric risk profile and less of them received chemotherapy. Patients in this group 
were more often functionally dependent and experienced their life as not meaningful.  
Conclusion Five groups of symptoms were identified. Three patient groups were identified which 
reported different levels of functionality and experiencing life as meaningful. Healthcare professionals 
should be triggered to detect symptom clusters and be alert to the presence of the other symptoms 
in the cluster when identifying one symptom. They should also be alert to patients with a geriatric 
risk profile because of their higher risk of experiencing physical and psychological symptoms and the 
influence these symptoms have on being functionally dependent and experiencing life as not 
meaningful.  
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INTRODUCTION 
Cancer remains a leading cause of death worldwide and in Europe accounting for 
respectively 13% and 20% of all deaths (Ferlay et al., 2015; Ferlay et al., 2013). For those patients for 
which curative treatment is no longer possible, palliative care is important (World Health 
Organisation, 2002). The management of symptoms is one of the essential parts of palliative care 
(World Health Organisation, 2002). Older patients are more likely in need of palliative care due to the 
higher incidence of cancer, and higher occurrence of contraindications for curative treatment in older 
patients (Anisimov et al., 2009; Pallis et al., 2010). In palliative care, older patients are confronted with 
multiple symptoms (Van Lancker et al., 2014). According to Kim et al. (2005): 
‘‘A symptom cluster consists of two or more symptoms that are related to each other and 
that occur together. Symptom clusters are composed of stable groups of symptoms, are 
relatively independent of other clusters, and may reveal specific underlying dimensions of 
symptoms. Relationships among symptoms within a cluster should be stronger than 
relationships among symptoms across different clusters. Symptoms in a cluster may or may 
not share the same aetiology.’’  
Research on the clustering of symptoms has increased in the last years (Kirkova, Aktas, Walsh, & Davis, 
2011; Miaskowski et al., 2006; Walsh & Rybicki, 2006). Two different approaches exist to symptom 
clustering (Miaskowski, Aouizerat, Dodd, & Cooper, 2007). The first approach looks at the grouping 
of symptoms to identify symptoms which may occur together (Miaskowski et al., 2007). Symptoms 
within a cluster may have a similar aetiology or biological basis (Aktas, Walsh, & Rybicki, 2010; 
Miaskowski et al., 2007). Consequently, the treatment of one symptom in the clustering may have a 
positive influence on the occurrence of the other symptoms within the cluster (Aktas et al., 2010; 
Barsevick, 2007). Knowledge on symptom clustering may help healthcare professionals to be alert to 
the occurrence of other symptoms within the cluster alongside an already identified symptom 
(Barsevick, 2007). The second approach looks at the grouping of individuals who experience similar 
groups of symptoms (Miaskowski et al., 2007). The identification of patient groups may assist 
healthcare professionals to define patients according to their need for interventions to control 
symptoms (Barsevick, 2007).  
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Different methods exist to identify symptom clustering of which cluster analysis is one 
method (Aktas et al., 2010; Beckstead, 2002). Cluster analysis groups similar symptoms together and 
has the advantage that no a priori knowledge about the grouping of symptoms or number of groups 
is needed and that sub-clusters can be identified (Beckstead, 2002). Walsh and Rybicki (2006) studied 
the clustering of symptoms in patients with advanced cancer and identified different clusters. Other 
studies identified patient groups based on pain, fatigue and insomnia. These symptoms were chosen 
because of their high prevalence in cancer patients (Cheng & Lee, 2011; Miaskowski et al., 2006). The 
authors found lower levels of functional dependence and quality of life in those patients with high 
symptom prevalences (Cheng & Lee, 2011; Miaskowski et al., 2006). All previously conducted studies 
focused on cancer patients in the curative stage of their disease or on younger patients. Older patients 
differ from younger in that they are confronted with a complex interplay of multiple problems related 
to the ageing process (Depp & Jeste, 2006). The ageing process results in, among other things, a 
higher occurrence of comorbidities and poly-pharmacy, functional decline, psychosocial problems 
and cognitive impairment (Depp & Jeste, 2006). Therefore, evidence on the clustering of symptoms 
and identification of patient groups based on groups of symptoms in younger palliative cancer 
patients cannot be generalised to an older younger population. Research in older palliative cancer 
patients is lacking. 
  
AIM  
The aim was (1) to study symptom clustering in older palliative cancer patients, (2) to identify 
patient groups based on the clustering of symptoms, and (3) to evaluate the difference in functional 
dependence and experiencing life as not meaningful between the identified patient groups.  
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METHODS  
Design and setting  
A multi-centre cross-sectional was performed in seven acute care hospitals in Flanders, 
Belgium. The geriatric and internal wards of six general hospitals and one teaching hospital 
participated in the study.  
Sample  
A convenience sample of older palliative cancer patients fulfilling the following inclusion 
criteria were eligible for the study: (1) being 65 years or older, (2) having a current diagnosis of cancer, 
(3) being a palliative patient, and (4) being able to interact with the interviewer. Patients in the terminal 
phase of their illness were excluded from the study. The criteria for defining the palliative patient and 
terminal phase was operationalised by a panel of experts (n = 7) in geriatric, oncologic and/or 
palliative care. The criteria were based on definitions reported in the literature (Desmedt et al., 2011; 
Pastrana, Junger, Ostgathe, Elsner, & Radbruch, 2008; Van Lancker et al., 2014; Van Mechelen et al., 
2013; World Health Organisation, 2002). Palliative patients are suffering from incurable cancer based 
on treatment options, general condition of the patient, multipathology and/or patient preferences. In 
contrast to healing, stabilisation of the cancer is possible. Patients in the terminal phase are 
characterised by global organ failure which is clinically apparent by physical (e.g., respiratory) and 
mental (e.g., agitation) changes.  
Instrument  
The frequency and intensity of symptoms were assessed using the Assessment Symptoms 
Palliative Elderly (ASPE) scale (Van Lancker, Beeckman, et al., 2016a). The ASPE collects data on 24 
physical, 10 psychological, 3 functional, 2 social and 1 existential symptom. All items, except the item 
weight loss (yes/no), were rated on a (1) 5-point Likert scale to assess frequency (1 = never to 5 = 
always) and (2) 4-point Likert scale to assess intensity (1 = not to 4 = very serious). Functional 
dependence was defined as experiencing a difficulty on at least one of the three functionality items. 
Face- and content validity of the instrument was obtained (Van Lancker, Beeckman, et al., 2016a). The 
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test–retest reliability showed a mean observed agreement of 0.85, and a weighted kappa > 0.60 for 
87.5% of the items and a weighted kappa between 0.52 and 0.60 for the remaining five items (Van 
Lancker, Beeckman, et al., 2016a). 
Demographic and patient-related clinical variables were collected using a standardised form. 
Demographic variables were: age, gender, marital status, and living arrangements. Clinical variables 
were: cognition assessed by the Clock Drawing Test (CDT) (Shulman et al., 1993) expected prognosis, 
cancer type and treatment, presence or absence of metastasis, presence or absence of co-morbidities, 
and geriatric risk profile. Two geriatric screening tools are used in clinical practice to identify older 
patients with a geriatric risk profile: the Flemish Triage Risk Screening Tool (fTRST) (Deschodt et al., 
2011) and the G8 (Bellera et al., 2012). The fTRST is a multidimensional screening tools including five 
items which are scored as present or absent (Deschodt et al., 2011). The final score ranges from 0 to 
5 and has a cut-off score of >2 indicating a geriatric risk profile (Deschodt et al., 2011). The G8 is a 
screening tool including eight items (Bellera et al., 2012). The total score ranges from 0 to 17 with a 
cut-off of ≤14 indicating a geriatric risk profile (Bellera et al., 2012). 
Data collection  
The ASPE was completed by patients based on a structured interview with the researcher 
between March 2013 and February 2015. All interviews were performed by the same researcher and 
instructions and guidance provided to the patients were standardised to enhance the validity of the 
results. The administration of a questionnaire to older palliative cancer patients could be questioned 
in terms of burden. However, the patients did not seemed to be burdened by the administration of 
the instrument. Even so, some patients expressed feeling of gratitude to be able to talk about their 
burden. Demographic and clinical variables were collected during the structured interview with the 
patient or through consultation of the medical record or responsible healthcare professional.  
Ethical approval  
Ethical approval was obtained by the ethics review committee of the teaching hospital and 
general hospitals (B670201317036). The participants received oral and written information before 
deciding to participate and giving written informed consent.  
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DATA ANALYSIS  
An priori sample size calculation was performed based on a prevalence of 50% because the 
prevalence of symptoms in the current population was unknown. A sample size of 400 patients is 
more than sufficient for a prevalence of 50% and a two-sided 95% confidence interval with a width 
equal to 0.10 (Fleiss et al., 2013; Newcombe, 1998). There is no rule of thumb about the sample size 
for cluster analysis, but according to Comrey and Lee (1992) a sample size of 300 is good for factor 
analysis.  
Descriptive data are presented in frequencies for categorical variables, and means with 
standard deviations for ordinal variables with more than five response options and continuous 
variables. The prevalence (P) of symptoms was obtained by recoding the frequency of the symptom 
in 0 if the symptom was never or rarely present and 1 if the symptom was sometimes, often or always 
present.  
Multilevel analysis indicated that there were no significant differences between wards and 
hospitals. This was therefore not further considered in the analysis of the data.  
An agglomerative hierarchical clustering analysis was used to analyse the structure of the 
data and to assign similar symptoms to groups, based on their proximity (distance) or similarity 
(correlation) across individuals (Skerman, Yates, & Battistutta, 2009). The distance measure used to 
evaluate the proximity was the squared Euclidean distance (Beckstead, 2002). This distance measure 
has the advantage over a correlation coefficient to account for differences in elevation. Firstly, single 
symptoms with the smallest distance between them are grouped. Once two symptoms have merged, 
they remain grouped. Secondly, the groups of symptoms with the smallest distance are grouped and 
so forth until one single cluster is obtained combining and containing all the symptoms (Beckstead, 
2002). Many algorithms exist to link the clusters of symptoms, of which the Ward’s method is one 
linkage method (Murtagh & Legendre, 2014). This method was chosen because it produces 
homogenous clusters with maximal distances and is the most widely used method in cluster analysis 
(Beckstead, 2002). This process of clustering is graphically represented by a dendogram, in which the 
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joining of branches represent the aggregation of symptoms into clusters. The dendogram was used 
to identify the number of clusters.  
Two agglomerative hierarchical cluster analyses were conducted. Firstly, a cluster analysis by 
symptoms was performed to identify symptoms that are more likely to occur together. Secondly, 
patient groups were identified in a cluster analysis by participants. The ten symptoms with the highest 
prevalence and intensity were included in this latter analysis.  
The silhouette indices were calculated using the silhouette to confirm the number of clusters 
(Rousseeuw, 1987). For the cluster analysis by symptoms the average silhouette width was 0.14. For 
the cluster analysis by participants, the average silhouette width was 0.19. Despite these low values, 
the cluster analyses giving the most clinically relevant solutions were chosen.  
Significant difference between patients groups on demographical and clinical variables, 
functional dependence, and experiencing life as not meaningful was determined using the chi-
square-test. A statistical significance level of 0.05 was used. Post hoc pairwise chi-square test were 
performed to identify the source of the relationship. For these tests, the p-value was adjusted to 0.017 
by using the Bonferroni correction.  
All the data were analysed using SPSS, version 22 (IBM Corp. Released 2013. Armonk, NY: 
IBM Corp). Silhouette coefficient was calculated with R package ‘‘cluster’’.  
 
RESULTS  
A total of 400 older palliative patients with cancer were included in the study (response rate 
89%). The distribution in gender was 209 men and 191 women with a mean age of 75.7 years (SD 6.8) 
(Table 1). The majority of the participants had a geriatric risk profile (fTRST 72.5% and G8 95.5%).  
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Table 1 Demographic- and Clinical Characteristics, and Functionality and Experiencing life as 
not Meaningful of the Total Sample and Difference between Patient Groups. 
 Total sample 
(N=400) 
N (%) 
SFGa 
(N=153) 
N (%) 
PhGa 
(N=110) 
N (%) 
PhPsGa 
(N=137) 
N (%) 
Statistics  
Demographic variables 
Ageb 
Gender 
Male 
Female 
Marital status 
Unmarried 
Married 
Divorced 
Widow/widower 
Living arrangements 
Alone 
Living with partner 
Living with others 
Clinical variables 
Cancer type 
Lung cancer 
Gynaecological cancer 
Gastro-intestinal cancer 
Breast cancer 
Prostate cancer 
Other type of cancer 
Metastasis 
No 
Yes 
Expected prognosis 
Months 
Years 
Number of co-
morbidities 
Clock drawing testc 
Normal 
Risk cognitive deficit 
fTRSTd 
Normal 
Geriatric risk profile 
G8e 
Normal 
Geriatric risk profile 
Chemotherapyf 
No 
Yes 
Radiotherapyf 
No 
 
75.7 (6.8) 
 
209 (52.2) 
191 (47.8) 
 
22 (5.5) 
236 (59.0) 
31 (7.7) 
111 (27.8) 
 
125 (31.3) 
229 (57.3) 
46 (11.4) 
 
 
95 (23.8) 
48 (12.0) 
42 (10.5) 
41 (10.3) 
36 (9.0) 
137 (34.5) 
 
100 (25.0) 
300 (75.0) 
 
304 (77.4) 
89 (22.6) 
 
2.0 (1.6) 
 
191 (47.8) 
209 (52.3) 
 
110 (27.5) 
290 (72.5) 
 
18 (4.5) 
382 (95.5) 
 
245 (61.4) 
154 (38.6) 
 
360 (90.2) 
 
76.0 (6.7) 
 
89 (58.2) 
64 (41.8) 
 
9 (5.9) 
95 (62.1) 
8 (5.3) 
41 (26.8) 
 
46 (30.1) 
91 (59.5) 
16 (10.5) 
 
 
33 (21.6) 
22 (14.4) 
18 (11.8) 
12 (7.8) 
11 (7.2) 
57 (37.3) 
 
44 (28.8) 
109 (71.2) 
 
112 (74.7) 
38 (25.3) 
 
2.0 (1.5) 
 
80 (52.3) 
73 (47.7) 
 
51 (33.3) 
102 (66.7) 
 
13 (8.5) 
140 (91.5) 
 
80 (52.6) 
72 (47.4) 
 
139 (91.4) 
 
75.1 (6.4) 
 
56 (50.9) 
54 (49.1) 
 
6 (5.5) 
68 (61.8) 
9 (8.2) 
27 (24.5) 
 
32 (29.1) 
65 (59.1) 
13 (11.8) 
 
 
32 (29.1) 
10 (9.1) 
8 (7.3) 
13 (11.8) 
12 (10.9) 
35 (31.8) 
 
24 (21.8) 
86 (78.2) 
 
83 (77.6) 
24 (22.4) 
 
2.3 (1.7) 
 
55 (50.0) 
55 (50.0) 
 
36 (32.7) 
74 (67.3) 
 
5 (4.5) 
105 (95.5) 
 
71 (64.5) 
39 (35.5) 
 
98 (89.1) 
 
75.8 (7.3) 
 
64 (46.7) 
73 (53.3) 
 
7 (5.1) 
73 (53.3) 
14 (10.2) 
43 (31.4) 
 
47 (34.3) 
73 (53.3) 
17 (12.4) 
 
 
30 (21.9) 
16 (11.7) 
16 (11.7) 
16 (11.7) 
13 (9.5) 
46 (33.6) 
 
32 (23.4) 
105 (76.6) 
 
109 (80.1) 
27 (19.9) 
 
2.0 (1.6) 
 
56 (40.9) 
81 (59.1) 
 
23 (16.8) 
114 (93.2) 
 
0 (0.0) 
137 (100.0) 
 
94 (68.6) 
43 (31.4) 
 
123 (89.8) 
 
F(2,397)=0.73; p=0.48 
 
χ²=3.9; p=0.14 
 
 
χ²=4.7; p=0.58 
 
 
 
 
χ²=1.7; p=0.83 
 
 
 
 
χ²=7.9; p=0.64 
 
 
 
 
 
 
χ²=1.9; p=0.38 
 
 
χ²=1.22; p=0.54 
 
 
F(2,369)=1.37; p=0.26 
 
χ²=4.08; p=0.13 
 
 
χ²=12.00; p<0.001 
 
 
χ²=12.14; p<0.001 
 
 
χ²=8.40; p=0.02 
 
 
χ²=0.45; p=0.80 
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 Total sample 
(N=400) 
N (%) 
SFGa 
(N=153) 
N (%) 
PhGa 
(N=110) 
N (%) 
PhPsGa 
(N=137) 
N (%) 
Statistics  
Yes 
Oxygenf 
No 
Yes 
Functionality 
Independent 
Dependent 
Experiencing life as not 
meaningful 
No 
Yes 
39 (9.8) 
 
334 (83.7) 
65 (16.3) 
 
132 (33.0) 
268 (67.0) 
 
 
277 (69.3) 
123 (30.7) 
13 (8.6) 
 
133 (87.5) 
19 (12.5) 
 
67 (43.8) 
86 (56.2) 
 
 
112 (79.7) 
31 (20.3) 
12 (10.9) 
 
89 (80.9) 
21 (19.1) 
 
34 (30.9) 
76 (69.1) 
 
 
87 (79.1) 
23 (20.9) 
14 (10.2) 
 
112 (81.8) 
25 (18.2) 
 
31 (22.6) 
106 (77.4) 
 
 
78 (56.9) 
59 (43.1) 
 
 
χ²=2.62; p=0.27 
 
 
χ²=14.94; p=0.001 
 
 
 
χ²=22.58; p<0.001 
 
Chi-square statistics were used. If the expected number of patients per cells was small the Fisher Exact test was 
used. 
a SFG: Symptom free group; PhG: Physical discomfort group; PhPsG: Physical and psychological discomfort group. 
b Continuous variable: mean and standard deviation are presented 
c Clock Drawing Test (CDT) (Shulman et al. 1993). A cognitive screening tool. A score of ≥ 2 represents a possible 
cognitive deficit, while a score of 0 and 1 is considered to be normal. Seven missing values, three in cluster 1 and 2 
and one in cluster 3. 
d fTRST: Flemish Triage Risk Screening Tool. A score of > 2 represents a geriatric risk profile, while a score of 0 and 
1 is considered to be normal. 
e G8. A score of < 14 represents a geriatric risk profile, while a score of ≥ 14 is considered to be normal. 
f Treatment in the period of symptom assessment. One variable missing in cluster symptom free. 
 
 
Symptoms  
Description of the frequency and intensity (I) of the symptoms is described in (Van Lancker 
et al. 2016). The mean number of symptoms per patient was 13.85 (SD 5.78; range 1–31). The physical 
and psychological symptoms reported by at least 65.0% of the participants as being moderately to 
seriously intensive were: physical fatigue (P: 69.3%; I: 85.5%), lack of energy (P: 65.8%; I: 88.4%), lack 
of appetite (P: 58.0%; I: 68.4%), shortness of breath (P: 53.3%; I: 77.2%), brooding (P: 51.8%; I: 82.8%), 
physical pain (P: 49.3%; I: 87.7%), psychological fatigue (P: 46.0%; I: 93.8%), nervousness (P: 39.0%; I: 
69.8%), depressed mood (P: 36.3%; I: 88.8%), and lack of willpower (P: 29.5%; I: 86.2%) (Fig. 1). 
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Figure 1. Bar chart of percentage of frequency and intensity of symptoms. 
Percentage frequency: symptoms rated as sometimes to always present 
Percentage intensity: symptoms rated as moderate to seriously bothersome 
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Symptom clustering  
Looking at the horizontal joining of branches, the dendogram showed the presence of five 
clinically relevant symptom clusters (Fig. 2).  
Cluster 1 included symptoms related to urological and gastrointestinal problems: faecal and 
urine incontinence, diarrhoea, vomiting, heartburn, itching, sore mouth, nausea and dizziness. Three 
symptoms in this cluster being anger, not feeling supported and confusion were less directly linked 
to the urological or gastrointestinal system, but could be seen as treatment associated. 
Cluster 2 mainly included psychological symptoms, not being satisfied with his/her social 
life, and experiencing life as not meaningful. Within this second cluster, the psychological symptoms, 
with the exception of lack of willpower and difficulties concentrating, were more closely linked 
compared to not being satisfied with their social life, and experiencing life as not meaningful. Lack of 
willpower and difficulties concentrating were more linked to being not satisfied with his/her social life 
and experiencing life as not meaningful. 
Cluster 3 included physical pain, constipation, sleeplessness, airway symptoms, changes in 
taste of food, and tingling in hand/feet. The airway symptoms and the symptoms physical pain, 
obstipation and sleep were more grouped.  
Cluster 4 included symptoms in the functional domain: difficulties with self-care, moving 
inside and outside. 
Cluster 5 included lack of energy, physical fatigue, lack of appetite and dry mouth.  
The dendogram (Fig. 2) showed that the second and third cluster, and the fourth and fifth 
cluster were more directly linked.  
Analysis of patient groups  
To identify patient groups a cluster analysis by participants was performed. The classification 
based on a three cluster solution was chosen because it demonstrated the most clinically relevant 
clustering, and therefore the best separation into similar groups. The first patient group comprised 
38.3% (n = 153) of the patients. Patients in this group reported no or rarely symptoms and can 
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        Figure 2 Dendogram of Symptom Clusters 
 
therefore be defined as the symptom-free group (SFG). The second patient group comprised 27.5% 
(n = 110) of the patients. Patients in this group mainly reported symptoms in the physical domain 
and can therefore be defined as the physical discomfort group (PhG). The third patient group 
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comprised 34.3% (n = 137) of the patients. Patients in this group reported symptoms in the physical 
and psychological domain and can be defined as the physical and psychological discomfort group 
(PhPsG).  
Differences in demographic and clinical characteristics between patient groups  
Few differences could be observed between the three patient groups for demographic and 
clinical characteristics (Table 1). Differences between patient groups indicated that more women and 
widows/widowers were present in the PhPsG. However, these observed differences were not 
significant. The groups did not differ on clinical variables, except for geriatric risk profile (fTRST and 
G8) and chemotherapy. Post hoc testing indicated that significantly more patients with a geriatric risk 
profile were in the PhPsG compared to the SFG (fTRST: χ² = 10.41, p = 0.001; G8: χ² = 12.19, p < 0.001) 
and PhG (fTRST: χ² = 8.53, p = 0.004; G8: p = 0.017, two-tailed Fisher’s exact test). Patients in the 
PhPsG received significantly less chemo-therapy compared to patients in the SFG (χ² = 7.68, p = 
0.006).  
Differences in functional dependence and experiencing life as not meaningful between patient groups  
The experience of functional dependence was significantly different between the three 
groups (χ² = 14.94, p = 0.001) (Table 1). Post hoc testing indicated that significantly less patients were 
functionally dependent in the SFG compared to the PhPsG (χ² = 14.47, p < 0.001) and PhG (χ² = 4.49, 
p = 0.034). After applying a Bonferonni correction of p < 0.017, only the firmer association remained 
significant. No differences were found for functional dependence between the PhPsG and PhG.  
The number of participants experiencing life as not meaningful was significantly different 
between the three groups (χ² = 22.58, p < 0.001). Post hoc testing indicated that significantly more 
patients experienced life as not meaningful in the PhPsG compared to the SFG (χ² = 21.74, p < 0.001) 
and PhG (χ² = 21.43, p < 0.001). No differences were found for experiencing life as not meaningful 
between the SFG and PhG.  
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DISCUSSION  
This is the first study to evaluate symptom clustering in older palliative cancer patients, and 
to identify patient groups based on the clustering of symptoms.  
The clustering of symptoms revealed five clinically relevant symptoms groups. The first 
cluster mostly included urological and gastrointestinal symptoms. The second cluster included 
psychological symptoms, not being satisfied with their social life, and experiencing life as not 
meaningful. This cluster indicates a connection between being confronted with psychological 
symptoms and experiencing life as not meaningful. This was also observed in the analysis on patient 
groups in which significantly more patients in the PhPsG experienced life as not meaningful compared 
to psychological symptom-free patients. Also, the clustering of the psychological symptoms indicates 
a possible interaction between the different psychological symptoms and the influence they have on 
each other. The third cluster included physical pain, obstipation, sleeplessness and airway problems. 
In this cluster physical pain, obstipation and sleeplessness are more connected to each other. Many 
studies suggest the clustering of pain, fatigue, depression and sleeplessness (Aktas et al., 2010; 
Kirkova et al., 2011; Miaskowski et al., 2006). This is in contrast with the findings of the present study, 
which only found the clustering of pain and sleeplessness. Nevertheless, Kirkova et al. (2011) observed 
in their review on symptom clustering in cancer patients that the grouping of symptoms is influenced 
by methodological issues such as population type, method of analysis and number and types of 
symptoms evaluated. Another explanation is the distinction made between physical and 
psychological pain and fatigue in the present study. This distinction was based on patient input for 
whom pain and fatigue are not solely physically based but also psychologically (Van Lancker, 
Beeckman, et al., 2016a). The link between pain and constipation was also observed by Walsh and 
Rybicki (2006). Constipation is a common side-effect of opioids which are prescribed to alleviate 
physical pain (Benyamin et al., 2008; Camilleri et al., 2014). The grouping of sleeplessness and pain is 
in line with the literature which indicates that sleep has a causal influence on pain levels (Finan, 
Goodin, & Smith, 2013). The fourth cluster included functional symptoms. The grouping of the three 
functional items (problems with self-care, moving inside and moving outside) is not surprising (Katz, 
Ford, Moskowitz, Jackson, & Jaffe, 1963). The fifth cluster included fatigue, lack of appetite and 
energy, and dry mouth. Walsh and Rybicki (2006) also observed this clustering and hypothesised that 
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the connection between fatigue and dry mouth may indicate that fatigue is mediated by a dysfunction 
of the parasympathetic nervous system like for dry mouth. A lack of appetite or fatigue could lead to 
less energy and weakness, which in turn could lead to fatigue or lack of appetite, respectively 
(Radbruch et al., 2008). The closer link between cluster four and five in comparison to the other 
clusters indicates a connection between functional dependence and fatigue.  
The analysis of patient groups based on symptom clustering revealed three clinically relevant 
patient groups. The first group was free of symptoms, the second group experienced physical 
symptoms and the third group experienced physical and psychological symptoms. Patients in these 
three groups differed on their prescription of palliative chemotherapy and having a geriatric risk 
profile. Significantly more patients in the physical and psychological discomfort group had a geriatric 
risk profile and significantly less of them received palliative chemotherapy. This is in line with the 
literature which demonstrated that in clinical practice a geriatric risk assessment influences treatment 
decisions mostly regarding chemotherapy (Decoster et al., 2013). Also, a trend to differences in 
gender and marital status could be observed, suggesting that more women and widow(er)s might 
experience physical and psychological symptoms. In addition, more patients in the PhPsG were 
functionally dependent and experienced life as not meaningful. A possible explanation for the latter 
is that older cancer patients often use avoidance coping strategies to cope with their situation and 
therefore are confronted with more psychological problems which have an impact on their general 
well-being (Aarts et al., 2015).  
Implications for clinical practice and research  
Five clinically relevant symptom clusters were identified. Overall, the present study confirms 
the existing knowledge on the clustering of symptoms aside from some differences due to the 
inclusion of more symptoms in the present study. This may indicate that older palliative cancer 
patients do not very much differ from patients with advanced cancer in general. The identification of 
five symptom clusters may assist healthcare professional in identifying symptoms and setting 
priorities in symptom management, especially if time is restricted. When healthcare professionals 
identify one symptom, they should prompt patients about the other symptoms within the same 
cluster because of their higher probability of occurrence. Fig. 3 could be used in education of 
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healthcare professionals about this clustering to improve symptom management as the treatment of 
one symptom may positively influence another symptom. However, the influence of treatment of one 
symptom on another symptom within the cluster needs to be further investigated.  
Three distinct and clinically relevant patients groups were identified in the present study. 
The present study adds to the current knowledge on older palliative cancer patients, in that patients 
with a geriatric risk profile were at higher risk of experiencing physical and psychological symptoms. 
Healthcare professionals should be alert to older palliative cancer patients with a geriatric risk profile 
and they should systemically question them about both physical and psychological symptoms. In 
addition, healthcare professionals should give special attention to older palliative cancer patients who 
experience psychological symptoms because they are at higher risk of being functionally dependent 
and experiencing life as not meaningful. This patient group may benefit from a geriatric, psychological 
and/or palliative support alongside medical treatment. Education of healthcare professionals about 
the identification of these patients groups and the involvement of specialised support teams may 
reduce symptom burden in patients.  
Strengths and limitations  
A limitation of the present study is the design which is cross-sectional. A longitudinal design 
would allow to identify more causal relationships between symptoms and symptom clusters on 
functionality and experiencing life as meaningful (Aktas et al., 2010). Additional limitations are the use 
of convenience sampling which might influence the generalisability of the results, and the collection 
of clinical variables through the medical record. However, when needed a healthcare professional was 
questioned to improve the validity of the data-collection. Also, the silhouette indices showed low 
values, this despite the fact that clinically relevant clusters were obtained. Therefore, the obtained 
clustering needs to be confirmed in further studies. The present study has several strengths which 
enhance the validity of the results. The study used a validated instrument to collect data on the 
frequency and intensity of 40 symptoms in multiple domains. In addition, a large sample of older 
palliative cancer patients were included in the study.  
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CONCLUSION  
The study evaluated the clustering of symptoms in older palliative cancer patients, and 
identified patient groups based on the clustering of symptoms. Five symptom clusters and three 
patient groups were identified. Healthcare professionals need to prompt patients about symptoms 
within a cluster. Healthcare professionals should be alert to patients with a geriatric risk profile and 
patients with psychological symptoms because of the negative impact on functionality and 
experiencing life as not meaningful. Further research is needed about the influence of treatment on 
different symptoms within a cluster and on the effectiveness of involving specialised teams on 
symptom burden. 
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Figure 3 Summary of Findings of Clustering of Symptoms 
Legend: = closer link between clusters;  influence on
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CHAPTER VI 
A COMPARISON OF SYMPTOMS IN OLDER HOSPITALISED PALLIATIVE CANCER AND NON-
CANCER PATIENTS: SECONDARY ANALYSIS OF TWO CROSS-SECTIONAL STUDIES. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Based on the article of Van Lancker A., Van Hecke A., Verhaeghe S., Mattheeuws M., & Beeckman D. 
(2016). A comparison of symptoms in older hospitalised palliative cancer and non-cancer patients: 
secondary analysis of two cross-sectional studies. Submitted.
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ABSTRACT 
Aims To determine the differences in symptoms between older, hospitalised palliative cancer and 
non-cancer patients. 
Background Evidence on the differences in symptom patterns between older palliative cancer and 
non-cancer patients is lacking.  
Methods A secondary analysis of two multi-centre cross-sectional studies was performed. A validated 
instrument was used to assess the frequency and intensity of 40 symptoms in older hospitalised 
palliative cancer patients (n=100) and older palliative non-cancer patients (n=100). Differences 
between groups were measured.  
Results Non-cancer patients experienced significantly more physical symptoms and functional 
dependence than cancer patients. Patients with cancer experienced higher levels of frequency and 
intensity of psychological symptoms compared to non-cancer patients. 
Conclusions Healthcare professionals should be sensitised to the high occurrence of symptoms in 
both cancer and non-cancer patients, and they should be educated about the systematic assessment 
of symptoms in multiple domains by accounting for the occurrence of generic symptoms and disease-
specific symptoms. 
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INTRODUCTION 
In palliative care, which aims to improve the quality of life of patients facing multiple 
symptoms related to a life-threatening illness and that of their family, particular emphasis is placed 
on the assessment and management of symptoms (World Health Organisation, 2002). For some time, 
palliative care has focused on the care of patients with cancer (Zheng et al., 2013). Currently, more 
attention is devoted to introducing palliative care early in the trajectory of patients facing chronic 
illnesses other than cancer (Zheng et al., 2013). However, the referral of these patients to palliative 
care remains difficult because of the unpredictable course of chronic illness and the lack of adequate 
education on palliative care in caregivers (Aldridge et al., 2015).  
Two systematic reviews have examined the occurrence of symptoms in patients with 
advanced cancer and other chronic illnesses (Moens et al., 2014; Solano, Gomes, & Higginson, 2006). 
The authors of both reviews observed that cancer and non-cancer patients experienced multiple 
problems, with some commonalities in symptom patterns between the two groups (Moens et al., 
2014; Solano et al., 2006). However, these conclusions were based on their interpretation of the data 
rather than on the statistical measurement of a difference between groups. Moreover, the authors 
concluded that most studies focused on physical symptoms and that only a few studies investigated 
social and existential problems. Additionally, Moens et al. (2014) noted that more research is needed 
to compare symptoms in cancer and non-cancer patients using the same instrument and time point.  
The available evidence focuses on adults in general (Moens et al., 2014; Solano et al., 2006). 
The results of these studies cannot be generalised to older populations due to the changes in 
physiology related to the ageing process and the higher prevalence of multimorbidity in this 
population (Rowe & Kahn, 1997). Consequently, older patients are more vulnerable to experiencing 
a complex interplay of multiple problems and symptoms in different domains, concerning not only 
the physical domain but also the psychological, social, existential, and functional domains (Depp & 
Jeste, 2006).  
To our knowledge, there is a lack of evidence on the differences in symptom patterns 
between older palliative cancer and non-cancer patients. Gaining insight into the differences in 
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symptoms in multiple domains between both groups is important for allowing clinicians and nurses 
to provide tailored care.  
 
AIMS 
The aim of this study was to determine the differences in (1) the number of symptoms per 
patient group and (2) the frequency and intensity of symptoms between hospitalised older palliative 
cancer and non-cancer patients. 
 
METHODS 
Design  
A secondary analysis of two multi-centre cross-sectional studies was performed. The first 
study focused on the frequency and intensity of symptoms and the treatments administered in 
hospitalised older palliative patients with cancer (Van Lancker, Beeckman, Van Den Noortgate, 
Verhaeghe, & Van Hecke, 2016a). The second study was part of a study that focused on the frequency 
and intensity of symptoms in hospitalised older palliative patients without cancer (Mattheeuws, Van 
Lancker, & Beeckman, 2015). 
Setting and participants 
The patients were recruited from geriatric and internal wards of nine acute care hospitals 
(one teaching hospital and eight general hospitals) in Flanders, Belgium. 
A convenience sample of older palliative cancer and non-cancer patients was invited to 
participate. Participants were eligible if they (1) were ≥ 65 years, (2) were diagnosed with cancer, heart 
failure, obstructive lung disease, renal failure, or liver failure, (3) were a palliative patient, (4) were able 
to communicate with the researcher, and (5) were able to provide written informed consent. Patients 
in the terminal phase of their disease were excluded. A set of criteria was formulated by a panel of 
experts (n=7) with clinical expertise in oncology, palliative care and/or geriatric care and defined 
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palliative patients and patients in the terminal phase of their disease. The criteria were based on 
definitions reported in the literature (Desmedt et al., 2011; Pastrana, Junger, Ostgathe, Elsner, & 
Radbruch, 2008; Van Lancker et al., 2014; Van Mechelen et al., 2013; World Health Organisation, 2002). 
This resulted in the following criteria for palliative patients: “A patients with an incurable disease based 
on a lack of treatment options or for whom curative treatment is not/no longer recommended 
because the harm of treatment outweighs the benefit of treatment, a weak general condition, 
multipathology and/or preference of the patient to discontinue treatment. In contrast to healing, 
stabilisation of the disease is possible.” For patients in the terminal phase, the following criteria were 
used: “The last phase of life, as characterised by global organ failure that is clinically apparent in 
physical (e.g., respiratory) and mental (e.g., agitation) changes.” 
Instruments 
SYMPTOMS IN CANCER PATIENTS  
The frequency and intensity of symptoms were collected using the Assessment Symptoms 
Palliative Elderly (ASPE) (Van Lancker, Beeckman, et al., 2016b). This instrument was developed to 
assess the frequency and intensity of symptoms in older palliative cancer patients. The instrument 
has shown good validity and reliability. In total, 40 symptoms (Figure 1), including 24 physical, 10 
psychological, and 3 functional symptoms and 2 items in the social and 1 item in the spiritual domain, 
were measured on (1) a 5-point Likert scale to assess frequency (1=never; 2=rarely; 3=sometimes; 
4=often; 5=always) and (2) a 4-point Likert scale to assess intensity (1=not; 2=somewhat; 
3=moderate; 4=very serious). The ‘weight loss’ item had a dichotomised answer category (‘yes’ or 
‘no’). 
SYMPTOMS IN NON-CANCER PATIENTS  
An adapted version of the ASPE was used. Based on a literature review of instruments 
developed to assess the symptoms of adults with heart failure, obstructive lung disease, renal failure 
and liver failure, eight items were added to the ASPE to increase the content validity of the instrument 
for non-cancer patients. These eight additional items were not included in the analysis, because a 
comparison was not possible with the cancer group. 
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DEMOGRAPHIC AND CLINICAL VARIABLES 
Demographic and clinical variables were collected using a standardised form. The 
demographic variables were as follows: age, gender, living status, and living arrangements. The clinical 
variables included the following: type of illness for which the patient was considered in need of 
palliative care, presence or absence of co-morbidities, and the Flemish Triage Risk Screening Tool 
(fTRST) (Deschodt et al., 2011). The fTRST is a screening tools that includes five items scored as present 
or absent (Deschodt et al., 2011). The total score ranges between 0 and 5, in which a score > 2 
indicates having a geriatric risk profile (Deschodt et al., 2011). 
Data Collection 
In the period between March 2013 and June 2015, the researchers contacted the participating wards 
weekly to identify eligible patients, after which a researcher approached the patient. Two researchers 
collected data on the frequency and intensity of symptoms. One researcher (AVL) collected data from 
the cancer patients, whereas the other researcher (MM) collected data from the non-cancer patients. 
The researchers completed the ASPE and the demographic variables based on a structured interview 
with the patient. The instructions and guidance provided by the researchers were reduced to a 
minimum and were standardised to improve the validity of the results. The first author (AVL), who 
developed the instrument and was therefore familiar with its use, explained the application of the 
instrument to the second researcher (MM) to optimise consistency in data collection. The clinical 
variables were collected through the electronic medical and paramedical records of the patients or 
were obtained from the responsible medical doctor or nurse. 
Ethical Approval 
Ethical approval was obtained from the ethics review committee of the teaching hospital and general 
hospitals (B670201317036 and B670201523233). The participants received oral information about the 
aim of the study from a healthcare professional within the hospital. After preliminary consent, the 
researcher approached the participant to provide more detailed information about both the aim of 
the study and the participant’s anonymity. Written informed consent was obtained from all 
participants. 
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DATA ANALYSIS 
Descriptive data were reported as the mean values with a standard deviation for normally 
distributed continuous variables, median values with 25th – 75th interquartile ranges for ordinal 
variables, and percentages for nominal variables. To improve the interpretation of the results, mean 
values with a standard deviation were also provided for the comparison of the frequency and intensity 
of symptoms between groups (cancer and non-cancer patients).  
In the study in older palliative cancer patients, 400 patients participated. In the second study, 
100 older palliative non-cancer patients participated. Cancer patients were significantly younger than 
non-cancer patients (75.68 years versus 81.02 years, t (498) = 6.17, p < 0.001) and significantly fewer 
cancer patients (72.5%) had a geriatric risk profile compared to the non-cancer patients (90.0%) (χ² 
(1) = 13.43; p < 0.001). To control for age and geriatric risk profile, 100 cancer patients were matched 
to the 100 non-cancer patients on these two variables. Only those 200 patients were included in the 
analysis. No missing data were present. 
The difference in symptoms between both groups was measured using an independent 
sample t-test for continuous variables, Wilcoxon Mann-Whitney U-test for ordinal variables and Chi-
square test for nominal variables.    
A p-value < 0.05 was considered statistically significant. Data were analysed using SPSS, 
version 22 (Chicago, IL, USA). 
 
RESULTS 
Demographics 
A total of 200 patients were included in the analysis (Table 1). Of these, 100 patients had a 
primary diagnosis of cancer, and the remaining patients had a primary diagnosis of heart failure 
(22.5%), obstructive lung disease (13.5%), renal failure (12.5%), or liver failure (1.5%). Approximately 
49.5% were men, and 50.5% were women. The mean age of the patients was 81.1 years (SD 7.8). Most 
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patients had a geriatric risk profile (87.5%). There were no significant differences between the cancer 
and non-cancer patients in demographic or clinical characteristics. 
Table 1. Demographic  and Clinical Characteristics of  Patients (N=200) 
 Total sample  
(N=200) 
Cancer patients  
(N=100) 
Non-cancer patients 
(N=100) 
 Mean (SD) N (%) Mean (SD) N (%) Mean (SD) N (%) 
Age (years) 
Gender 
Male  
Female 
Living status 
Married 
Widow/widower 
Unmarried 
Living arrangements 
Living alone 
Living with partner 
Living with others 
Pathology 
Cancer 
Heart failure 
Obstructive lung disease 
Renal failure 
Liver failure 
Number of comorbidities 
fTRSTa 
Normal 
Geriatric risk profile 
81.1 (7.8) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.1 (1.6) 
 
 
99 (49.5) 
101 (50.5) 
 
92 (46.0) 
81 (40.5) 
27 (13.5) 
 
76 (38.0) 
94 (47.0) 
30 (15.0) 
 
100 (50.0) 
45 (22.5) 
27 (13.5) 
25 (12.5) 
3 (1.5) 
 
 
25 (12.4) 
175 (87.5) 
81.12 (7.5) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2 (1.6) 
 
 
 
 
49 (49.0) 
51 (51.0) 
 
53 (53.0) 
35 (35.0) 
12 (12.0) 
 
35 (35.0) 
53 (53.0) 
12 (12.0) 
 
100 (100.0) 
 
 
 
 
 
 
15 (15.0) 
85 (85.0) 
81.02 (8.0) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.1 (1.6) 
 
 
 
 
 
50 (50.0) 
50 (50.0) 
 
39 (39.0) 
46 (46.0) 
15 (15.0) 
 
41 (41.0) 
41 (41.0) 
18 (18.0) 
 
 
45 (45.0) 
27 (27.0) 
25 (25.0) 
3 (3.0) 
 
 
10 (10.0) 
90 (90.0) 
No statistical differences between the groups were observed using the independent sample t-test for 
continuous variables and the Chi-square test for nominal variables. 
SD: Standard Deviation; N: number of patients 
afTRST: Flemish Triage Risk Screening Tool.  
 
Difference in number of symptoms  
On average, patients reported 17.28 symptoms (SD 5.05; range 6-31) (Table 2). Cancer 
patients reported significantly fewer symptoms than non-cancer patients (t (198) = 2.72; p = 0.007). 
Cancer patients reported significantly fewer physical symptoms (Figure 1) than non-cancer patients 
(t (198) = 2.49; p = 0.013). Significantly fewer cancer patients (79.0%) experienced functional 
dependence compared to non-cancer patients (90.0%) (χ² (1) = 4.62; p = 0.032). There was no 
significant difference between the two groups for psychological symptoms. 
  SYMPTOM IN OLDER PALLIATIVE CANCER AND NON-CANCER PATIENTS 
 
139 
 
Table 2. Number of Symptoms per Patient (N=200) 
 Total sample 
(N=200) 
Cancer 
patients 
(N=100) 
Non-cancer 
patients 
(N=100) 
t df p-
value 
 Mean (SD) Mean (SD) Mean (SD) 
All symptomsa 
Physical symptomsa 
Psychological symptomsa 
Functional dependenceb  
17.28 (5.05) 
9.14 (3.22) 
3.70 (2.48) 
169 (84.5) 
16.32 (4.80) 
8.58 (3.05) 
3.73 (2.47) 
79 (79.0) 
18.23 (5.13) 
9.70 (3.30) 
3.66 (2.44) 
90 (90.0) 
2.72 
2.49 
-0.20 
4.62 
198 
198 
198 
1 
0.007 
0.013 
0.840 
0.032 
a The maximal number of symptoms was 40. The maximal number of physical symptoms was 24. The 
maximal number of psychological symptoms was 10. 
b Functional dependence defined as experiencing difficulties on at least one functional item (self-
care, moving inside, and moving outside) was a dichotomous variable. Therefore numbers with 
percentages instead of means with SD are reported. The difference between groups was assessed 
using the Chi-square test.  
 
Difference in frequency of symptoms  
The frequency of symptoms in both patient groups is displayed in Figure 1. The five symptoms with 
the highest frequency in cancer patients were dry mouth, physical fatigue, difficulties moving 
outside, difficulties with self-care, and lack of energy. The five symptoms with the highest frequency 
in non-cancer patients were difficulties moving outside, difficulties with self-care, lack of energy, 
difficulties moving inside, and shortness of breath. The differences in the symptom frequency 
between cancer and non-cancer patients are presented in Table 3. 
  
 
   
Figure 1. Frequency and intensity of symptoms in older palliative cancer and non-cancer patients  
Mean values are presented.  
For frequency values ranged from 0 to 4, with 4 indicating always present.  
For intensity, values ranged from 0 to 3, with 3 indicating high intensity. 
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Cancer patients reported significantly higher frequencies compared to non-cancer patients for 
physical fatigue (Z = -2.78; p = 0.005), psychological pain (Z = -2.16; p = 0.031), and not being satisfied 
with social life (Z = -3.46; p = 0.001). Non-cancer patients reported significantly higher frequencies 
of the following symptoms compared to cancer patients: shortness of breath (Z = -2.16; p = 0.031), 
itching (Z = -2.07; p = 0.038), airway mucus (Z = -2.01; p = 0.045), confusion (Z = -2.46; p = 0.014), 
lack of willpower (Z = -5.01; p < 0.001), difficulties with self-care (Z = -2.00; p = 0.045), difficulties 
moving inside (Z = -4.64; p < 0.001), and difficulties moving outside (Z = -2.71; p = 0.007). 
Differences in intensity of symptoms 
The intensity of symptoms in both patient groups is displayed in Figure 1. The following five 
symptoms reported by at least 50% of the cancer patients received the highest intensity: 
psychological fatigue, brooding, physical fatigue, lack of energy, and psychical pain. The following 
five symptoms were reported by at least 50% of the non-cancer patients as being the highest 
intensity: lack of energy, physical pain, lack of willpower, airway mucus, and physical fatigue. The 
differences in symptom intensity between cancer and non-cancer patients are presented in Table 3. 
Cancer patients reported significantly higher intensity levels than non-cancer patients for 
psychological fatigue (Z = -3.10; p = 0.002), brooding (Z = -3.83; p < 0.001), tension (Z = -2.22; p = 
0.026), and anger (Z = -2.29; p = 0.022). Non-cancer patients reported significantly higher intensity 
levels compared to cancer patients for physical pain (Z = -2.30; p = 0.021), shortness of breath (Z = -
4.15; p < 0.001), lack of willpower (Z = -3.39; p = 0.001), difficulties with self-care (Z = -2.34; p = 
0.019), and perceiving life as not meaningful (Z = -3.75; p<0.001). 
  
 
Table 3. Difference in Symptom Frequency and Intensity between Cancer and Non-Cancer Patients. 
 Frequency Intensity 
 Cancer Patients 
(N=100) 
Non-Cancer Patients 
(N=100) 
Wilcoxon 
Mann 
Whitney U-
test 
Cancer Patients  
(N=100) 
Non-Cancer Patients 
(N=100) 
Wilcoxon 
Mann 
Whitney U-
test 
 Median 
(25-75 IQ) 
Mean 
(SD) 
Median 
(25-75 IQ) 
Mean 
(SD) 
Z p-
value 
N Median 
(25-75 IQ) 
Mean 
(SD) 
N Median 
(25-75 IQ) 
Mean 
(SD) 
Z p-
value 
Physical               
Lack of appetite 
Fatigue (physical) 
Pain (physical) 
Lack of energy 
Nausea 
Sleeplessness 
Vomiting 
Dizziness 
Heartburn/belching 
Tingling hand/feet 
Difficulties 
concentrating 
Sore mouth/pain 
when swallowing 
Shortness of breath 
Dry mouth 
Cough 
Urinary incontinence 
Faecal incontinence 
Itching 
Changes in food taste 
Airway mucus 
Confusion 
Constipation 
2.0 (0.0-4.0) 
3.0 (2.0-4.0) 
2.0 (0.0-3.0) 
3.0 (0.0-4.0) 
0.0 (0.0-1.0) 
0.0 (0.0-3.0) 
0.0 (0.0-0.0) 
0.0 (0.0- 2.0) 
0.0 (0.0- 0.0) 
0.0 (0.0- 2.0) 
0.0 (0.0- 2.0) 
 
0.0 (0.0-0.0) 
 
2.0 (0.0-3.0) 
3.0 (2.0-4.0) 
0.5 (0.0-2.0) 
0.0 (0.0-2.0) 
0.0 (0.0-0.0) 
0.0 (0.0-0.0) 
0.0 (0.0-2.5) 
0.0 (0.0-2.0) 
0.0 (0.0-0.0) 
0.0 (0.0-2.0) 
1.89 (1.69) 
2.53 (1.55) 
1.66 (1.65) 
2.26 (1.69) 
0.59 (1.01) 
1.23 (1.53) 
0.32 (0.82) 
0.78 (1.12) 
0.42 (0.93) 
1.10 (1.61) 
0.98 (1.48) 
 
0.50 (1.20) 
 
1.59 (1.55) 
2.58 (1.35) 
1.09 (1.25) 
0.94 (1.28) 
0.29 (0.82) 
0.38 (0.94) 
0.95 (1.67) 
1.07 (1.39) 
0.25 (0.73) 
1.22 (1.44) 
2.0 (0.0-3.0) 
2.0 (2.0-3.0) 
2.0 (0.0-4.0) 
3.0 (2.0-4.0) 
0.0 (0.0-1.0) 
2.0 (0.0-3.0) 
0.0 (0.0-0.0) 
0.0 (0.0-2.0) 
0.0 (0.0-0.0) 
0.0 (0.0-2.0) 
0.0 (0.0-2.0) 
 
0.0 (0.0-0.0) 
 
2.0 (1.0-4.0) 
2.0 (2.0-3.0) 
0.5 (0.0-2.0) 
0.0 (0.0-2.0) 
0.0 (0.0-0.0) 
0.0 (0.0-1.0) 
0.0 (0.0-2.0) 
2.0 (0.0-3.0) 
0.0 (0.0-0.8) 
2.0 (0.0-3.0) 
1.48 (1.46) 
2.30 (1.40) 
1.98 (1.68) 
2.55 (1.49) 
0.53 (0.96) 
1.61 (1.56) 
0.42 (0.90) 
0.76 (1.09) 
0.39 (0.93) 
1.11 (1.56) 
0.81 (1.13) 
 
0.53 (1.11) 
 
2.34 (1.49) 
2.25 (1.36) 
1.18 (1.32) 
0.91 (1.50) 
0.48 (1.07) 
0.62 (1.06) 
0.95 (1.54) 
1.46 (1.40) 
0.51 (0.93) 
1.47 (1.50) 
-1.74 
-1.53 
-1.39 
-0.98 
-0.19 
-1.87 
-0.76 
-0.05 
-0.46 
-0.15 
-0.16 
 
-0.57 
 
-3.42 
-1.85 
-0.42 
-0.81 
-1.22 
-2.07 
-0.47 
-2.01 
-2.46 
-1.18 
0.082 
0.127 
0.164 
0.325 
0.851 
0.062 
0.448 
0.643 
0.641 
0.883 
0.874 
 
0.566 
 
0.001 
0.065 
0.678 
0.420 
0.222 
0.038 
0.636 
0.045 
0.014 
0.239 
63 
79 
55 
68 
27 
44 
15 
36 
21 
36 
35 
 
17 
 
56 
85 
50 
40 
13 
16 
25 
43 
11 
46 
2.0 (0.0-3.0) 
2.0 (2.0-3.0) 
3.0 (2.0-3.0) 
3.0 (2.0-3.0) 
3.0 (2.0-3.0) 
3.0 (1.3-3.0) 
3.0 (2.0-3.0) 
2.5 (2.0-3.0) 
2.0 (1.0-3.0) 
2.0 (1.0-3.0) 
2.0 (1.0-3.0) 
 
3.0 (2.0-3.0) 
 
2.0 (2.0-3.0) 
2.0 (0.5-3.0) 
2.0 (0.8-3.0) 
3.0 (2.0-3.0) 
3.0 (3.0-3.0) 
1.5 (0.3-3.0) 
3.0 (1.5-3.0) 
2.0 (0.0-3.0) 
2.0 (1.0-3.0) 
3.0 (2.0-3.0) 
1.83 (1.28) 
2.47 (0.92) 
2.40 (0.76) 
2.43 (0.98) 
2.41 (0.93) 
2.18 (1.02) 
2.47 (0.92) 
2.17 (1.03) 
1.90 (1.04) 
2.08 (1.05) 
2.00 (1.11) 
 
2.47 (0.72) 
 
2.11 (1.00) 
1.86 (1.23) 
1.88 (1.22) 
2.40 (1.01) 
2.85 (0.38) 
1.69 (1.30) 
2.36 (1.04) 
1.93 (1.24) 
2.09 (1.04) 
2.33 (1.01) 
58 
79 
64 
81 
27 
60 
20 
37 
18 
38 
39 
 
21 
 
81 
80 
50 
30 
19 
29 
31 
58 
25 
55 
2.0 (1.0-3.0) 
2.0 (2.0-3.0) 
3.0 (2.3-3.0) 
3.0 (3.0-3.0) 
3.0 (2.0-3.0) 
3.0 (2.0-3.0) 
3.0 (2.3-3.0) 
2.0 (2.0-3.0) 
2.0 (1.0-3.0) 
3.0 (2.0-3.0) 
3.0 (2.0-3.0) 
 
3.0 (2.0-3.0) 
 
3.0 (3.0-3.0) 
2.5 (1.0-3.0) 
3.0 (2.0-3.0) 
3.0 (2.0-3.0) 
3.0 (2.0-3.0) 
2.0 (1.0-3.0) 
3.0 (2.0-3.0) 
3.0 (2.0-3.0) 
3.0 (2.0-3.0) 
2.0 (1.0-3.0) 
1.84 (0.97) 
2.47 (0.70) 
2.69 (0.61) 
2.70 (0.58) 
2.30 (0.99) 
2.25 (0.97) 
2.70 (0.57) 
2.14 (0.86) 
1.94 (0.80) 
2.45 (0.83) 
2.46 (0.85) 
 
2.38 (0.92) 
 
2.18 (0.95) 
2.44 (0.64) 
2.40 (0.89) 
2.47 (0.84) 
1.86 (1.16) 
2.58 (0.56) 
2.48 (0.66) 
2.48 (0.66) 
2.48 (0.77) 
2.09 (0.98) 
-0.40 
-0.87 
-2.30 
-1.47 
-0.39 
-0.28 
-0.65 
-0.55 
-0.13 
-1.59 
-1.88 
 
-0.05 
 
-4.15 
-1.49 
-1.94 
-0.24 
-1.22 
-0.45 
-0.14 
-1.82 
-1.09 
-1.44 
0.692 
0.387 
0.021 
0.141 
0.699 
0.781 
0.514 
0.586 
0.894 
0.111 
0.061 
 
0.960 
 
<0.001 
0.138 
0.052 
0.811 
0.225 
0.650 
0.892 
0.069 
0.274 
0.150 
  
 
 
 Frequency Intensity 
 Cancer Patients 
(N=100) 
Non-Cancer Patients 
(N=100) 
Wilcoxon 
Mann 
Whitney U-
test 
Cancer Patients  
(N=100) 
Non-Cancer Patients 
(N=100) 
Wilcoxon 
Mann 
Whitney U-
test 
 Median 
(25-75 IQ) 
Mean 
(SD) 
Median 
(25-75 IQ) 
Mean 
(SD) 
Z p-
value 
N Median 
(25-75 IQ) 
Mean 
(SD) 
N Median 
(25-75 IQ) 
Mean 
(SD) 
Z p-
value 
Diarrhoea 
Weight lossa 
0.0 (0.0-1.0) 
38 (38.0) 
0.63 (1.17) 
- 
0.0 (0.0-1.0) 
41 (41.0) 
0.60 (1.09) 
- 
-0.18 
0.19 
0.860 
0.664 
27 
- 
3.0 (1.0-3.0) 
- 
2.26 (1.10) 
- 
26 
- 
3.0 (2.0-3.0) 
- 
2.50 (0.91) 
- 
-0.69 
- 
0.492 
- 
Psychological               
Fatigue (psychological) 
Pain (psychological) 
Brooding 
Depressed mood 
Lack of willpower 
Nervousness 
Tension 
Anger 
Loneliness 
Fear 
2.0 (0.0-3.0) 
0.0 (0.0-2.0) 
2.0 (0.0-3.0) 
0.0 (0.0-2.0) 
0.0 (0.0-2.0) 
0.0 (0.0-2.0) 
0.0 (0.0-2.0) 
0.0 (0.0-0.0) 
0.0 (0.0-2.0) 
0.0 (0.0-1.0) 
1.54 (1.52) 
0.96 (1.37) 
1.49 (1.42) 
1.11 (1.24) 
0.86 (1.22) 
1.27 (1.52) 
0.90 (1.31) 
0.55 (1.04) 
0.92 (1.26) 
0.62 (1.14) 
0.0 (0.0-2.0) 
0.0 (0.0-0.0) 
2.0 (0.0-2.8) 
0.0 (0.0-2.0) 
2.0 (0.0-3.0) 
0.0 (0.0-2.0) 
0.0 (0.0-2.0) 
0.0 (0.0-0.8) 
0.0 (0.0-2.0) 
0.0 (0.0-0.0) 
0.96 (1.39) 
0.57 (1.14) 
1.48 (1.41) 
1.09 (1.33) 
1.91 (1.51) 
1.11 (1.31) 
0.93 (1.20) 
0.51 (0.96) 
1.13 (1.45) 
0.37 (0.85) 
-2.78 
-2.16 
-0.08 
-0.29 
-5.01 
-0.55 
-0.47 
-0.03 
-0.94 
-1.63 
0.005 
0.031 
0.940 
0.769 
<0.001 
0.582 
0.641 
0.978 
0.347 
0.104 
56 
36 
57 
49 
37 
48 
36 
24 
39 
27 
3.0 (2.3-3.0) 
3.0 (3.0-3.0) 
3.0 (2.0-3.0) 
3.0 (2.0-3.0) 
2.0 (1.5-3.0) 
2.0 (0.3-3.0) 
3.0 (2.0-3.0) 
3.0 (2.0-3.0) 
3.0 (2.0-3.0) 
3.0 (2.0-3.0) 
2.72 (0.57) 
2.72 (0.57) 
2.51 (0.74) 
2.55 (0.68) 
1.97 (1.07) 
1.90 (1.21) 
2.39 (0.84) 
2.50 (0.89) 
2.36 (0.87) 
2.41 (0.89) 
38 
23 
59 
46 
70 
48 
42 
25 
44 
18 
2.0 (2.0-3.0) 
3.0 (2.0-3.0) 
2.0 (1.0-3.0) 
2.0 (2.0-3.0) 
2.0 (2.0-3.0) 
2.0 (2.0-3.0) 
2.0 (2.0-3.0) 
2.0 (1.0-3.0) 
3.0 (2.0-3.0) 
2.0 (2.0-3.0) 
2.32 (0.66) 
2.43 (0.73) 
1.90 (0.90) 
2.30 (0.70) 
2.63 (0.57) 
2.00 (0.85) 
2.12 (0.63) 
1.84 (1.14) 
2.39 (0.75) 
2.28 (0.67) 
-3.10 
-1.73 
-3.83 
-1.94 
-3.39 
-0.24 
-2.22 
-2.29 
-0.09 
-1.03 
0.002 
0.084 
<0.001 
0.053 
0.001 
0.813 
0.026 
0.022 
0.931 
0.305 
Functional               
Difficulties self-care 
Difficulties with 
moving inside 
Difficulties with 
moving outside 
3.5 (0.0-4.0) 
4.0 (0.0-4.0) 
 
4.0 (0.0-4.0) 
 
2.32 (1.87) 
1.35 (1.82) 
 
2.40 (1.92) 
 
4.0 (2.0-4.0) 
3.0 (1.0-4.0) 
 
4.0 (3.0-4.0) 
 
2.89 (1.56) 
2.45 (1.71) 
 
3.23 (1.35) 
 
-2.00 
-4.64 
 
-2.71 
0.045 
<0.001 
 
0.007 
64 
37 
 
62 
1.0 (0.0-2.8) 
3.0 (2.0-3.0) 
 
3.0 (1.0-3.0) 
1.23 (1.27) 
2.46 (0.96) 
 
2.05 (1.25) 
82 
77 
 
89 
2.0 (1.0-3.0) 
3.0 (2.0-3.0) 
 
3.0 (2.0-3.0) 
1.67 (1.03) 
2.38 (0.90) 
 
2.29 (0.96) 
-2.34 
-0.71 
 
-0.87 
0.019 
0.480 
 
0.384 
Social               
Not feeling 
supported 
Not satisfied with 
social life 
 
0.0 (0.0-0.0) 
 
0.0 (0.0-2.0) 
0.40 (1.04) 
 
1.04 (1.48) 
0.0 (0.0-0.0) 
 
0.0 (0.0-0.0) 
0.33 (0.80) 
 
0.45 (1.00) 
-0.09 
 
-3.46 
0.927 
 
0.001 
16 
 
42 
0.0 (0.0-0.0) 
 
0.0 (0.0-0.3) 
0.00 (0.00) 
 
0.26 (0.48) 
16 
 
20 
0.0 (0.0-0.8) 
 
0.0 (0.0-0.8) 
0.25 (0.45) 
 
0.30 (0.57) 
0.04 
 
-0.15 
0.239 
 
0.880 
  
 
 Frequency Intensity 
 Cancer Patients 
(N=100) 
Non-Cancer Patients 
(N=100) 
Wilcoxon 
Mann 
Whitney U-
test 
Cancer Patients  
(N=100) 
Non-Cancer Patients 
(N=100) 
Wilcoxon 
Mann 
Whitney U-
test 
 Median 
(25-75 IQ) 
Mean 
(SD) 
Median 
(25-75 IQ) 
Mean 
(SD) 
Z p-
value 
N Median 
(25-75 IQ) 
Mean 
(SD) 
N Median 
(25-75 IQ) 
Mean 
(SD) 
Z p-
value 
Existential               
Experiencing life as 
not meaningful 
0.0 (0.0-2.0) 
 
1.21 (1.54) 
 
2.0 (0.0-2.0) 
 
1.35 (1.22) 
 
-1.28 0.201 46 0.0 (0.0-0.0) 
 
0.15 (0.42) 53 0.0 (0.0-1.0) 
 
0.53 (0.62) -3.75 <0.001 
a Weight loss is a dichotomous variable. The number of patients reporting the symptom with its percentage are reported. Difference between groups was measured using the 
Chi-square test. 
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DISCUSSION 
This study is the first to evaluate the differences in symptom patterns between older 
hospitalised palliative cancer and non-cancer patients. Overall, similarities in symptom patterns could 
be observed between cancer and non-cancer patients. Patients in both groups experienced problems 
with functionality, physical fatigue, lack of energy, shortness of breath and physical pain with a high 
frequency and physical fatigue, lack of energy, and physical pain with a high intensity. Similar 
symptom patterns were also observed in the systematic reviews of Solano et al. (2006) and Moens et 
al. (2014) concerning the prevalence of symptoms in palliative patients with different diseases. 
Although the high-frequency and high-intensity symptoms experienced were similar in both groups, 
differences could be observed in the frequency and intensity of symptoms. Non-cancer patients 
experienced significantly more physical symptoms and functional dependence compared to cancer 
patients. In addition, the frequency and intensity of functional dependence were significantly higher 
for non-cancer patients compared to the cancer group. A possible explanation of this finding could 
be that interventions to decrease symptoms focus more on palliative cancer patients than on non-
cancer patients. Only in recent years has research emphasised that more attention should be paid to 
palliative non-cancer patients (Aldridge et al., 2015; Moens et al., 2014). A few physical symptoms 
occurred more often in cancer patients such as physical fatigue and dry mouth. These symptoms are 
common side effects of chemotherapy.  
Regarding psychological symptoms, no differences were observed between the groups in 
terms of the number of psychological symptoms per patient. However, when examining the individual 
symptoms, cancer patients appeared to experience a higher frequency and intensity of psychological 
symptoms, with the exception of lack of willpower. The high frequency and intensity of psychological 
symptoms might be related to patients’ illness perceptions, which help them make sense of their 
experienced symptoms and subsequently guide their coping strategies (Leventhal et al., 1997). For 
patients without cancer, the long-lasting and fluctuating nature of chronic illness presents a challenge 
for identifying ways to cope with their illness (de Ridder, Geenen, Kuijer, & van Middendorp, 2008). 
In contrast, a cancer diagnosis is marked by an immediate change from well-being to feelings of 
uncertainty and the threat of death (Annunziata, Muzzatti, & Bidoli, 2011).  
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Implications for clinical practice and research  
The occurrence and intensity of symptoms were high in both older palliative cancer and non-
cancer patients. It is worth noting that patients in the present study were not terminal patients, 
indicating that multiple symptoms with a high frequency and intensity are already experienced before 
the end-of-life stage. Accordingly, attention should be devoted to older patients’ experience of 
symptoms in the palliative phase to decrease the frequency and intensity of their symptoms. 
Healthcare professionals should be sensitised to this high symptom occurrence in both cancer and 
non-cancer patients. In addition, they should be educated on systematic symptom assessment in 
multiple domains.  
Additionally, the commonalities in symptom patterns indicate that both cancer and non-
cancer patients may need support in reducing symptom burden. Depending on the need of the 
patient, the patient could be referred to a specialised care team. Both patient groups might benefit 
from a referral to palliative support teams, as these teams are specialised in managing symptoms to 
improve quality of life. The literature indicates that an early referral to a palliative support team 
increases patients’ quality of life (Bakitas et al., 2009). For clinicians, it is difficult to identify when 
patients should be referred to a palliative support team (Aldridge et al., 2015). This is especially true 
for non-cancer patients because of the unpredictable course of their illness (Aldridge et al., 2015). 
Despite this challenge, healthcare professions should be educated about referring patients to 
palliative support teams early on in their care. Moreover, to improve this referral, attention should be 
paid to professional-related barriers to referring patients to palliative care, such as a lack of 
knowledge and an inadequate perception of palliative care (Aldridge et al., 2015). Also, a referral to a 
specialised geriatric care team might be beneficial for patients who are confronted with age-related 
disability, chronic conditions, decreased functionality and psychosocial problems and the care goal is 
to increase the patient’s independence, physical and mental health and functionally (Baztán, Suárez-
García, López-Arrieta, Rodríguez-Mañas, & Rodríguez-Artalejo, 2009; Fox et al., 2012). Healthcare 
professionals could use a screening tool in older patients to identify those patients in need of a further 
geriatric evaluation (Decoster et al., 2015). Nevertheless, the benefits of referral should be weighed 
against the risk of fragmentation of care when involving different healthcare professionals.  
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The observed differences between cancer and non-cancer patients indicate that there are 
some disease-specific differences that should be addressed in clinical practice. Healthcare 
professionals should devote attention to both generic symptoms and disease-specific symptoms. 
Education on these aspects is advised. 
In the present study, cancer and non-cancer patients were compared. Further research could 
evaluate the differences in symptoms between different non-cancer patient groups.   
Strengths and limitations 
This study has some strengths and limitations. To our knowledge, this study is the first to 
evaluate the differences in symptoms between older hospitalised palliative cancer and non-cancer 
patients using the same instrument and time point to evaluate symptoms. This consistency enhanced 
the validity of the results. A limitation of the present study is the possible difference between groups 
in terms of additional, non-collected demographic and clinical variables. Nevertheless, both groups 
were matched for age and geriatric risk profile to decrease a possible influence of these factors on 
the outcomes.  
 
CONCLUSION 
Similarities in symptom patterns could be observed between cancer and non-cancer 
patients. In both groups, a high frequency was observed for functionality, physical fatigue, lack of 
energy, shortness of breath, and physical pain, and a high intensity was observed for physical fatigue, 
lack of energy, and physical pain. Despite these similarities, non-cancer patients experienced 
significantly more physical symptoms and functional dependence compared to cancer patients, and 
cancer patients experienced a higher frequency and intensity of psychological symptoms. Healthcare 
professionals should be sensitised to the high symptom occurrence in both cancer and non-cancer 
patients. Additionally, they should be educated about systematic symptom assessment in multiple 
domains by accounting for the occurrence of generic symptoms and disease-specific symptoms.
CHAPTER VI 
 
148 
 
REFERENCES 
Aldridge, M. D., Hasselaar, J., Garralda, E., van der Eerden, M., Stevenson, D., McKendrick, K., . . . Meier, 
D. E. (2015). Education, implementation, and policy barriers to greater integration of palliative 
care: A literature review. Palliative Medicine, 30(3), 224-239. doi:10.1177/0269216315606645  
Annunziata, M. A., Muzzatti, B., & Bidoli, E. (2011). Psychological distress and needs of cancer 
patients: a prospective comparison between the diagnostic and the therapeutic phase. 
Supportive Care in Cancer, 19(2), 291-295. doi:10.1007/s00520-010-0818-9 
Bakitas, M., Lyons, K. D., Hegel, M. T., Balan, S., Brokaw, F. C., Seville, J., . . . Byock, I. R. (2009). Effects 
of a palliative care intervention on clinical outcomes in patients with advanced cancer: the 
Project ENABLE II randomized controlled trial. The Journal of the American Medical 
Association, 302(7), 741-749. doi:10.1001/jama.2009.1198 
Baztán, J. J., Suárez-García, F. M., López-Arrieta, J., Rodríguez-Mañas, L., & Rodríguez-Artalejo, F. 
(2009). Effectiveness of acute geriatric units on functional decline, living at home, and case 
fatality among older patients admitted to hospital for acute medical disorders: meta-analysis. 
British Medical Journal, 338, b50. doi:10.1136/bmj.b50 
de Ridder, D., Geenen, R., Kuijer, R., & van Middendorp, H. (2008). Psychological adjustment to 
chronic disease. The Lancet, 372(9634), 246-255. doi:10.1016/S0140-6736(08)61078-8 
Decoster, L., Van Puyvelde, K., Mohile, S., Wedding, U., Basso, U., Colloca, G., . . . Steer, C. (2015). 
Screening tools for multidimensional health problems warranting a geriatric assessment in 
older cancer patients: an update on SIOG recommendations. Annals of Oncology, 26(2), 288-
300. doi:10.1093/annonc/mdu210 
Depp, C. A., & Jeste, D. V. (2006). Definitions and predictors of successful aging: a comprehensive 
review of larger quantitative studies. The American Journal of Geriatric Psychiatry, 14(1), 6-20. 
doi:10.1097/01.JGP.0000192501.03069.bc 
Deschodt, M., Wellens, N. I. H., Braes, T., De Vuyst, A., Boonen, S., Flamaing, J., . . . Milisen, K. (2011). 
Prediction of functional decline in older hospitalized patients: a comparative multicenter study 
of three screening tools. Aging Clinical and Experimental Research, 23(5-6), 421-426. 
doi:10.1007/BF03325237 
  SYMPTOM IN OLDER PALLIATIVE CANCER AND NON-CANCER PATIENTS 
 
149 
 
Desmedt, M. S., de la Kethulle, Y. L., Deveugele, M. I., Keirse, E. A., Paulus, D. J., Menten, J. J., . . . 
Beguin, C. M. (2011). Palliative inpatients in general hospitals: a one day observational study 
in Belgium. BMC palliative care, 10(1), 2. doi:10.1186/1472-684X-10-2 
Fox, M. T., Persaud, M., Maimets, I., O'Brien, K., Brooks, D., Tregunno, D., & Schraa, E. (2012). 
Effectiveness of Acute Geriatric Unit Care Using Acute Care for Elders Components: A 
Systematic Review and Meta‐Analysis. Journal of the American Geriatrics Society, 60(12), 2237-
2245. doi:10.1111/jgs.12028 
Leventhal, H., Benyamini, Y., Brownlee, S., Diefenbach, M., Leventhal, E. A., Patrick-Miller, L., & 
Robitaille, C. (1997). Illness representations: theoretical foundations. Perceptions of Health and 
Illness, 2, 19-46.  
Mattheeuws, M., Van Lancker, A., & Beeckman, D. (2015). [Symptom assessment in serverly ill older 
patients] Unpublished Master Thesis. Ghent University. Ghent.  
Moens, K., Higginson, I. J., Harding, R., & On behalf of EURO IMPACT. (2014). Are there differences 
in the prevalence of palliative care-related problems in people living with advanced cancer 
and eight non-cancer conditions? A systematic review. Journal of Pain and Symptom 
Management, 48(4), 660-677. doi:10.1016/j.jpainsymman.2013.11.009 
Pastrana, T., Junger, S., Ostgathe, C., Elsner, F., & Radbruch, L. (2008). A matter of definition--key 
elements identified in a discourse analysis of definitions of palliative care. Palliative Medicine, 
22(3), 222-232. doi:10.1177/0269216308089803 
Rowe, J. W., & Kahn, R. L. (1997). Successful aging. The Gerontologist, 37(4), 433-440.  
Solano, J. P., Gomes, B., & Higginson, I. J. (2006). A comparison of symptom prevalence in far 
advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal 
disease. Journal of Pain and Symptom Management, 31(1), 58-69. 
doi:10.1016/j.jpainsymman.2005.06.007 
Van Lancker, A., Beeckman, D., Van Den Noortgate, N., Verhaeghe, S., & Van Hecke, A. Frequency 
and Intensity of Symptoms and Treatment Interventions in Hospitalized Older Palliative Cancer 
Patients: a Multicenter Cross-sectional Study (2016a). Journal of Advanced Nursing. Accepted  
Van Lancker, A., Beeckman, D., Verhaeghe, S., Van Den Noortgate, N., Grypdonck, M., & Van Hecke, 
A. (2016b). An instrument to collect data on frequency and intensity of symptoms in older 
CHAPTER VI 
 
150 
 
palliative cancer patients: a development and validation study. European Journal of Oncology 
Nursing, 21, 38-47. doi:10.1016/j.ejon.2015.11.003 
Van Lancker, A., Velghe, A., Van Hecke, A., Verbrugghe, M., Van Den Noortgate, N., Grypdonck, M., 
. . . Beeckman, D. (2014). Prevalence of symptoms in older palliative cancer patients: a 
systematic review and meta-analysis. Journal of Pain and Symptom Management, 47(1), 90-
104. doi:10.1016/j.jpainsymman.2013.02.016 
Van Mechelen, W., Aertgeerts, B., De Ceulaer, K., Thoonsen, B., Vermandere, M., Warmenhoven, F., . 
. . De Lepeleire, J. (2013). Defining the palliative care patient: a systematic review. Palliative 
Medicine, 27(3), 197-208. doi:10.1177/0269216311435268 
World Health Organisation. (2002). National cancer control programmes: policies and managerial 
guidelines (2nd edition ed.). Geneva: Switserland: World Health Organisation. 
Zheng, L., Finucane, A. M., Oxenham, D., McLoughlin, P., McCutcheon, H., & Murray, S. A. (2013). 
How good are we at identifying patients who need palliative care: a mixed methods study. 
European Journal of Palliative Care, 20(5), 2016-2222.  
 
  
 
PART II. 
NURSING CARE FOR THE OLDER PALLIATIVE CANCER PATIENT 
  
 
CHAPTER VII 
SYMPTOM ASSESSMENT IN HOSPITALIZED OLDER PALLIATIVE PATIENTS WITH CANCER: 
AGREEMENT BETWEEN PATIENTS, NURSES AND PROXIES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Based on the article of Van Lancker A., Cypers S., Vanwynsberghe E., Verhaeghe S., Van Hecke A., 
Beeckman D. (2015). Symptom assessment in hospitalized older palliative patients with cancer: 
agreement between patients, nurses and proxies. Oncology Nursing Forum, 42 (2), E73-E90. doi: 
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ABSTRACT 
Objective To evaluate the level of agreement of symptom assessment among older adult palliative 
patients with cancer, nurses and patients’ proxies. 
Design A cross-sectional study. 
Setting Two general hospitals in Flanders, Belgium. 
Participants 120 palliative patients with cancer, aged 65 years and older. 
Methods A validated 36-item instrument developed to assess physical, psychological, functional, 
social, and existential symptoms in older palliative patients with cancer was independently 
completed by patients, the nurses and proxies. 
Main research variables Frequency and intensity of 36 symptoms. 
Results The study indicates that nurses and proxies tend to underestimate physical and social 
symptoms and overestimate psychological, functional and existential symptoms. Agreement scores 
between patients and nurses and patients and proxies were only significantly different in 39% and 
20% of the cases, respectively. Higher intra-class correlation coefficients were measured between 
patients and proxies compared to patients and nurses. Agreement was associated with 
demographic and clinical factors such as gender and prognosis. 
Conclusion This study indicates discrepancies among patient, nurse and proxy in the assessment of 
symptoms.  
Implication for nursing Patients should be encouraged to report their true experiences. Nurses 
and proxies should be taught to recognize and assess symptoms and to communicate about them 
with patients.  
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INTRODUCTION 
Palliative care is defined as “an approach that improves the quality of life of patients and 
their families facing the problems associated with life-threatening illness, through the prevention and 
relief of suffering by means of early identification and impeccable assessment and treatment of pain 
and other problems, physical, psychosocial and spiritual” (World Health Organisation, 2002). Cancer 
remains one of the leading causes of death (Ferlay, Shin, et al., 2010); therefore, patients with cancer 
represent an important proportion of the patients in the palliative care setting.  
Palliative patients with cancer suffer from multiple symptoms and sometimes with high 
prevalences (Teunissen et al., 2007; Van Lancker et al., 2014). Subsequently, symptom management 
is seen as the most important aspect of palliative care (World Health Organisation, 2002). This requires 
adequate symptom assessment, which allows identification of symptoms on multiple domains, such 
as the physical, psychological, social, functional, and existential (World Health Organisation, 2002). 
Like palliative care, care of older adults requires a multifaceted approach. Older adults are often 
confronted with co-morbidity, polypharmacy, functional decline, cognitive problems, and loss of 
homeostatic reserve which can result in symptoms on multiple domains (Depp & Jeste, 2006; 
Marengoni et al., 2011). Adequate symptom assessment is essential to be able to implement attuned 
intervention to control symptoms.  
Patient self-reported symptoms are seen as the gold standard in symptom assessment 
(Pautex et al., 2003). However, patients are not always able to report their symptoms because of a 
variety of reasons that are especially relevant for the older adult patient in palliative care (Kaye et al., 
2010). Patients are, for instance, not able to report their symptoms if they are confronted with 
cognitive problems, confusion, and weakness (Kaye et al., 2010; Nekolaichuk et al., 1999). For those 
patients, symptoms can only be assessed indirectly or estimated by a formal (e.g. nurse and physician) 
or informal (proxy) caregiver. The validity and reliability of those assessments are unclear. As a result, 
underreporting may result in undertreatment, and overreporting may lead to unnecessary 
interventions, such as high doses of medication (Kaye et al., 2010; Winn & Dentino, 2005). This may 
reduce the quality of life of the patient and lead to discomfort.   
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Studies on the agreement of symptom assessment among the patient, the healthcare 
provider and the proxy have been performed in different settings and populations (Higginson & Gao, 
2008; Laugsand et al., 2010; Pautex et al., 2003; Yip et al., 2001). To the author’s knowledge, only one 
study focused on a population of older adult palliative care patients (Pautex et al., 2003). Overall, 
healthcare professionals and proxies have a tendency to under- and overreport symptoms, 
respectively. Lower agreement has been observed for more subjective symptoms, such as depression, 
and less prevalent symptoms, such as poor sleep (Laugsand et al., 2010; Pautex et al., 2003). In a 
population of older palliative patients, Pautex et al. (2003) used the Edmonton Symptom Assessment 
Scale (ESAS) and confirmed that healthcare providers tend to underestimate physical and objective 
symptoms, and overestimate physiological and subjective symptoms. However, Pautex et al. (2003) 
assessed only a limited number of symptoms with a small sample (N=42).  
Therfeore, the aim of the current study was to evaluate the level of agreement of symptom 
assessment (physical, psychological, functional, social, existential) among older palliative patients with 
cancer, nurses and  proxies.  
 
METHODS 
A cross-sectional study was performed from November 2012 to May 2013. The study was 
conducted in two general hospitals in Flanders (Belgium): General Hospital Groeninge, Kortrijk, and 
General Hospital OLV Lourdes, Waregem. Patients were recruited in eight internal medicine units and 
one geriatric ward.  
A convenience sample of older palliative patients with cancer participated in the study. 
Patients were eligible for the study if they met following criteria: (a) being aged 65 years or older, (b) 
being a palliative patient as defined by Desmedt et al. (2011) "A patient suffering from an incurable, 
progressive, life-threatening disease, with no possibility of obtaining remission, stabilization or 
improvement of this illness" (p. 3), (c) having a current diagnosis of a malignant disease, (d) being 
able to interact with the interviewer, (e) being able to provide written, informed consent, and (f) being 
hospitalized for at least one week so that the nurses could make an adequate estimation of the 
occurrence of symptoms. The patient indicated a proxy who was able to provide an accurate 
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estimation of the occurrence of symptom. Patients were excluded if they had not received any visits 
in the last week and if they were in a terminal phase of illness (defined as the last phase of life 
characterized by general organ failure).  
 
INSTRUMENTS 
Symptoms were assessed using a validated 36-item instrument specifically designed for 
older palliative cancer patients (Van Lancker et al., 2012). The instrument was developed based on an 
extensive literature review. Face- and content validity were evaluated using a double Delphi 
procedure with 11 clinical and/or research experts in oncology, palliative care, geriatric care, and 
nursing. The Item Content Validity Index (I-CVI) ranged between 89.9% and 100%. Lynn (1986) 
recommended an I-CVI of 80.0% or greater. The Scale Content Validity Index (S-CVI) was 93%. Polit 
and Beck (2011) recommended a S-CVI of 90.0% or greater. The instrument was pilot-tested for clarity 
and ambiguity in a sample of 10 hospitalized older adult patients. Changes were made following the 
Delphi and pilot study. The instrument assesses symptoms on five domains: physical, psychological, 
functional, social, and existential domain. The test-retest reliability (30-minutes interval) showed a 
weighted kappa from 0.53 to 1.00, with the majority of the items (87.5%) showing substantial (0.61-
0.80) to almost perfect (greater than 0.80) agreement. 
The symptoms are rated on a 5-point Likert scale to assess frequency of symptoms which 
they encountered in the last week, ranging from 1 (never) to 5 (always), and a 4-point Likert scale to 
assess intensity of the prevalent symptoms experienced in the last week, ranging from 1 (not serious) 
to 4 (very serious). One symptom, weight loss, receives a dichotomized answer category (0 for “yes” 
or 1 for “no”). 
Additional demographics and clinical data were collected, including age, gender, living 
status, and living arrangements (see Table 1). Clinical data collected included cognition assessed by 
the Clock Drawing Test (CDT) (Shulman et al., 1993) or Mini Mental State Examination (MMSE) 
(Tombaugh & McIntyre, 1992), life expectancy (weeks, months, years), type of malignant disease, 
metastases (yes/no), and Flemish Triage Risk Screening Tool (TRST) (Deschodt et al., 2011). 
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Table 1 Characteristics of patients (N=120) 
  Mean (SD) N (%) 
Age (years) 
Gender 
Male  
Female 
Living status 
Married 
Widow/widower 
Unmarried 
Divorced 
Cancer type 
Gastro-intestinal cancer 
Lung cancer 
Breast cancer 
Prostate cancer 
Urogenital cancer 
Hematological cancer 
Other type of cancer 
Metastases 
Yes 
No 
Life expectancy 
Weeks 
Months 
Years 
Cognitive statusa 
Normal 
Deficit 
 77.5 (0.7) 
 
 
 
 
 
 
 
 
 
 
 
78 (65.0) 
42 (35.0) 
 
77 (64.1) 
32 (26.7) 
8 (6.7) 
3 (2.5) 
 
55 (45.8) 
21 (17.5) 
12 (10.0) 
11 (9.2) 
9 (7.5) 
7 (5.8) 
5 (4.2) 
 
98 (81.7) 
22 (18.3) 
 
19 (15.8) 
69 (57.5) 
32 (26.7) 
 
97 (80.8) 
23 (19.2) 
a For the Clock Drawing Test (CDT), a score of 2 or greater represented a cognitive deficit, whereas a score of 0  
or 1 was considered to be normal. For the Mini Mental State  Examination, a score of 23 or greater  was  
considered to be normal. 
 
DATA COLLECTION 
Ethical approval was obtained by the ethics review committee of the two general hospitals 
(B/670201215149). Eligible patients were identified by the attending physicians. The physicians 
provided oral information about the study to the patient. After consent, the patients, proxies, and 
nurses were approached by one of the two researcher assistants who explained the study more 
extensively. Patients who agreed to participate were asked to sign an informed consent. Proxies and 
nurses provided oral consent.    
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Patients, nurses and proxies of the patients assessed the symptoms independently on the 
same day using the validated instrument. Patients completed the instrument by means of a 
standardized and structured interview with one of the two researchers. The nurses and proxies 
received the instrument in hard copy.  
 
DATA ANALYSIS 
The data was analyzed using the statistical software program SPSS (version 20) (SPSS Inc., 
Chicago, IL, USA). Descriptive statistics and symptoms were presented in absolute numbers and 
frequencies.  
The level of agreement was examined using three different methods as described by 
Laugsand et al. (2010). First, agreement at group level was measured using the Wilcoxon Signed-Rank 
test to compare the frequency and intensity of symptoms as assessed by the three assessors. Second, 
differences in scores were measured for frequency and intensity of each symptom. The difference 
score was computed by (a) subtracting the score obtained of the patient from the score of the nurse 
and (b) subtracting the score of the patient from the score of the proxy. Patient assessment was seen 
as the gold standard. Difference scores (DS) were interpreted as follows: DS ± 1, good agreement, DS 
of -2 or lower, underestimation; DS of 2 or greater, overestimation. Third, agreement at individual 
level was measured using the intraclass correlation coefficient (ICC), two-way mixed effect model, and 
the absolute agreement. The ICC was reported with its 95% confidence interval (CI). The strength of 
agreement was interpreted according to Landis and Koch (1977): 0.00-0.20, poor; 0.21-0.40, fair; 0.41-
0.60, moderate; 0.61-0.80, substantial; 0.81-1.00, almost perfect.  
The DS were used to investigate the demographic and disease-related factors associated 
with under- and overestimation and good agreement. The chi-square test was used to measure this 
association. A p value of less than 0.05 was considered significant.       
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RESULTS 
A total of 120 hospitalized patients participated in the study. Patients had a mean age of 
77.5 (SD = 0.7) years. The five most prevalent symptoms were fatigue (85.8%), lack of energy (84.2%), 
lack of appetite (80.9%), dry mouth (79.2%), and difficulties with self-care abilities (73.3%). 
Agreement scores of symptom assessment at group level between patients, and nurses and 
proxies is provided in Table 2.  
Nurses tended to report lower symptom frequency and intensity compared to patients; 
however, for 61% of the symptoms, no significant difference in agreement between patients and 
nurses was noted. Proxies tended to report higher symptom frequency and intensity compared to 
patients. However, this was not the case for all symptoms. No significant difference were noted 
between patients and their proxies for the frequency (80.5%) and intensity (88.9%) of symptoms. 
The direct over- and underestimation of symptoms defined as a DS of -2 or less or +2 or 
greater are provided in Tables 3.  
The frequency of symptoms most underestimated by nurses were dry mouth (42.5%) and 
changes in the taste of food (39.2%). Best agreement was found for the assessment of fecal 
incontinence (92.5%), vomiting (91.7%), and diarrhea (91.7%). The intensity of symptoms most 
underestimated by nurses were fatigue (8.3%) and difficulties with self-care (8.3%). The frequency of 
the symptom most often overestimated by nurses was fear (19.2%). The intensity of the symptom 
most often overestimated by nurses was difficulties with self-care (5.0%).  
The frequency of symptoms most underestimated by proxies were dry mouth (19.2%) and 
tingling in hands or feet (15.0%). Best agreement was found for feeling supported (96.7%), vomiting 
(93.3%), and fecal incontinence (92.5%). The intensity of the symptom most underestimated by 
proxies was anger (6.7%). The frequency of the symptom most often overestimated by proxies were 
brooding (24.2%), tension (23.3%), nervousness (23.3%), and fear (23.3%). The symptom intensity 
most often overestimated by proxies was lack of energy (5.8%). 
  
  
Table 2 Frequency and intensity of symptoms rated by patients, nurses and proxies 
Symptom Assessor Never 
 
 
N (%) 
Rarely 
 
 
N (%) 
Some-
times 
 
N (%) 
Often 
 
 
N (%) 
Always 
 
 
N (%) 
Wilcox 
signed 
rank test 
P-value 
Not 
 
 
N (%) 
Some- 
what 
 
N (%) 
Moder- 
ate 
 
N (%) 
Very 
serious 
 
N (%) 
Wilcox 
signed 
rank test 
P-value 
Physical             
Lack of appetite Patient 
Nurse 
Proxy 
23 (19.1) 
19 (11.0) 
26 (21.7) 
5 (4.2) 
21 (17.5) 
3 (2.5) 
17 (14.2) 
32 (26.7) 
16 (13.3) 
36 (30.0) 
25 (20.8) 
40 (33.3) 
39 (32.5) 
23 (19.2) 
35 (29.2) 
 
0.00** 
0.29 
6 (6.2) 
3 (3.0) 
5 (5.3) 
16 (16.5) 
22 (21.8) 
8 (8.5) 
29 (29.9) 
51 (50.5) 
39 (41.5) 
46 (47.4) 
25 (24.8) 
42 (44.7) 
 
0.13 
0.44 
Fatigue Patient 
Nurse 
Proxy 
17 (14.2) 
11 (9.2) 
10 (8.3) 
4 (3.3) 
10 (8.3) 
4 (3.3) 
23 (19.2) 
36 (30.0) 
23 (19.2) 
35 (29.2) 
39 (32.5) 
47 (39.2) 
41 (34.2) 
24 (20.0) 
36 (30.0) 
 
0.16 
0.32 
3 (2.9) 
2 (1.8) 
4 (3.6) 
13 (12.6) 
22 (20.2) 
12 (10.9) 
48 (46.6) 
70 (64.2) 
55 (50.0) 
39 (37.9) 
15 (13.8) 
39 (35.5) 
 
0.00** 
0.98 
Pain Patient 
Nurse 
Proxy 
34 (28.3) 
26 (21.7) 
30 (25.0) 
10 (8.3) 
19 (15.8) 
4 (3.3) 
21 (17.5) 
31 (25.8) 
33 (27.5) 
33 (27.5) 
35 (29.2) 
29 (24.2) 
22 (18.3) 
9 (7.5) 
24 (20.0) 
 
0.20 
0.55 
2 (2.3) 
2 (2.1) 
3 (3.6) 
4 (4.7) 
19 (20.2) 
6 (7.2) 
33 (38.4) 
25 (26.6) 
16 (19.3) 
47 (54.7) 
48 (51.1) 
58 (69.9) 
 
0.22 
0.06 
Lack of energy Patient 
Nurse 
Proxy 
19 (15.8) 
12 (10.0) 
16 (13.3) 
11 (9.2) 
14 (11.7) 
6 (5.0) 
27 (22.5) 
35 (29.2) 
29 (24.2) 
36 (30.0) 
50 (41.7) 
40 (33.3) 
27 (22.5) 
9 (7.5) 
29 (24.2) 
 
0.50 
0.21 
6 (5.9) 
2 (1.9) 
2 (1.9) 
20 (19.8) 
25 (23.1) 
15 (14.4) 
42 (41.6) 
70 (56.5) 
48 (46.2) 
33 (32.7) 
20 (18.5) 
39 (37.5) 
 
0.14 
0.07 
Nausea Patient 
Nurse 
Proxy 
66 (55.0) 
58 (48.3) 
63 (52.5) 
4 (3.3) 
19 (15.8) 
15 (12.5) 
27 (22.5) 
27 (22.5) 
25 (20.8) 
17 (14.2) 
15 (12.5) 
12 (10.0) 
6 (5.0) 
1 (0.8) 
5 (4.2) 
 
0.35 
0.21 
3 (5.6) 
5 (8.1) 
1 (1.8) 
7 (13.0) 
18 (29.0) 
11 (19.3) 
15 (27.8) 
23 (37.1) 
16 (28.1) 
29 (53.7) 
16 (25.8) 
29 (50.9) 
 
0.16 
0.39 
Sleeplessness Patient 
Nurse 
Proxy 
70 (58.3) 
52 (43.3) 
51 (42.4) 
7 (5.8) 
20 (16.7) 
11 (9.2) 
24 (20.0) 
37 (30.8) 
29 (24.2) 
32 (26.7) 
8 (6.7) 
23 (19.2) 
7 (5.8) 
3 (2.5) 
6 (5.0) 
 
0.00** 
0.26 
3 (4.3) 
4 (5.9) 
4 (5.8) 
9 (12.9) 
21 (30.9) 
8 (11.6) 
32 (45.7) 
32 (47.1) 
33 (47.8) 
26 (37.1) 
11 (16.2) 
24 (34.8) 
 
0.00** 
0.79 
Vomiting Patient 
Nurse 
Proxy 
92 (76.6) 
85 (70.8) 
87 (72.4) 
2 (1.7) 
12 (10.0) 
8 (6.7) 
8 (6.7) 
14 (11.7) 
11 (9.2) 
14 (11.7) 
9 (7.5) 
12 (10.0) 
4 (3.3) 
0 (0.0) 
2 (1.7) 
 
0.31 
0.83 
0 (0.0) 
2 (5.7) 
0 (0.0) 
1 (3.6) 
8 (22.9) 
4 (12.1) 
10 (35.7) 
11(31.4) 
12 (36.4) 
17 (60.7) 
14 (40.0) 
17 (51.5) 
 
0.22 
0.76 
Dizziness Patient 
Nurse 
Proxy 
82 (68.3) 
69 (57.5) 
68 (56.6) 
9 (7.5) 
21 (17.5) 
14 (11.7) 
18 (15.0) 
20 (16.7) 
27 (22.5) 
6 (5.0) 
10 (8.3) 
9 (7.5) 
5 (4.2) 
0 (0.0) 
2 (1.7) 
 
0.41 
0.16 
2 (5.3) 
8 (15.7) 
4 (7.7) 
12 (31.6) 
22 (43.1) 
18 (34.6) 
12 (31.6) 
16 (31.4) 
18 (34.6) 
12 (31.6) 
5 (9.8) 
12 (23.1) 
 
0.00*** 
0.97 
Tension Patient 
Nurse 
Proxy 
79 (65.9) 
55 45.8) 
55 (45.8) 
12 (10.0) 
31 (25.8) 
12 (10.0) 
19 (15.8) 
22 (18.3) 
36 (30.0) 
7 (5.8) 
11 (9.2) 
11 (9.2) 
3 (2.5) 
1 (0.8) 
6 (5.0) 
 
0.06 
0.00** 
3 (7.3) 
0 (0.0) 
2 (3.1) 
11 (26.8) 
28 (43.1) 
13 (20.0) 
19 (46.3) 
31 (47.7) 
30 (46.2) 
8 (19.5) 
6 (9.2) 
20 (30.8) 
 
0.14 
0.27 
  
Symptom Assessor Never 
 
 
N (%) 
Rarely 
 
 
N (%) 
Some-
times 
 
N (%) 
Often 
 
 
N (%) 
Always 
 
 
N (%) 
Wilcox 
signed 
rank test 
P-value 
Not 
 
 
N (%) 
Some- 
what 
 
N (%) 
Moder- 
ate 
 
N (%) 
Very 
serious 
 
N (%) 
Wilcox 
signed 
rank test 
P-value 
Heartburn/belching Patient 
Nurse 
Proxy 
77 (64.2) 
83 (69.2) 
85 (70.8) 
11 (9.2) 
14 (11.7) 
3 (2.5) 
15 (12.5) 
18 (15.0) 
21 (17.5) 
13 (10.8) 
5 (4.2) 
8 (6.7) 
4 (3.3) 
0 (0.0) 
3 (2.5) 
 
0.02* 
0.31 
5 (11.6) 
1 (2.7) 
3 (8.6) 
16 (37.2) 
22 (59.5) 
11 (31.4) 
13 (30.2) 
14 (37.8) 
13 (37.1) 
9 (20.9) 
0 (0.0) 
8 (22.9) 
 
0.56 
0.42 
Constipation Patient 
Nurse 
Proxy 
72 (60.0) 
71 (59.2) 
75 (62.5) 
5 (4.2) 
13 (10.8) 
6 (5.0) 
15 (12.5) 
17 (14.2) 
18 (15.0) 
16 (13.3) 
15 (12.5) 
11 (9.2) 
12 (10.0) 
4 (3.3) 
10 (8.3) 
 
0.16 
0.34 
4 (8.3) 
3 (6.1) 
2 (4.4) 
8 (16.7) 
20 (40.8) 
13 (28.9) 
21 (43.8) 
15 (30.6) 
13 (28.9) 
15 (31.3) 
11 (22.4) 
17 (37.8) 
 
0.54 
0.28 
Diarrhea Patient 
Nurse 
Proxy 
83 (69.1) 
83 (69.1) 
80 (66.7) 
8 (6.7) 
17 (14.2) 
15 (12.5) 
13 (10.8) 
9 (7.5) 
14 (11.7) 
12 (10.0) 
10 (8.3) 
10 (8.3) 
4 (3.3) 
1 (0.8) 
1 (0.8) 
  
0.05* 
0.28 
0 (0.0) 
3 (8.1) 
1 (2.5) 
6 (16.2) 
12 (32.4) 
6 (20.0) 
10 (27.0) 
9 (24.3) 
11 (27.5) 
21 (56.8) 
13 (35.1) 
20 (50.0) 
 
0.30 
0.11 
Tingling hand/feet Patient 
Nurse 
Proxy 
91 (75.8) 
110 (91.2) 
101 (84.1) 
3 (2.5) 
8 (6.7) 
6 (5.0) 
12 (10.0) 
1 (0.8) 
3 (2.5) 
6 (5.0) 
1 (0.8) 
4 (3.3) 
8 (6.7) 
0 (0.0) 
6 (5.0) 
 
0.00*** 
0.02 
6 (20.7) 
1 (10.0) 
0 (0.0) 
7 (24.1) 
6 (60.0) 
5 (26.3) 
5 (17.2) 
3 (30.0) 
5 (26.3) 
11 (37.9) 
0 (0.0) 
9 (47.4) 
 
0.16 
0.58 
Sore mouth/pain 
when swallowing 
Patient 
Nurse 
Proxy 
84 (70.0) 
84 (70.0) 
86 (71.7) 
2 (1.7) 
13 (10.8) 
6 (5.0) 
14 (11.7) 
7 (5.8) 
6 (5.0) 
12 (10.0) 
15 (12.5) 
14 (11.7) 
8 (6.7) 
1 (0.8) 
8 (6.7) 
 
0.07 
0.53 
0 (0.0) 
1 (2.8) 
1 (2.9) 
7 (19.4) 
12 (33.3) 
5 (14.7) 
13 (36.1) 
19 (52.8) 
13 (38.2) 
16 (44.4) 
4 (11.1) 
15 (44.1) 
 
0.02* 
0.53 
Shortness of breath Patient 
Nurse 
Proxy 
56 (46.7) 
52 (43.3) 
53 (44.2) 
6 (5.0) 
14 (11.7) 
4 (3.3) 
21 (17.5) 
27 (22.5) 
30 (25.0) 
25 (20.8) 
17 (14.2) 
16 (13.3) 
12 (10.0) 
10 (8.3) 
17 (14.2) 
 
0.34 
0.50 
1 (1.6) 
1 (1.5) 
2 (3.0) 
5 (7.8) 
17 (25.0) 
3 (4.5) 
21 (32.8) 
21 (30.9) 
20 (29.9) 
37 (57.8) 
29 (42.6) 
42 (62.7) 
 
0.02* 
0.15 
Dry mouth Patient 
Nurse 
Proxy 
25 (20.8) 
51 (42.5) 
31 (25.8) 
3 (2.5) 
21 (17.5) 
7 (5.8) 
26 (21.7) 
25 (20.8) 
34 (28.3) 
40 (33.3) 
19 (15.8) 
36 (30.0) 
26 (21.7) 
4 (3.3) 
12 (10.0) 
 
0.00*** 
0.00** 
5 (5.3) 
6 (8.7) 
11 (12.4) 
31 (32.6) 
34 (49.3) 
25 (28.1) 
35 (36.8) 
24 (34.8) 
31 (34.8) 
24 (25.3) 
5 (7.2) 
22 (24.7) 
 
0.01* 
0.28 
Cough Patient 
Nurse 
Proxy 
64 (53.3) 
66 (55.0) 
69 (57.5) 
10 (8.3) 
19 (15.8) 
8 (6.7) 
20 (16.7) 
15 (12.5) 
17 (14.2) 
18 (15.0) 
17 (14.2) 
21 (17.5) 
8 (6.7) 
3 (2.5) 
5 (4.2) 
 
0.04* 
0.32 
1 (1.8) 
3 (5.6) 
7 (13.7) 
14 (25.0) 
25 (46.3) 
10 (19.6) 
26 (46.4) 
23 (42.6) 
19 (37.3) 
15 (26.8) 
3 (5.6) 
15 (29.4) 
 
0.00*** 
0.09 
Itching Patient 
Nurse 
Proxy 
80 (66.7) 
101 (84.2) 
88 (73.3) 
2 (1.7) 
10 (8.3) 
4 (3.3) 
10 (8.3) 
5 (4.2) 
8 (6.7) 
8 (6.7) 
4 (3.3) 
4 (3.3) 
20 (16.7) 
0 (0.0) 
16 (13.3) 
 
0.16 
0.12 
4 (20.0) 
2 (10.5) 
2 (12.5) 
6 (30.0) 
11 (57.9) 
7 (43.8) 
5 (25.0) 
4 (21.1) 
4 (25.0) 
5 (25.0) 
2 (10.5) 
3 (18.8) 
 
0.27 
0.32 
Changes in food 
tasting 
Patient 
Nurse 
Proxy 
48 (40.0) 
74 (61.2) 
45 (37.5) 
5 (4.2) 
13 (10.8) 
4 (3.3) 
16 (13.3) 
20 (16.7) 
7 (5.8) 
16 (13.3) 
10 (8.3) 
34 (28.3) 
35 (29.2) 
3 (2.5) 
30 (25.0) 
 
0.00*** 
0.52 
6 (8.3) 
2 (4.3) 
4 (5.3) 
13 (18.1) 
18 (39.1) 
28 (9.3) 
22 (30.6) 
21 (45.7) 
13 (45.3) 
31 (43.1) 
5 (10.9) 
9 (40.0) 
 
0.27 
0.19 
  
Symptom Assessor Never 
 
 
N (%) 
Rarely 
 
 
N (%) 
Some-
times 
 
N (%) 
Often 
 
 
N (%) 
Always 
 
 
N (%) 
Wilcox 
signed 
rank test 
P-value 
Not 
 
 
N (%) 
Some- 
what 
 
N (%) 
Moder- 
ate 
 
N (%) 
Very 
serious 
 
N (%) 
Wilcox 
signed 
rank test 
P-value 
Airway mucus Patient 
Nurse 
Proxy 
62 (50.8) 
67 (55.8) 
66 (55.0) 
8 (6.7) 
11 (9.2) 
4 (3.3) 
22 (18.3) 
24 (20.0) 
28 (23.3) 
17 (14.2) 
15 (12.5) 
13 (10.8) 
12 (10.0) 
3 (2.5) 
9 (7.5) 
 
0.03* 
0.25 
3 (5.1) 
4 (7.5) 
2 (3.7) 
18 (30.5) 
21 (39.6) 
17 (31.5) 
22 (37.3) 
22 (41.5) 
23 (42.6) 
16 (27.1) 
6 (11.3) 
12 (22.2) 
 
0.05* 
0.68 
Urinary 
incontinence 
Patient 
Nurse 
Proxy 
97 (80.8) 
99 (82.5) 
99 (82.5) 
4 (3.3) 
4 (3.3) 
3 (2.5) 
11 (9.2) 
8 (6.7) 
9 (7.5) 
5 (4.2) 
4 (3.3) 
5 (4.2) 
3 (2.5) 
5 (4.2) 
4 (3.3) 
 
0.89 
0.78 
0 (0.0) 
1 (4.5) 
2 (9.5) 
3 (13.0) 
4 (18.2) 
0 (0.0) 
3 (26.1) 
8 (36.4) 
9 (42.9) 
14 (60.9) 
9 (40.9) 
10 (47.6) 
 
0.06 
1.00 
Fecal incontinence Patient 
Nurse 
Proxy 
105 (87.5) 
103 (85.8) 
108 (90.0) 
2 (1.7) 
6 (5.0) 
3 (2.5) 
7 (5.8) 
3 (2.5) 
5 (4.2) 
3 (2.5) 
4 (3.3) 
2 (1.7) 
3 (2.5) 
4 (3.3) 
2 (1.7) 
 
0.89 
0.15 
0 (0.0) 
0 (0.0) 
1 (8.3) 
2 (13.3) 
5 (29.4) 
1 (8.3) 
0 (0.0) 
6 (35.3) 
4 (33.3) 
13 (86.7) 
6 (35.3) 
6 (50.0) 
 
0.19 
0.08 
Weight lossb Patient 
Nurse 
Proxy 
34 (28.3) 
44 (36.7) 
35 (29.2)  
   86 (71.7) 
76 (63.3)  
85 (70.8) 
 
0.00*** 
0.00*** 
     
Psychological             
Brooding Patient 
Nurse 
Proxy 
42 (35.0) 
21 (17.5) 
18 (15.0) 
10 (8.3) 
22 (18.3) 
11 (9.2) 
23 (19.2) 
46 (38.3) 
39 (32.5) 
33 (27.5) 
25 (20.8) 
37 (30.8) 
12 (10.0) 
6 (5.0) 
15 (12.5) 
 
0.56 
0.00*** 
4 (5.1) 
0 (0.0) 
3 (2.9) 
14 (17.9) 
25 (25.3) 
15 (14.7) 
37 (47.4) 
67 (62.6) 
51 (50.0) 
23 (29.5) 
12 (12.1) 
33 (32.4) 
 
0.34 
0.06 
Depressed mood Patient 
Nurse 
Proxy 
54 (45.0) 
37 (30.8) 
35 (29.1) 
10 (8.3) 
31 (25.8) 
12 (10.0) 
41 (34.2) 
34 (28.3) 
40 (33.3) 
13 (10.8) 
16 (13.3) 
28 (23.3) 
2 (1.7) 
2 (1.7) 
5 (4.2) 
 
0.24 
0.00*** 
0 (0.0) 
0 (0.0) 
2 (2.4) 
9 (13.6) 
22 (26.5) 
7 (8.2) 
32 (48.5) 
40 (48.5) 
31 (36.5) 
25 (37.9) 
21 (25.3) 
45 (52.9) 
 
0.14 
0.02* 
Nervousness Patient 
Nurse 
Proxy 
56 (46.7) 
60 (50.0) 
44 (36.7) 
11 (9.2) 
25 (20.8) 
7 (5.8) 
26 (21.7) 
21 (17.5) 
30 (25.0) 
19 (15.8) 
11 (9.2) 
24 (20.0) 
8 (6.7) 
3 (2.5) 
15 (12.5) 
 
0.02* 
0.00** 
2 (3.1) 
2 (3.3) 
9 (11.8) 
20 (31.3) 
30 (50.0) 
23 (30.3) 
26 (40.6) 
21 (35.0) 
33 (43.4) 
16 (25.0) 
7 (11.7) 
11 (14.5) 
 
0.00** 
0.08 
Fear Patient 
Nurse 
Proxy 
72 (60.0) 
41 (34.1) 
52 (43.3) 
9 (7.5) 
28 (23.3) 
2 (1.7) 
21 (17.5) 
34 (28.3) 
42 (35.0) 
11 (9.2) 
15 (12.5) 
16 (13.3) 
7 (5.8) 
2 (1.7) 
8 (6.7) 
 
0.01* 
0.00*** 
2 (4.2) 
1 (1.3) 
1 (1.5) 
6 (12.5) 
17 (21.5) 
6 (8.8) 
17 (35.4) 
38 (48.1) 
23 (33.8) 
23 (47.9) 
23 (29.1) 
38 (55.9) 
 
0.14 
0.02* 
Difficulties 
concentrating 
Patient 
Nurse 
Proxy 
63 (52.5) 
60 (50.0) 
55 (45.8) 
7 (5.8) 
16 (13.3) 
12 (10.0) 
30 (25.0) 
34 (28.3) 
34 (28.3) 
18 (15.0) 
9 (7.5) 
14 (11.7) 
2 (1.7) 
0 (0.0) 
5 (4.2) 
 
0.33 
0.33 
3 (5.3) 
3 (5.1) 
7 (10.8) 
15 (26.3) 
23 (39.0) 
19 (29.2) 
22 (38.6) 
27 (45.8) 
24 (36.9) 
17 (29.8) 
6 (10.2) 
15 (23.1) 
 
0.31 
0.15 
Anger Patient 
Nurse 
Proxy 
85 (70.8) 
78 (65.0) 
63 (52.5) 
2 (1.7) 
15 (12.5) 
19 (15.8) 
21 (17.5) 
25 (20.8) 
34 (28.3) 
11 (9.2) 
2 (1.7) 
2 (1.7) 
1 (0.8) 
0 (0.0) 
1 (0.8) 
 
0.40 
0.12 
0 (0.0) 
1 (2.4) 
3 (5.4) 
2 (5.7) 
15 (35.7) 
15 (26.8) 
19 (54.3) 
22 (52.4) 
22 (39.3) 
14 (40.0) 
4 (9.5) 
16 (28.6) 
 
0.03* 
0.00** 
  
Symptom Assessor Never 
 
 
N (%) 
Rarely 
 
 
N (%) 
Some-
times 
 
N (%) 
Often 
 
 
N (%) 
Always 
 
 
N (%) 
Wilcox 
signed 
rank test 
P-value 
Not 
 
 
N (%) 
Some- 
what 
 
N (%) 
Moder- 
ate 
 
N (%) 
Very 
serious 
 
N (%) 
Wilcox 
signed 
rank test 
P-value 
Loneliness Patient 
Nurse 
Proxy  
76 (63.3) 
58 (48.3) 
68 (56.7) 
6 (5.0) 
21 (17.5) 
13 (10.8) 
24 (20.0) 
32 (26.7) 
25 (20.8) 
12 (10.0) 
9 (7.5) 
14 (11.7) 
2 (1.7) 
0 (0.0) 
0 (0.0) 
 
0.40 
0.49 
0 (0.0) 
4 (6.5) 
1 (1.9) 
5 (11.4) 
12 (19.4) 
2 (3.8) 
15 (34.1) 
26 (41.9) 
17 (32.7) 
24 (54.5) 
20 (32.3) 
32 (61.5) 
 
0.13 
0.16 
Confusion Patient 
Nurse 
Proxy 
92 (76.7) 
98 (81.7) 
89 (74.1) 
7 (5.8) 
9 (7.5) 
7 (5.8) 
17 (14.2) 
10 (8.3) 
20 (16.7) 
4 (3.3) 
3 (2.5) 
3 (2.5) 
0 (0.0) 
0 (0.0) 
1 (0.8) 
 
0.08 
0.40 
0 (0.0) 
3 (13.6) 
4 (12.9) 
6 (21.4) 
7 (31.8) 
4 (12.9) 
11 (39.3) 
11 (50.0) 
18 (58.1) 
11 (39.3) 
1 (4.5) 
5 (16.1) 
 
0.05* 
0.74 
Functional             
Difficulties with 
self-care  
Patient 
Nurse 
Proxy 
32 (26.7) 
14 (11.7) 
22 (18.3) 
3 (2.5) 
11 (9.2) 
7 (5.8) 
11 (9.2) 
20 (16.7) 
17 (14.2) 
19 (15.8) 
25 (20.8) 
20 (16.7) 
55 (45.8) 
50 (41.7) 
54 (45.0) 
 
0.04* 
0.16 
21 (23.9) 
23 (21.7) 
21 (21.4) 
20 (22.7) 
47 (44.3) 
28 (28.6) 
30 (34.1) 
32 (30.2) 
34 (34.7) 
17 (19.3) 
4 (3.8) 
15 (15.3) 
 
0.00** 
0.51 
Difficulties with 
moving 
Patient 
Nurse 
Proxy 
38 (31.7) 
24 (20.0) 
30 (25.0) 
11 (9.2) 
16 (13.3) 
11 (9.2) 
15 (12.5) 
28 (23.3) 
17 (14.2) 
23 (19.2) 
23 (19.2) 
28 (23.3) 
33 (27.5) 
29 (24.2) 
34 (28.3) 
 
0.22 
0.09 
11 (13.4) 
7 (7.3) 
15 (16.7) 
15 (18.3) 
38 (39.6) 
14 (15.6) 
33 (40.2) 
33 (40.6) 
36 (40.0) 
23 (28.0) 
12 (12.5) 
25 (27.8) 
 
0.09 
0.32 
Social             
Satisfied with social 
life 
Patient 
Nurse 
Proxy 
4 (0.3) 
11 (0.9) 
1 (0,1) 
4 (3.3) 
10 (8.3) 
6 (5.0) 
15 (12.5) 
21 (17.5) 
26 (21.7) 
23 (19.2) 
38 (31.7) 
29 (24.2) 
74 (61.7) 
40 (33.3) 
58 (48.3) 
 
0.00*** 
0.04* 
0 (0.0) 
0 (0.0) 
1 (0.8) 
10 (8.6) 
11 (9.3) 
9 (7.6) 
28 (24.1) 
49 (41.5) 
37 (31.1) 
78 (67.2) 
58 (49.2) 
72 (60.5) 
 
0.00** 
0.54 
Feeling supported Patient 
Nurse 
Proxy 
1 (0,1) 
1 (0.1) 
0 (0.0) 
3 (2.5) 
7 (5.8) 
3 (2.5) 
8 (6.7) 
15 (12.5) 
4 (3.3) 
21 (17.5) 
40 (33.3) 
34 (28.3) 
87 (72.5) 
57 (47.5) 
79 (65.8) 
 
0.00*** 
0.88 
0 (0.0) 
0 (0.0) 
0 (0.0) 
4 (3.4) 
5 (4.2) 
3 (2.5) 
23 (19.3) 
36 (30.3) 
21 (17.5) 
92 (77.3) 
78 (65.5) 
96 (80.0) 
 
0.00** 
0.22 
Existential             
Experience life as 
meaningful 
Patient 
Nurse 
Proxy 
5 (0.4) 
1 (0.1) 
2 (0.2) 
10 (8.3) 
7 (5.8) 
6 (5.0) 
14 (11.7) 
21 (17.5) 
16 (13.3) 
29 (24.2) 
46 (38.3) 
29 (24.2) 
62 (51.7) 
45 (37.5) 
67 (55.8) 
 
0.55 
0.11 
1 (0.9) 
0 (0.0) 
1 (0.8) 
6 (5.2) 
10 (8.4) 
1 (0.8) 
31 (27.0) 
37 (31.1) 
23 (19.5) 
77 (67.0) 
72 (60.5) 
93 (78.8) 
  
0.44 
0.00** 
*p<0.05; **p<0.01; ***p<0.001 
a Symptom frequency was assessed for all patients (n=120). Symptom intensity was only rated when the symptom was not assessed never present. Therefore, the 
number of rating for symptom intensity varies per symptom and per rater.  
b The item weight loss was a dichotomous variable: yes/no. This was transformed to never/always to allow representation in the table. Chi-square test was used to 
measure the difference between raters. 
 
 
  
 
 
Table 3 Under- and overestimation of symptoms 
  Symptom frequency   Symptom intensity 
  Underestimation Good agreement Overestimation   Underestimation Good agreement Overestimation 
  -4 -3 -2 %  0 ±1 %  +2 +3 +4 %   -3 -2 %  0 ±1 %  +2 +3 % 
PATIENT VERSUS NURSES                            
Physical Symptoms                            
Lack of appetite 2 6 17 20.8  50 37 72.5  6 2 0 6.7   0 6 5.0  38 40 91.7  4 0 3.3 
Fatigue 1 6 12 15.8  48 38 71.7  11 4 0 12.5   1 9 8.3  49 36 90.8  1 0 0.8 
Pain 0 5 12 14.2  46 47 77.5  5 5 0 8.3   1 5 5.0  48 22 94.2  1 0 0.8 
Lack of energy 0 5 9 11.7  49 43 76.7  11 3 0 11.7   0 3 2.5  37 51 95  3 0 2.5 
Nausea 0 3 13 13.3  60 34 78.3  8 2 0 8.3   2 3 4.2  21 12 93.3  2 1 2.5 
Sleeplessness 0 11 18 24.2  44 36 66.7  9 2 0 9.2   0 6 5.0  25 14 95.0  0 0 0.0 
Vomiting 0 3 4 5.8  91 19 91.7  2 1 0 2.5   1 1 1.7  12 9 98.3  0 0 0.0 
Dizziness 1 3 4 6.7  68 32 83.3  9 3 0 10.0   0 1 0.8  14 12 99.2  0 0 0.0 
Tensions 1 4 7 10.0  49 39 73.3  13 6 1 16.7   0 2 1.7  9 15 98.3  0 0 0.0 
Constipation 4 8 11 19.2  60 24 70.0  7 5 1 10.8   0 4 3.3  11 13 95.8  1 0 0.8 
Diarrhea 0 2 7 7.5  83 27 91.7  1 0 0 0.8   1 1 1.7  17 4 97.5  1 0 0.8 
Heartburn/belching 2 9 10 17.5  74 14 73.3  11 0 0 9.2   0 1 0.8  11 8 99.2  0 0 0.0 
Tingling hand/feet 6 6 12 20.0  86 10 80.0  0 0 0 0.0   0 0 0.0  2 2 100.0  0 0 0.0 
Sore mouth/pain when swallowing 1 8 8 14.2  77 20 80.8  5 0 1 5.0   1 2 2.5  8 9 97.5  0 0 0.0 
Shortness of breath 0 4 8 10.0  60 39 82.5  6 3 0 7.5   0 6 5.0  28 17 95.0  0 0 0.0 
Dry mouth 12 17 22 42.5  32 32 53.3  3 2 0 4.2   0 6 5.0  20 28 93.3  2 0 1.7 
Cough 1 5 8 11.7  75 27 85.0  2 2 0 3.3   0 5 4.2  16 19 95.8  0 0 0.0 
Itching 0 5 9 11.7  89 12 84.2  2 3 0 4.2   0 0 0.0  1 5 100.0  0 0 0.0 
Change in food tasting 22 10 15 39.2  44 21 54.2  3 5 0 6.7   1 3 3.3  11 14 95.8  1 0 0.8 
   
 
 
  Symptom frequency   Symptom intensity 
  Underestimation Good agreement Overestimation   Underestimation Good agreement Overestimation 
  -4 -3 -2 %  0 ±1 %  +2 +3 +4 %   -3 -2 %  0 ±1 %  +2 +3 % 
Airway mucus 3 7 11 18.3  64 25 74.2  7 3 0 8.3   0 4 3.3  19 14 95.8  1 0 0.8 
Urinary incontinence 1 1 6 6.7  92 12 86.7  4 2 1 5.8   0 2 1.7  8 2 98.3  0 0 0.0 
Fecal incontinence 0 0 5 4.2  98 13 92.5  3 0 1 3.3   0 2 1.7  4 2 98.3  0 0 0.0 
Psychological symptoms                           
Brooding 0 5 12 14.2  40 44 70.0  13 5 1 15.8   0 4 3.3  33 30 93.3  4 0 3.3 
Depressed mood 0 3 9 10.0  55 26 67.5  14 3 0 14.2   0 3 2.5  32 20 96.7  1 0 0.8 
Nervousness 1 10 19 25.0  44 31 62.5  9 3 3 12.5   0 5 4.2  19 13 95.8  0 0 0.0 
Fear 1 2 8 9.2  46 40 71.7  17 5 1 19.2   0 2 1.7  22 14 98.3  0 0 0.0 
Difficulties concentrating 0 9 12 17.5  61 22 69.2  13 3 0 13.3   0 4 3.3  13 18 95.8  1 0 0.8 
Anger 0 3 11 11.7  75 22 80.8  8 2 0 8.3   1 2 2.5  11 8 97.5  0 0 0.0 
Loneliness 0 1 13 11.7  65 27 76.7  12 2 0 11.7   0 3 2.5  17 11 97.5  0 0 0.0 
Confusion 0 1 10 9.2  93 12 87.5  4 0 0 3.3   2 1 2.5  7 4 97.5  0 0 0.0 
Functional                           
Difficulties with self-care 0 2 2 3.3  71 32 85.8  7 6 0 10.8   2 8 8.3  34 37 86.7  5 1 5.0 
Difficulties with moving 0 3 7 8.3  64 29 77.5  14 3 0 14.2   1 3 3.3  29 39 93.3  3 1 3.3 
Social                           
Satisfied with social life 2 5 12 15.8  59 37 80.0  3 1 1 4.2   0 2 1.7  73 39 98.3  0 0 0.0 
Feeling supported 0 4 6 8.3  75 34 90.8  0 1 0 0.8   0 0 0.0  86 32 100.0  0 0 0.0 
Existential                           
Experience life as meaningful 0 3 6 7.5  59 41 83.3  7 2 2 9.2   0 4 3.3  71 38 95.0  2 0 1.7 
PATIENTS VERSUS PROXIES                           
  
 
 
  Symptom frequency   Symptom intensity 
  Underestimation Good agreement Overestimation   Underestimation Good agreement Overestimation 
  -4 -3 -2 %  0 ±1 %  +2 +3 +4 %   -3 -2 %  0 ±1 %  +2 +3 % 
Physical symptoms                           
Lack of appetite 0 1 5 5.0  76 33 90.8  1 4 0 4.1   1 1 1.7  50 34 92.5  4 0 2.5 
Fatigue 0 4 6 8.8  55 40 79.2  7 6 2 12.5   1 5 5.0  50 39 92.5  3 0 2.5 
Pain 2 6 8 13.4  57 29 71.6  12 3 3 15.0   0 0 0.0  51 16 97.5  3 0 2.5 
Lack of energy 0 6 6 10.0  58 30 73.3  13 5 2 16.7   0 3 2.5  43 40 91.7  6 1 5.8 
Nausea 1 1 11 10.8  76 27 85.8  4 0 0 3.3   0 2 1.7  27 11 95.8  3 0 2.5 
Sleeplessness 1 6 9 13.3  52 40 76.7  8 3 1 10.0   1 3 3.3  27 20 95.0  0 2 1.7 
Vomiting 0 3 2 4.2  97 15 93.3  1 2 0 2.5   0 0 0.0  13 11 100.0  0 0 0.0 
Dizziness 0 2 9 9.2  71 26 80.8  8 4 0 10.0   0 2 1.7  11 14 95.8  3 0 2.5 
Tensions 1 4 5 12.0  57 25 68.3  17 7 4 23.3   0 1 0.8  16 9 97.5  1 1 1.7 
Constipation 4 7 5 13.3  70 22 76.7  9 1 2 10.0   0 0 0.0  13 17 99.2  1 0 0.8 
Diarrhea 0 1 5 5.0  87 23 91.7  3 1 0 3.3   0 1 0.8  18 10 99.2  0 0 0.0 
Heartburn/belching 1 3 10 11.7  78 18 80.0  4 6 0 8.3   0 2 1.7  9 12 97.5  1 0 0.8 
Tingling hand/feet 2 4 12 15.0  88 10 81.7  0 1 3 3.3   0 1 0.8  8 2 98.3  1 0 0.8 
Sore mouth/pain when swallowing 1 4 6 9.2  88 15 85.8  1 3 2 5.0   0 0 0.0  15 10 100.0  0 0 0.0 
Shortness of breath 1 4 5 8.3  70 29 82.5  7 2 2 9.2   0 1 0.8  33 18 97.5  2 0 1.7 
Dry mouth 4 6 13 19.2  51 36 72.5  7 2 1 7.5   2 4 5.0  39 32 93.3  2 0 1.7 
Cough 1 3 6 8.3  78 24 85.0  4 2 2 8.0   1 1 1.7  26 14 98.3  0 0 0.0 
Itching 0 4 5 7.5  97 10 89.2  4 0 0 3.3   0 1 0.8  3 5 99.2  0 0 0.0 
Change in food tasting 2 4 4 8.3  74 22 80.0  7 2 5 11.7   0 0 0.0  42 15 95.8  4 1 4.2 
Airway mucus 2 3 9 14.0  77 19 80.0  6 2 2 8.3   0 2 1.7  18 23 95.8  3 0 2.5 
Urinary incontinence 1 2 7 7.5  95 9 86.7  2 2 2 6.0   0 0 0.0  7 4 99.2  1 0 0.8 
   
 
 
  Symptom frequency   Symptom intensity 
  Underestimation Good agreement Overestimation   Underestimation Good agreement Overestimation 
  -4 -3 -2 %  0 ±1 %  +2 +3 +4 %   -3 -2 %  0 ±1 %  +2 +3 % 
Fecal incontinence 1 0 6 5.8  105 6 92.5  2 0 0 1.7   0 0 0.0  4 3 100.0  0 0 0.0 
Psychological symptoms                           
Brooding 0 3 3 5.0  48 37 70.8  23 5 1 24.2   1 1 1.7  35 31 94.2  5 0 4.2 
Depressed mood 0 0 7 5.8  56 34 75.0  17 3 3 19.2   0 0 0.0  22 32 97.5  3 0 2.5 
Nervousness 0 2 8 8.3  59 23 68.3  18 8 2 23.3   0 2 1.7  21 28 96.7  2 0 1.7 
Fear 0 1 5 5.0  64 22 71.7  22 3 3 23.3   0 0 0.0  24 14 97.5  3 0 2.5 
Difficulties concentrating 0 2 8 8.3  75 20 79.2  10 3 2 12.5   2 3 4.2  22 16 93.3  3 0 2.5 
Anger 0 2 5 8.3  76 22 81.7  15 1 0 13.3   0 8 6.7  16 8 93.3  0 0 0.0 
Loneliness 0 1 5 5.0  80 26 88.3  6 2 0 6.7   1 0 0.8  15 18 97.5  2 0 1.7 
Confusion 0 1 4 4.2  94 13 89.2  7 1 0 6.7   0 0 0.0  10 9 100.0  0 0 0.0 
Functional                           
Difficulties with self-care 2 0 3 4.2  85 21 88.3  6 0 3 7.5   3 3 5.0  40 35 92.5  2 1 2.5 
Difficulties with moving 1 1 6 6.7  77 21 81.7  10 1 3 11.7   2 4 5.0  42 27 94.2  0 1 0.8 
Social                           
Satisfied with social life 1 1 8 10.0  69 35 86.7  3 2 1 5.0   0 0 0.0  79 34 98.3  2 0 1.7 
Feeling supported 0 1 0 0.8  97 19 96.7  2 1 0 2.5   0 0 0.0  95 24 100.0  0 0 0.0 
Existential                           
Experience life as meaningful 0 1 5 5.0  70 35 87.5  4 4 1 7.5   0 0 0.0  78 34 98.3  2 0 1.7 
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Agreement of symptoms at individual level between patients, nurses and proxies is provided 
in Table 4. Higher agreement existed concerning the frequency of symptoms compared to the 
intensity of  symptoms. In addition, better ICCs were identified between patients and proxies 
compared to patients and nurses. The agreement between patients and proxies was for the frequency 
of all symptoms moderate to excellent, except the symptom tension (ICC = 0.18). Fifteen symptoms 
showed poor to fair agreement between patients and nurses for frequency. Agreement on the 
intensity of symptoms was low for both dyads. 
The 120 patients, nurses and proxies each assessed 35 symptoms. The symptom weight loss 
was not included in this analysis on factors associated with the over- and underestimation of 
symptoms because a DS could not be calculated for this dichotomous variable. This yielded a total of 
4,200 patient-nurse and patient-proxy observations for symptom frequency. Less dyads (range = 
1,560 – 1,800) were available for symptom intensity because the latter could only be rated for 
prevalent symptoms.  
The agreement between patients and nurses on symptom frequency was associated with 
gender, marital status, living status, metastases, expected prognosis, and radiotherapy (see Table 5). 
Nurses more often underestimated symptom frequency in female patients, patients living with both 
partner and other(s), and patients receiving radiotherapy. Overestimation of symptom frequency by 
nurses was more prevalent in male patients, divorced patients, patients living alone, and patients 
having metastases. The agreement between patients and nurses on symptom intensity was associated 
with gender, marital status, living status, cancer type metastases, expected prognosis, and 
radiotherapy. Nurses more often underestimated symptom intensity in male patients, patients aged 
75-79 years, patients living with both partner and/or other(s), patients with no metastases, patient 
with a life expectancy of years (compared to weeks and months) and patients receiving radiotherapy. 
Overestimation of symptom intensity by nurses was more prevalent in male patients, patients aged 
70-74 years, and patients with breast cancer. 
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 Table 4 Intraclass correlation of patient-nurse and patient-proxy pairs of symptoms 
  Symptom frequency Symptom intensity 
 
Patient-proxy Patient-nurse Patient-proxy Patient-nurse 
  ICC (95% CI) ICC (95% CI) ICC (95% CI) ICC (95% CI) 
Physical symptoms         
Lack of appetite 0.81** 0.53** 0.53** 0.34** 
  (0.73-0.86) (0.37-0.65) (0.37-0.67) (0.15-0.51) 
Fatigue 0.44** 0.39** 0.31** 0.21* 
  (0.29-0.57) (0.23-0.53) (0.12-0.48) (0.02-0.38) 
Pain 0.51** 0.56** 0.61** 0.32* 
  (0.36-0.63) (0.42-0.67) (0.44-0.74) (0.11-0.51) 
Lack of energy 0.43** 0.46** 0.32** 0.33** 
  (0.28-0.57) (0.30-0.59) (0.13-0.49) (0.14-0.50) 
Nausea 0.72** 0.56** 0.44* 0.18 
  (0.62-0.80) (0.42-0.67) (0.16-0.65) (-0.12-0.45) 
Sleeplessness 0.51** 0.36** 0.06 0.35* 
  (0.37-0.63) (0.19-0.50) (-0.22-0.33) (0.07-0.58) 
Vomiting 0.78** 0.73** 0.21 0.15 
  (0.70-0.84) (0.63-0.80) (-0.22-0.57) (-0.25-0.52) 
Dizziness 0.52** 0.45 0.25 0.61* 
  (0.38-0.64) (0.30-0.58) (-0.13-0.56) (0.09-0.84) 
Tension 0.18* 0.13 0.31* 0.20 
  (0.01-0.34) (-0.42-0.30) (-0.05-0.61) (-0.18-0.53) 
Constipation 0.50** 0.34** 0.56** 0.20 
  (0.35-0.62) (0.18-0.49) (0.27-0.76) (-0.19-0.52) 
Diarrhea 0.76** 0.74** 0.63** 0.31 
  (0.67-0.82) (0.64-0.81) (0.35-0.80) (-0.10-0.63) 
Heartburn/belching 0.48** 0.25* 0.38* 0.35 
  (0.33-0.61) (0.07-0.40) (-0.02-0.68) (-0.11-0.68) 
Tingling hand/feet 0.43** 0.12 0.56* 0.63 
  (0.28-0.57) (-0.35-0.28) (-0.003-0.85) (-0.20-0.97) 
Sore mouth/pain when 
swallowing 0.64** 0.52** 0.63** 0.05 
  (0.52-0.74 (0.37-0.64) (0.32-0.82) (-0.26-0.41) 
Shortness of breath 0.67** 0.68** 0.34* 0.23* 
  (0.55-0.76) (0.57-0.76) (0.09-0.56) (-0.03-0.47) 
Dry mouth 0.43** 0.13* 0.45** 0.28* 
  (0.27-0.57) (-0.30-0.29) (0.26-0.61) (0.03-0.50) 
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  Symptom frequency Symptom intensity 
 
Patient-proxy Patient-nurse Patient-proxy Patient-nurse 
  ICC (95% CI) ICC (95% CI) ICC (95% CI) ICC (95% CI) 
Cough 0.65** 0.64** 0.61** 0.19 
  (0.53-0.74) (0.52-0.74) (0.38-0.77) (-0.07-0.45) 
Itching 0.49** 0.18* 0.62* 0.62* 
  (0.35-0.62) (0-0.35) (0.02-0.90) (0.02-0.90) 
Change in food tasting 0.67** 0.11 0.60** 0.19 
  (0.56-0.76) (-0.05-0.26) (0.41-0.74) (-0.17-0.51) 
Airway mucus 0.61** 0.47** 0.27* 0.34* 
  (0.48-0.71) (0.32-0.60) (-0.02-0.52) (0.04-0.58) 
Urinary incontinence 0.47** 0.55** -0.02 0.13 
  (0.32-0.60) (0.41-0.67) (-0.65-0.56) (-0.29-0.59) 
Fecal incontinence 0.67** 0.69** 0 0.10 
  (0.56-0.76) (0.59-0.78) (-0.38-62) (-0.51-0.70) 
Weight lossa 0.66** 0.82**   
  (0.52-0.80) (0.70-0.93)   
Psychological symptoms         
Brooding 0.50** 0.37** 0.25* 0.15 
  (0.33-0.63) (0.21-0.52) (0.02-0.45) (-0.09-0.37) 
Depressed mood 0.45** 0.41** 0.12** 0.36* 
  (0.28-0.60) (0.25-0.55) (-0.12-0.36) (0.11-0.56) 
Nervousness 0.50** 0.16* 0.45** 0.33* 
  (0.34-0.62) (-0.11-0.33) (0.22-0.64) (0.03-0.58) 
Fear 0.51** 0.34** 0.53** 0.37* 
  (0.35-0.64) (0.18-0.49) (0.27-0.72) (0.06-0.61) 
Difficulties concentrating 0.55** 0.27* 0.27* 0.21 
  (0.41-0.66) (0.10-0.43) (-0.01-0.51) (-0.13-0.50) 
Anger 0.51** 0.41** 0.06 -0.07 
  (0.36-0.63) (0.25-0.55) (-0.18-0.33) (-0.37-0.31) 
Loneliness 0.69** 0.47** -0.17 0.18 
  (0.58-0.77) (0.32-0.60) (-0.47-0.16) (-0.16-0.50) 
Confusion 0.60** 0.50** 0.18 -0.14 
  (0.48-0.71) (0.35-0.62) (-0.31-0.59) (-0.48-0.33) 
Functional symptoms         
Difficulties with self-care 0.78** 0.76** 0.49** 0.31** 
  (0.70-0.84) (0.67-0.83) (0.31-0.63) (0.12-0.49) 
Difficulties with moving 0.73** 0.71** 0.56** 0.36** 
  (0.63-0.80) (0.61-0.79) (0.38-0.69) (0.15-0.54) 
Social symptoms         
Satisfied with social life 0.44** 0.29** 0.55** 0.55** 
  (0.29-0.58) (0.12-0.45) (0.41-0.67) (0.40-0.67) 
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  Symptom frequency Symptom intensity 
 
Patient-proxy Patient-nurse Patient-proxy Patient-nurse 
  ICC (95% CI) ICC (95% CI) ICC (95% CI) ICC (95% CI) 
Feeling supported 0.66** 0.48** 0.57** 0.54** 
  
(0.54-0.75) 
 
(0.28-0.62) 
 
(0.43-0.68) 
 
(0.38-0.66) 
 
Existential symptoms         
Experience life as meaningful 0.53** 0.35** 0.46** 0.32** 
  (0.39-0.65) (0.19-0.50) (0.30-0.59) (0.14-0.47) 
*p<0.05; **p<0.01; ***p<0.001 
a The item weight loss was a dichotomous variable: yes/no. The Cohen’s kappa statistic was used instead of the 
intraclass correlation. 
 
 
The agreement between patients and proxies on symptom frequency was associated with 
marital status, living status, cognitive status, cancer type, metastases, expected prognosis and 
chemotherapy. Proxies more often underestimated symptom frequency in patients living with both 
partner and other(s), patients with impaired cognition, and patients with breast and hematological 
cancer. Overestimation of symptom frequency by proxies was more prevalent in widowed patients, 
patients living alone and with others, patients with a normal cognition, patients with urogenital and 
lung cancer, patients with no metastases, and patients with chemotherapy. The agreement between 
patients and proxies on symptom intensity was associated with gender, age, marital status, cognitive 
status, metastases, expected prognosis, radiotherapy and chemotherapy. Proxies more often 
underestimated symptom intensity in male patients, patients aged 65-69 years, unmarried patients, 
patients with no metastases, patients with a life expectancy of years and patients receiving 
radiotherapy. Overestimation of symptom intensity by proxies was more prevalent in female patients, 
patients aged 85-89 years, patients with impaired cognition, and patients not receiving 
chemotherapy.  
  
 
Table 5 Association at univariate level of difference scores, and demographic and clinical factors 
  Symptom frequency   Symptom intensity   
  Under-
estimation 
Good 
agreement 
Over-
estimation 
Chi-
square 
p-
value 
Under-
estimation 
Good 
agreement 
Over-
estimation 
Chi-
square 
p-
value 
  N % N % N %   N % N % N %   
Patient versus nurse  
Gender Male 370 13.6 2103 77.1 256 9.4 13.984 0.00** 94 8.7 967 89.7 17 1.6 9.810 0.01** 
 Female 219 14.9 1161 79.0 90 6.1   33 5.6 541 91.2 19 3.2   
Age 65-69 126 15.7 603 74.9 76 9.4 16.831 0.08 30 9.1 293 89.3 5 1.5 28.607 0.00*** 
 70-74 83 11.9 567 81.0 50 7.1   7 2.5 262 92.9 13 4.6   
 75-79 119 14.2 654 77.9 67 8.0   29 10.4 245 88.1 4 1.4   
 80-84 179 15.0 913 76.7 98 8.2   42 8.8 431 89.8 7 1.5   
 85-89 45 11.7 309 80.3 31 8.1   10 5.7 162 92.6 3 1.7   
 ≥ 90 0 0.0 32 91.4 3 8.6   0 0.0 17 100.0 0 0.0   
Marital  
status 
Married 378 14.0 2095 77.8 221 8.2 30.781 0.00** 70 6.7 947 91.2 21 2.0 5.362a 0.45 
Widow(er) 168 15.0 869 77.6 83 7.4   41 8.5 429 88.8 13 2.7   
 Divorced 8 7.6 74 70.5 23 21.9a   5 10.6 41 87.2 1 2.1   
 Unmarried 35 12.5 226 80.7 19 6.8   11 10.7 91 88.3 1 1.0   
Living  Alone 154 15.2 758 74.7 103 10.1 34.274 0.00** 38 9.7 343 87.7 10 2.6 18.416a 0.01** 
status With partner 376 14.4 2072 77.9 211 7.9   66 6.5 927 91.4 21 2.1   
 With partner 
and other(s) 
29 20.7 98 70.0 13 9.3   8 13.6 50 84.7 1 1.7   
 With 
child(ren) 
16 6.5 215 87.8 14 5.7   3 2.4 119 96.0 2 1.6   
 With others 14 10.0 121 86.4 5 3.6   12 14.5 69 83.1 2 2.4   
Cognitive 
status 
< 2 457 13.5 2651 78.1 296 8.4 5.059 0.08 93 7.2 1177 90.9 25 1.9 2.931 0.23 
≥ 2 132 16.4 613 76.1 60 7.5   34 9.0 331 88.0 11 2.9   
TRST < 2 234 13.9 1309 77.9 137 8.2 0.056 0.97 45 7.2 565 91.0 11 1.8 0.895 0.64 
≥ 2 355 14.1 1955 77.6 209 8.3   82 7.8 943 89.8 25 2.4   
Cancer 
type 
Gastro-
intestinal 
260 13.5 1521 79.0 144 7.5 20.688 0.06 64 8.2 713 90.8 8 1.0 27.500a 0.01** 
  
  Symptom frequency   Symptom intensity   
  Under-
estimation 
Good 
agreement 
Over-
estimation 
Chi-
square 
p-
value 
Under-
estimation 
Good 
agreement 
Over-
estimation 
Chi-
square 
p-
value 
  N % N % N %   N % N % N %   
Lung 101 13.7 560 76.2 74 10.1   17 6.2 251 92.4 4 1.5   
 Breast 68 16.2 324 77.1 28 6.7   12 7.0 147 85.5 13 7.6   
 Prostate 58 15.1 300 77.9 27 7.0   12 7.4 145 89.5 5 3.1   
 Urogenital 50 15.9 225 71.7 39 12.4   10 8.8 100 87.7 4 3.5   
 Hematological 32 13.1 190 77.6 23 9.4   9 9.5 84 88.4 2 2.1   
 Other 20 11.4 144 82.3 11 6.3   3 4.2 68 95.8 0 0.0   
Metastases Yes 112 14.5 578 75.1 80 10.4 6.331 0.04* 92 6.6 1276 91.1 33 2.4 14.478 0.00*** 
 No 477 13.9 2686 78.3 266 7.8   35 13.0 232 85.9 3 1.1   
Expected 
prognosis 
Months 436 14.2 2396 77.8 247 8.0 0.822 0.66 83 6.4 1182 91.1 33 2.5 15.618 0.00** 
Years 153 13.7 868 77.5 99 8.8   44 11.8 326 87.4 3 0.8   
Radio- 
therapy 
Yes 179 16.5 813 74.9 93 8.6 8.039 0.02* 50 11.0 389 85.7 15 3.3 14.816 0.00** 
No 410 13.2 2451 78.7 253 8.1   77 6.3 1119 91.9 21 1.4   
Chemo-
therapy 
Yes 316 13.7 1817 78.7 177 7.7 3.087 0.21 68 7.3 838 90.5 20 2.2 0.195 0.91 
No 273 14.5 1447 76.6 169 8.9   59 7.9 670 89.9 16 2.1   
Patient versus proxies  
Gender Male 204 7.5 2251 82.5 275 10.1 2.190 0.34 52 4.6 1049 92.3 36 3.2 7.291 0.03* 
 Female 128 8.7 1202 81.8 140 9.5   20 3.0 608 91.7 35 5.3   
Age 65-69 75 9.3 634 78.8 96 11.9 14.7 0.14 24 6.7 321 89.7 13 3.6 27.418 0.00** 
 70-74 50 7.1 583 82.3 67 9.6   12 4.0 276 91.7 13 4.3   
 75-79 73 8.7 687 81.8 80 9.5   12 4.0 280 93.6 7 2.3   
 80-84 89 7.5 990 83.2 111 9.3   20 3.8 493 93.0 17 3.2   
 85-89 24 6.2 333 86.5 28 7.3   1 0.6 163 90.6 16 8.9   
 ≥ 90 2 5.7 31 88.6 2 5.7   0 0.0 15 100.0 0 0.0   
Marital  
status 
Married 229 8.5 2207 81.9 259 9.6 16.152 0.01* 47 4.2 1024 92.1 41 3.7 14.079a 0.02* 
Widow(er) 86 7.7 906 80.9 128 11.4   14 2.6 487 91.9 29 5.5   
 Divorced 2 1.9 96 91.4 7 6.7   2 4.3 44 95.7 0 0.0   
 Unmarried 15 5.4 244 87.1 21 7.5   9 8.0 102 91.1 1 0.9   
Living 
status 
Alone 77 7.6 826 81.4 112 11.0 28.164 0.00*** 16 3.7 402 92.6 16 3.7 13.362 0.08 
With partner 214 8.0 2189 82.3 257 9.7   47 4.3 1014 92.0 41 3.7   
  
 
  Symptom frequency   Symptom intensity   
  Under-
estimation 
Good 
agreement 
Over-
estimation 
Chi-
square 
p-
value 
Under-
estimation 
Good 
agreement 
Over-
estimation 
Chi-
square 
p-
value 
  N % N % N %   N % N % N %   
 With partner 
and other(s) 
21 15.0 102 72.9 17 12.1   1 1.6 61 96.8 1 1.6   
 With 
child(ren) 
7 2.9 224 91.4 14 5.7   3 2.4 118 94.4 4 3.2   
 With others 13 9.3 112 80.0 15 10.7   5 6.6 62 81.6 9 11.8   
Cognitive 
status 
< 2 251 7.4 2833 83.4 311 9.2 18.437 0.00*** 55 3.9 1320 92.8 47 3.3 7.749 0.02* 
≥ 2 81 10.1 620 77.0 104 12.9   17 4.5 337 89.2 24 6.3   
TRST < 2 127 7.6 1385 82.4 168 10.0 0.480 0.79 32 4.6 630 91.3 28 4.1 1.243 0.54 
≥ 2 205 61.7 2068 82.1 247 9.8   40 3.6 1027 92.5 43 3.9   
Cancer 
type 
Gastro-
intestinal 
121 6.3 1635 84.9 169 8.8 50.342 0.00*** 41 4.7 806 91.9 30 3.4   
Lung 53 7.2 591 80.4 91 12.4   13 4.2 279 90.3 17 5.5 19.051 0.07 
 Breast 52 12.4 330 78.6 38 9.0   6 3.4 165 93.8 5 2.8   
 Prostate 30 7.8 328 85.2 27 7.0   2 1.2 164 95.3 6 3.5   
 Urogenital 30 9.5 240 76.2 45 14.3   6 5.4 104 92.9 2 1.8   
 Hematological 29 11.8 184 75.1 32 13.1   3 3.7 70 95.4 9 11.0   
 Other 17 9.7 145 82.9 13 7.4   1 1.4 69 95.8 2 2.8   
Metastases Yes 262 7.6 2864 83.5 304 8.9 25.053 0.00*** 48 3.2 1416 93.0 59 3.9 18.838 0.00*** 
 No 70 9.1 589 76.5 11 14.4   24 8.7 241 87.0 12 4.3   
Expected 
prognosis  
Months 251 8.1 2554 82.9 275 8.9 12.180 0.00** 42 3.0 1300 92.6 62 4.4 20.025 0.00** 
Years 81 7.2 899 80.3 140 12.5   30 7.6 357 90.2 9 2.3   
Radio-
therapy 
Yes 84 7.7 897 82.7 104 9.6 0.216 0.90 30 6.0 453 89.9 21 4.2 7.118 0.03* 
No 248 8.0 2556 82.1 311 10.0   42 3.2 1204 92.9 50 3.9   
Chemo-
therapy 
Yes 
No 
150 
182 
6.5 
9.6 
1953 
1500 
84.5 
79.4 
207 
208 
9.0 
11.0 
20.723 0.00*** 40 
32 
3.9 
4.1 
953 
704 
93.2 
90.5 
29 
42 
2.8 
5.4 
7.754 0.02* 
TRST: Triage Risk Screening Tool (Flemish version) 
*p<0.05; **p<0.01; ***p<0.001 
aFischer exact test 
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DISCUSSION 
This study investigated the agreement between patients, nurses and proxies with regard to 
symptom assessment. The results of this study indicate that nurses and patient proxies tend to 
underestimate physical and social symptoms and overestimate psychological, functional, and 
existential symptoms. However, agreement was for the majority (greater than 60%) of the symptoms 
not statistically significant (p > 0.05), which indicates that the observed differences might arise from 
chance only.  The agreement of the frequency of symptoms between patients and proxies was better 
than the agreement between patients and nurses. Overall, agreement was better for less subjective 
symptoms and symptoms that are less humiliating for patients to talk about (Brorsson, Lindbladh, & 
Rastam, 1998; A. Dewar, Gregg, White, & Lander, 2009). Agreement between the intensity assessment 
of symptoms was for most (greater than 50%) of the symptoms, rated as poor to fair between patient 
and nurse and patient and proxy.  
Most previous studies were conducted in a population and setting different from the 
hospitalized older palliative patients with cancer, except for the study of Pautex et al. (2003). The 
findings of the current study confirm the results of the latter study. However, our study included a 
larger number of patients and assessed symptoms in more domains.  
The findings are somewhat in contrast with a larger previously conducted multicenter study 
in adult patients with cancer (Laugsand et al., 2010). Laugsand et al. (2010) indicated that healthcare 
providers underestimate symptoms in about 10% of the patients, regardless of the type of symptom. 
However, the adult cancer patients included in de study of Laugsand et al. (2010) differs somewhat 
from the older palliative patients with cancer included in the present study because the latter is more 
vulnerable to comorbidity, cognitive problems, and dependency. The present study measured a 
significant association between cognitive status and the agreement of symptom frequency and 
intensity between patients and proxies, indicating underestimation by proxies. This association was 
not significant between patients and nurses, but the absolute values suggest an underestimation by 
nurses. These findings are in contrast with the findings of Laugsand et al. (2010), who reported less 
agreement in patient with a normal cognitive status. Less agreement seems to be present in patients 
of younger age. However, no significant association was measured for frequency, in contrast to 
intensity.  
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Differences in scores could be the result of patient bias. In the current study, patient report 
was seen as the gold standard. However, one could question the true representation of the symptoms 
as reported by patients. Literature suggests that patients, particularly older adult patients, sometimes 
minimize their symptoms due to a variety of reasons such as not wanting to be a burden to others 
(McPherson, Wilson, Chyurlia, & Leclerc, 2010; McPherson, Wilson, & Murray, 2007), seeing symptoms 
as part of aging (Kaye et al., 2010), and denying symptoms as coping mechanism (Arraras, Wright, 
Jusue, Tejedor, & Calvo, 2002; Hauer et al., 2009). 
This study has some strength which enhance the validity of the results. First, this study is the 
first, to the authors’ knowledge, to measure the agreement between patients and nurses and patients 
and proxies of symptom frequency and intensity on five domains (physical, physiological, functional, 
social and existential) in an older palliative patients with cancer. Second, patients had to be 
hospitalized for at least a week to allow nurses to build a relationship with the patient and to get to 
know the patient. In addition, patients had to receive visit from at least one person in the last week 
to enable a good estimation of the symptoms by the proxy.  
This study also has some limitations. First, no demographic information was gathered of the 
nurses and proxies. The collection of this data would have allowed us to identify if certain variables 
at nurse and proxy level could have explained under- or overestimation of symptoms. Bahrami, Parker, 
and Blackman (2008) reported that the clinical experience of a nurse with cancer patients was a 
significant predictor of agreement between patients and nurses. Higginson et al. (2008) reported that 
higher caregiver burden was significantly associated with agreement on symptom assessment. 
Second, this study was a cross-sectional study, which does not allow to identify a causal relationship. 
Third, generalization of the results could be limited because the study was performed in two non-
randomly selected general hospitals in Belgium. 
 
NURSING IMPLICATIONS AND RESEARCH 
The results of this study indicate that proxies are somewhat better than nurses in estimating 
the symptoms that patients experience. Nevertheless, the findings raise some concerns when 
treatment options and decisions are based on the estimation of symptoms made by nurses and 
proxies. The general underestimation of physical and social symptoms and overestimation of 
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psychological, functional, and existential symptoms could result in under- and overtreatment. 
Undertreatment could lead to needless discomfort and decreased quality of life. In palliative care, 
overtreatment in terms of receiving holistic attention could be judged unharmful. However, 
overtreatment in terms of higher doses of medication could have side effects and painful 
interventions are equivalent to undertreatment.       
As a result of the differences in assessment between patients and nurses/proxies, it is advised 
to combine patient-, nurse-, and proxy-reported symptom assessment in clinical practice and 
research. Treatment decisions should be based on this combined evaluation to optimize care. 
However, in clinical practice symptoms are often assessed by one party only. Patients should be 
encouraged to report their true experience, and misconceptions should be addressed by the means 
of education. Nurses and proxies should be taught to recognize and to assess symptoms and to 
communicate about it with patients. The literature implies that patients not always report their true 
experience, but strong evidence is lacking to support that implication. More research is needed on 
the reasons for disagreement on symptoms between patients, nurses, and proxies. This can be 
achieved by research focusing on (a) reasons why patients do or do not report their symptoms, (b) 
how nurses and proxies recognize and assess symptoms, and (c) the underlying thoughts of patients, 
nurses and proxies regarding the report and assessment of symptoms. These insights will provide 
indications to set up interventions to improve symptom assessment and symptom agreement.        
 
CONCLUSION 
The current study indicates that nurses and proxies tend to underestimate physical and social 
symptoms and overestimate psychological, functional and existential symptoms. Agreement was 
associated with multiple demographic and clinical factors such as gender and presence or absence 
of metastases. Treatment interventions should be based on a combined assessment of symptoms by 
the patient, a healthcare professional, and the patients’ proxies. More insight is needed in reasons of 
disagreement on symptoms between patients, nurses and proxies. These insights will provide 
indications to set up interventions to improve symptom assessment and symptom agreement. 
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CHAPTER VIII 
HOW DO NURSES CARE FOR HOSPITALISED OLDER PALLIATIVE CANCER PATIENTS: A 
DESCRIPTIVE STUDY  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Based on the article of Van Lancker A., Van Hecke A., Grypdonck M., Beeckman D., Van Den Noortgate 
N., Verhaeghe S. (2016). How do nurses care for hospitalised older palliative cancer patients: a 
qualitative study. Submitted.
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ABSTRACT 
Introduction Nurses play an important role in the identification and management of problems in 
patients. However, it remains unclear how they do this  in older palliative cancer patients.  
Objectives To gain insight into how nurses provide care for hospitalised palliative cancer patients.   
Method A qualitative study based on the principles of grounded theory was performed. Semi-
structured interviews were conducted with 17 nurses. These nurses worked at oncological or geriatric 
wards in four acute care hospitals. The constant comparative method was used. Credibility of the data 
collection and analysis process was enhanced by researcher triangulation.  
Results Nurses want to provide good care for older palliative cancer patients. They want to do what 
needs to be done. Nurses accomplish this by using two basic strategies: keeping control and 
managing problems. ‘Keeping control’ is focused on keeping the organisation running and avoiding 
problems. ‘Managing problems’ is focused on identifying and solving problems. The identification of 
problems is based on a mental picture nurses have of how the patient should be. This picture guides 
them in the evaluation of the situation as being normal or problematic. A problematic situation 
demands a quick, efficient and effective solution. In order to keep control and manage problems 
nurses use their experience and relationship with others. These relationships are functional, task-
oriented and nurse-centred. Nurses need confirmation (internally and externally) that they are doing 
a good job. This makes them feel good, which is exactly what they need to be able to carry on.  
Conclusions The study offers a framework of the nursing process of providing care for older palliative 
cancer patients. The findings of this study emphasise the need to reflect on nursing practice to provide 
person-centred care and to support nurses in coping with distress.  
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INTRODUCTION 
Belgium, as most other European countries, is characterised by an ageing population due to 
aspects such as progress in healthcare technology and medical treatments (Mathers, Stevens, Boerma, 
White, & Tobias, 2015). The number of older people will continue to rise over the next years and there 
will be a vast number of older patients requiring some form of care (Suzman, Beard, Boerma, & 
Chatterji, 2015). In addition, older patients are often confronted with a complex interplay of multiple 
problems due to the ageing process, more so than younger patients (Depp & Jeste, 2006).  
The incidence of cancer increases with age. Indeed, a large proportion of cancer patients are 
65 years and older (Ferlay et al., 2015). More often than in younger patients, cancer in older patients 
remains untreated due to multiple aspects such as contra-indications for treatment (Pallis et al., 2010). 
For these patients, the focus will eventually shift from ‘cure’ to ‘care’ (Pallis et al., 2010). In this type of 
‘care’, also defined as palliative care, there is an increased risk of experiencing multiple symptoms 
(Van Lancker et al., 2014). Nurses play an important role in the identification of problems in these 
patients. Literature indicates a discrepancy in the assessment of problems by older palliative cancer 
patients and nurses (Van Lancker et al., 2015). Literature also indicates that symptom assessment is 
rarely systematically performed by means of a standardised instrument (Kaasa et al., 2008). This lack 
of systematic assessment might be an explanation for the discrepancy between nurses and older 
patients regarding symptom assessment. However, if symptoms are not identified through systematic 
assessment, how do nurses identify problems in patients, and more specifically in older palliative 
cancer patients? Moreover, no literature is available on how nurses decide on which care to provide 
for the identified symptoms. Insight is needed into how nurses provide care for older palliative cancer 
patients in order to optimise care for this target population. 
 
AIM 
The aim of this study was to gain insight into how nurses provide care for older palliative 
cancer patients. 
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METHODS 
Design 
A qualitative study was performed based on the principles of the grounded theory to 
understand the underlying process of nursing care  (Glazer & Strauss, 1967).  
Sample and setting  
Nurses were recruited from four acute care hospitals in Flanders, Belgium. They were 
recruited through the head nurses of wards that hospitalise older palliative cancer patients. A 
purposive sampling method was used to obtain a balance in homogeneity and heterogeneity. 
Variation on the following criteria was sought: (1) gender (male versus female), (2) years of working 
experience, (3) part-time versus fulltime work contract (3) geriatric versus non-geriatric wards. Nurses 
were given time during their working hours to participate in the study. 
Data collection 
Semi-structured interviews were held with the participants in a quiet room on the ward at a time that 
was most convenient to them. Each interview started by presenting the  participants with a description 
of a case (Table 1). The case was developed by the research team and included aspects of psychical, 
functional, psychological, social, and existential care based on evidence and experience. During the 
study, the case was adapted by adding or removing information according to insights obtained from 
the preceding interviews. First, participants were asked to explain how they would care for the patient 
described in the exemplary case. Then, participants were asked to elaborate on their actions to obtain 
a better understanding of the underlying patterns and motives of their actions.   
Table 1. Exemplary case 
You have the morning shift today and one of your patients is Mrs Servaes, an 80-year old 
woman.  
Diagnosis: breast cancer with metastasis in bones and lungs (recent diagnosis). 
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All participants were interviewed by the main researcher. Seventeen nurses participated in 
the study. Participant characteristics are presented in Table 2. The interviews had an average duration 
of 55 minutes (ranging between 28 minutes and 87 minutes). They were audio-taped and transcribed 
verbatim. After each interview, the researcher made field notes about the context of the interview and 
her perspective on the interview. The number of interviews was determined by data saturation (Glazer 
& Strauss, 1967).  
 
Table 2. Characteristics of nurses (N=17) 
 Mean (SD) N (%) 
Age (years) 
Gender 
Female 
Male 
Nursing education 
Bachelor degree 
Diploma degree 
Ward 
Oncological ward 
Geriatric ward 
Years of experience in care 
Years of experience in 
oncology/geriatric care 
37.7 (10.0) 
 
 
 
 
 
 
 
 
 
15.0 (10.1) 
11.2 (7.8) 
 
 
15 (88.2) 
2 (11.8) 
 
10 (58.8) 
7 (41.1) 
 
10 (58.8) 
7 (41.1) 
 
 
Ethical Approval 
Ethical approval was obtained from the ethics review committee of the participating teaching 
hospital and the general hospitals (B670201317036). The participants received oral and written 
information before deciding to participate and giving written informed consent.  
 
DATA ANALYSIS 
Interviews were read and re-read in order to become familiar with the data. Subsequently, 
the interviews were coded. The interviews were analysed using the constant comparative method 
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which involves multiple stages of coding data, refining and categorising data (Glazer & Strauss, 1967). 
Data were constantly compared during and in between interviews. Provisional findings were checked 
and refined according to the emerging themes. Data collection and -analyses occurred in a cyclic 
process (Glazer & Strauss, 1967).  
The credibility of the research process was enhanced by involving three researchers, two of 
which had extensive experience in qualitative methodology and one in the research topic (researcher 
triangulation). At regular intervals, the researchers met to reflect on the interview style and the 
exemplary case, to discuss the data and to check the progressing analysis against the data. To 
enhance the quality of the analysis, a fourth researcher was involved in the data analysis at the end 
of the study. This researcher verified and confirmed the obtained results by reading several interviews 
and discussing the results. Reflexivity was applied throughout the process of analysis and data 
collection. Memos were written concerning to the initial interpretation of the findings. Immediately 
after each interview, the researcher documented the process of recruitment, as well as her 
impressions, ideas and reflections regarding the participants and the obtained data in light of the 
research question. In addition, the researcher debriefed with two colleagues and the research team 
after the interviews and during the analytic process to reflect on the findings.  
 
RESULTS 
In the nurses’ description of how they provide care for older palliative cancer patients, it is 
clear that they put an emphasis on providing good quality care. Not only do they pay attention to 
the provision of good quality care for individual patients, but they also pay attention to the needs of 
the entire group of patients and the ward/hospital. Herein, six components appears to be crucial: 
keeping control, managing problems, providing extras, relationship with others, experience, and 
feeling good. These six components are described below.  
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Keeping control 
The data show that ‘keeping control’ is an important aspect of providing good care. Indeed, 
it ensures that what needs to be done, can in fact be done. It is apparent from analyses that nurses 
mainly keep control by focusing on keeping the organisation running and by avoiding problems.     
KEEPING THE ORGANIZATION RUNNING 
A nurse’s primary means of keeping control is to focus on keeping the organisation (of their 
care) running. To this end, it is important to plan the care and to carry out that schedule. The schedule 
provides a structure and support, and ensures that the nurses can do what they deem is important to 
do. In drawing up a schedule, nurses tend to work according to a certain pattern, so they can establish 
a certain routine and efficiency. This enables the nurses to manage their extensive set of tasks.  
“The first time you see someone, you often do something of which you later 
think …Gosh, I should have done that differently. And the next day, you actually 
do it differently. And then, you do it better and better and after some time, you 
can do it faster too, because you know, first, I have to do this, then that, and 
then that…” (oncology nurse, 28 years old) 
In drawing up a schedule, nurses pay special attention to those items that offer them a certain 
level of certainty when it comes to ensuring that the care will be provided according to the set 
schedule. An interference with the schedule does not only threaten the individual patient care, but 
also the functioning of the entire organisation of what according to nurses must be done.  
AVOIDING PROBLEMS 
Avoiding problems is the second aspect on which nurses focus in order to keep control. 
Problems are defined as unexpected events or events that occur at a different moment than planned. 
These problems are a threat in terms of keeping control and should therefore be avoided as much as 
possible. Nurses find it much more efficient to anticipate problems than to remedy a disturbance of 
the schedule and having then to regain control. Moreover, problems often cause discomfort in 
patients. By anticipating problems, nurses want to preserve patients from discomfort.   
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Nurses mainly draw from their experience when trying to anticipate problems. They connect 
their experience to the information they have about a specific patient. This information come from a 
file or a colleague. The most reliable source of information, however, is the information they gathered 
themselves based on (previous) contact with the (group of) patient(s).  
“I: Why is it so important to you to maintain a healthy fluid balance?  
P: Well, it is important to … to prevent dehydration, actually. Otherwise, the level 
of electrolytes may decrease … which can cause confusion. It can cause a patient 
to experience symptoms much sooner.” (oncology nurse, 33 years old) 
When it comes to avoiding problems, nurses also take note of problems that have occurred in 
the past. The chances of these problems arising again are rated relatively highly. Consequently, nurses 
specifically look for strategies to avoid that.   
“Yes, anticipating problems. For instance, when I notice that I have an older 
patient who tends to become more restless towards the evening. That their day 
and night rhythm is not perfect, I try to give them dinner a bit earlier in the 
evening. To check whether or not that makes her less restless in the evening. 
Trying to anticipate things like that.” (geriatric nurse, 45 years old) 
Managing problems 
If, despite the efforts to prevent issues, problems do occur, it is of the utmost importance to 
nurses to deal with these problems adequately. They work according to a two-step problem 
management system: identifying the problem and solving the identified problem.  
IDENTIFYING PROBLEMS 
Nurses express that it is hard to describe the way in which they detect and identify problems. 
They indicate that it is all about a ‘feeling’. They ‘feel’ when something is not right. When further 
questioned about the source of that feeling, it becomes clear that nurses compare the reality to a 
mental picture that they have of the patient in question. If that mental picture does not corresponds 
to the reality, the feeling of something not being right emerges. This mental picture tells nurses how 
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(the care for) the patient should be and is relatively quickly made, based on the information that is 
available to the nurses. Important information includes, for instance, the patient’s diagnosis, 
observations made by colleagues, and the patient’s social situation. The most important piece of 
information on which the mental picture is based, is a nurse’s own observation of the patient.  
“This patient had breast cancer with metastases in bones and lungs. This is 
serious … she is very ill. A person’s appetite automatically decreases then.” 
(geriatric nurse, 41 years old) 
Contact with the patient may also lead a nurse to adjust a previously made mental picture.  
So when nurses record a discrepancy between reality and their mental picture, they get the 
feeling that something is not right.  
“Our senses are very important. Seeing, smelling, feeling … Also, daring to act 
on your intuition. … That you have a feeling of something not being right. When 
you start thinking hmmmm? No that is not right.” (geriatric nurse, 41 years old) 
Based on that feeling, they try to identify what problem could be. To that end, nurses primarily focus 
on physical aspects and their own observations. If they have a vague idea of the possible issue, but 
have no absolute certainty, they ask questions in function of that idea.  
In order to make a correct assessment of a patient’s situation, special attention is given to 
(technically) measuring and objectifying the nurses’ own observations. Regarding parameters, there 
is a double standard. On the one hand, taking a patient’s parameters is described as just a routine 
matter, something that is part of a nurse’s many tasks, something that is not given a moment’s 
thoughts. On the other hand, those parameters can also reassure or alarm the nurse of a patient’s 
condition. Based on a patient’s parameters, nurses can tell whether or not that person is in a life-
threatening situation. Furthermore, the readings of the parameters function as reference points when 
it comes to assessing changes in a patient’s condition.   
“It is partially routine because it is mentioned in the electronic patient file, but 
for me, even if it was not mentioned, I would do it. Because I like to know the 
figures, temperature, blood pressure, pulse, oxygen saturation, if needed 
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glycaemia, … so you know: yes, these are the figures to start with. So you have 
a reference point in case problems occur.” (oncology nurse, 41 years old) 
Apart from the technical measurement of parameters, nurses also point out the importance 
of objectifying the more subjective parameters. The most important parameter mentioned in this 
respect is pain. This parameter is objectified by asking the patient to rate the pain on a scale from 0 
to 10. However, this rating is not blindly accepted in terms of taking action. Apart from measuring 
and objectifying parameters, nurses also take notice of a patient’s non-verbal behaviour and 
appearance.  Physical aspects such as the condition of the skin, grimaces, groans and moans are 
observed and if the nurses are still not sure, they will ask additional, specific questions.   
“You can also see that in the way in which… Well some people will toss and turn 
and moan. But they don’t say that they are in pain and when you ask if they are, 
they say no. But you can see that they (nurse puts her hands to her side) … Well, 
so you know that she is in pain but she doesn’t want to say it.” (oncology nurse, 
23 years old) 
The answers to those questions should help identify the problem quite easily.  
“If you enter the room and she hasn’t eaten anything, you ask: «How come you 
haven’t eaten? Do you feel nauseous? How come you don’t have any appetite? 
Didn’t you like it? Do you prefer another kind of bread?» Because there are still 
some patients who are too polite to say that they prefer white bread when they 
got wholegrain or vice versa. Or they prefer tea but they got coffee.” (oncology 
nurse, 41 years old) 
All this information is compared and evaluated. For example: the value of a pain rating will 
be weighed against the patient’s attitude or behaviour but also against his/her history (e.g. how did 
he/she communicate about pain in the past) and the nurse’s evaluation of the patient’s rating.  
“If a patient usually never admits to having pain but you know that she is in 
pain, but she just won’t admit it. When she suddenly gives a score of eight or 
nine, you know that it could be serious, but if the patient easily says to be in 
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pain and she gives a score of eight or nine, you can say that it is very serious for 
this patient and for this patient it is serious, but maybe a bit less than …” 
(oncology nurse, 23 years old) 
As described above, nurses identify problems based on the discrepancy between reality and 
their mental picture. However, there is an additional factor in the identification of problems, and that 
is the knowledge that the potential problem can be solved. If the nurses perceive the potential 
problem as solvable, it is labelled as a problem. If it is perceived as unsolvable, it is labelled as fitting 
with the mental picture belonging to the (group of) patient(s) and it is not looked into any further.  
“I: What do you do when patients say they did not sleep well, because there was 
a lot of movement at night?
P: I always say to patients, you don’t come to hospital to rest, because we do 
disturb patients a lot, also at night, unfortunately. And I would also say, «At home 
you have your own bed, now you are in a different one» because that also makes 
a big difference.” (oncology nurse, 27 years old) 
SOLVING PROBLEMS 
The way in which nurses act is directly influenced by the identification and labelling of 
problems. Indeed, problems cannot be ignored. They have to be dealt with, they have to be solved.  
Although nurses realise that not every problem can be solved, their actions are nevertheless 
strongly focused on searching for and finding solutions. They point out that problems need to be 
solved quickly and efficiently. To this end, nurses think about how they can find solutions as quickly 
as possible, as efficiently as possible and with a limited use of resources.   
“Well, efficiency means that you deal with a problem as quickly as possible. For 
instance, if they say: I have this problem, you try to have it solved by the end of 
your shift or the next day.” (oncology nurse, 41 years old) 
Solutions should be effective too. This is defined as ‘the problem no longer exists’.  
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To ensure that the chosen approach actually does lead to the rapid, efficient and effective 
solution of a problem, nurses keep the finding and solving of a problem in their own management. 
Not the patients, but they are capable of selecting the best/most appropriate solution to a certain 
problem. Nurses feel like they have the experience to know what works for a specific problem and 
communicate this to the patient as well.   
Even in terms of solving problems, the primary focus of nurses is on physical aspects. Nurses 
are of the opinion that dealing with physical problems is their responsibility and expertise. Problems 
involving activities of daily living such as washing and dressing patients, helping them to go to the 
toilet and helping at mealtimes, are usually solved very effectively and rapidly. Sometimes other 
disciplines are mobilised for such activities, but when it comes to solving physical problems, the 
nurses usually remain closely involved.   
The nurses point out that they do not always give primary attention to non-physical 
problems, such as psychological, social, and existential problems. However, they do feel that it is 
important to acknowledge these type of problems. Because they often do not feel sufficiently 
competent to deal with non-physical issues, they describe their part in solving these matters mainly 
as gathering and passing on information to people from another discipline who are specifically 
trained to handle the problem in question.  
“If I notice that the home situation is difficult, I will pass this on to social services. 
For example if she is alone or if she does not get enough help at home … I 
would contact social services […] So they know which help is already available, 
and so they can further investigate how to optimize support […] Actually, we 
employ the help of social services quite quickly.” (geriatric nurse, 39 years old) 
An additional remark of many nurses is that, in case of psychological problems, the psychologist has 
the time to listen to the patient, which is something that they do not have.  
“I: What brings you to contact a psychologist? 
P: We do that rather quickly, actually. If it’s busy, we don’t have much time for 
family and patients and if we feel that they need to talk, you can contact the 
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psychologist, because they go deeper into certain things. They have more time to 
listen to patients.” (oncology nurse, 23 years old) 
Nurses consider non-physical problems solved when a professional from another discipline 
has been informed about it, not only because the responsibility for it has been temporarily passed on 
to somebody else, but also because they perceive the problem as solved as far as they are concerned. 
Providing extras 
Nurses mention that providing good care can also involves providing ‘extras’ to patients. 
Nurses realise that it is not always easy for patients to having to adapt to the organisational aspects 
of the care. In order to compensate the restrictions of the organisation somewhat, nurses provide 
extras, such as offering the patients a certain level of involvement or freedom of choice. Patients can, 
for instance, choose which pyjamas or nightgown they wish to wear that day.  
Making time for providing emotional care for a patient is also considered an ‘extra’.   
All ‘extras’ are important to nurses, but it is not their primary concern. Nurses will only 
consider offering ‘extras’ if this does not interfere with the tasks they really need to carry out, with 
keeping control and managing problems.  
“You know if it’s a person who likes to wake up early or who likes to wake up 
late. And I do feel like you should take this into account, when possible.” 
(oncology nurse, 27 years old) 
 
Relationship with others 
During the course of their work, nurses establish relationships with others, e.g. patients, 
family members, and colleagues. It is apparent from the interviews that the relationships between 
nurses and patients, family members and colleagues, are functional, task-oriented and nurse-centred 
ones. Within these relationships, nurses are focused on what they need in order to do their job as 
well as possible. The relationships are shaped by what is important for nurses, at the time when they 
need it. The focus of these relationships is on information. Nurses actively ask for information and 
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they accept/keep the information that is relevant to them. Relevant information is defined as 
information that helps them to keep control and solve problems.  
“I want to add that I will listen actively. If they mention something like: «Look, I 
am in pain, or I can’t take it anymore, or I’m having problems, my daughter and 
my husband don’t see eye to eye, and I would like …» By listening actively, I can 
provide help. I can say: «Look, I can contact the psychologist or get the 
physician, I can get you some more pain relief» That is what I mean with active, 
that I do something about it. […] I will act upon it.” (geriatric nurse, 26 years old) 
Experience 
From the interviews, it is apparent that personal experience is crucial when it comes to how 
shaping care. Nurses gain experience when carrying out their daily activities. They give meaning to 
the things they experience and based on that meaning, experiences are mentally stored. Experience 
in terms of problems and what helps to avoid and solve problems in particular is stored/recorded. 
Meaning is not only given to those experiences in function of the problems they are associated with, 
but also in function of the specific group of patients or context they are linked to. Nurses apply the 
principle that what happens with a specific patient, or what works in a specific context, can also be 
applied to all similar patients or contexts. Based on that principle, nurses fairly quickly generalize the 
things that occur and happen in practice.   
“For me it is important to know how well patients have understood the 
physician. Yes chemotherapy, and radiotherapy, for us it’s normal, but for them 
it’s not. My experience has taught me that if I provide the patient with the right 
information from the start, the patient will have a better start. That experience 
… I’ve got that.” (oncology nurse, 30 years old) 
The meaning of experiences is influenced by elements such as agreements made within the 
team, personal values and training. These elements further determine how nurses will mould the care 
they give. They are tested and then recorded as experience.  
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Nurses state that agreements or protocols are part of the ward’s culture. These agreements 
and the accompanying culture are not questioned. They are used when gaining and storing 
experience.  
“Then we ask to rate the visual analogue scale. Of course, we do this every 
morning because it is a standard parameter, you know, the VAS score” (geriatric 
nurse, 43 years old) 
Nurses also reflect on what they think is important in life and healthcare. They each have 
their own personal values, which are based on their own personal experiences and upbringing.  
“A minimum level of hygiene is important. .. I think, for your health. So yes, 
certainly the minimum … yes I think so. This fits with my idea of health. That 
people are at least freshened up a bit…. Yes maybe because I was brought up 
this way.” (geriatric nurse, 45 years old) 
In practice, nurses test certain things they have been taught during their training if they think 
that this is going to help them to do what should be done.  
“They also provide pain scales to evaluate pain in babies and patients with 
dementia. And also during clinical internship with patients with dementia … Yes 
through extra training and also experience” (geriatric nurse, 45 years old) 
Feeling good 
Nurses point out that it is important for them to feel good in their job. This feeling results 
from the meaning nurses give to their actions. If that meaning is positive, they are satisfied with what 
they have done and how they have realised it. That satisfaction leads to peace and stimulates them 
to carry on.   
They experience their work as positive if they were able to keep control and manage 
problems. An extra positive dimension is given to the solution of problems if the nurses were able to 
find a solution despite other people’s disbelief, doubt or opposition and if the nurse’s work is clearly 
appreciated.  
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“If you can convince them and … It was indeed successful, then afterwards they 
say «Yes, I actually feel a little better». Then you feel … for yourself … for your 
own work, it’s nice. That you feel like you have helped them.” (oncology nurse, 
28 years old) 
Nurses also experience their work as positive if none of the patients have complained about 
discomfort. Discomfort is a problem, so nurses try to avoid and solve discomfort as much as possible. 
However, often, discomfort, usually in the way of pain, cannot be solved, which is difficult to cope 
with for nurses.  
“Yes because for me it’s horrible to have to wash a patient who is moaning in 
pain.” (oncology nurse, 27 years old) 
Satisfaction in their work and being able to attach a positive dimension to it, is exactly what 
gives nurses the strength to carry on.  
How do nurses care for elderly palliative cancer patients?  
When analysing the data, we found the six components described above to be related to 
each other in a dynamic way. A conceptual framework could be developed interconnecting the 
different components and explaining their interaction in the nursing process (Figure 1).  
Nurses are driven to provide good care for older palliative cancer patients. All nurses express 
that the pursuit of good care is an important factor of feeling good about what they are doing and 
in being able to carry on. When defining ‘providing good quality care’, nurses immediately refer to 
activities and tasks which they categorise as ‘doing what needs to be done’. When asked further about 
how they interpret this concept of ‘doing what needs to be done’, it emerged that nurses have a 
preconceived mental image, a kind of picture in their head showing what good care should consist 
of. In order to meet that mental image, nurses apply two basic strategies, ‘keeping control’ and 
‘managing problems’. A third strategy consists of providing extras. As opposed to the two basic 
strategies, this latter strategy is not vital in order to comply with that mental image. 
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The first basic strategy, ‘keeping control’, is not only focused on the organisation of care but 
also on avoiding (potential) problems. In keeping control, nurses have the certainty of being able to 
realise the care they envision in their mental image in a smooth and efficient manner.  
The second basic strategy, ‘managing problems’, is focused on identifying and solving 
problems. Again, a preconceived mental picture is used as reference for identifying problems. Based 
on that mental picture nurses determine what is normal and what is problematic. When something is 
labelled as problematic, they immediately take appropriate action to resolve the issue. Preferably, the 
solution leads to measurable results in the short term and makes efficient use of the available time 
and resources.   
The third strategy, ‘providing extras’, is aimed at involving the patient in care and paying 
attention to the patient’s well-being. These extras are only provided if they do not interfere with 
keeping control and managing problems.   
Analyses have shown that there are two facilitators as regards the successful application of 
the basic strategies ‘keeping control’ and ‘managing problems’.  
The first facilitator is experience. Nurses use their experience to determine whether there are 
elements present that could prevent them from keeping control. Based on their experience, they 
anticipate certain factors that could hinder them in keeping the organisation running and they detect 
potential problems. By avoiding problems, nurses ensure a smooth organisation of the nursing 
process. It also enables them to guard patients from potential discomfort. Furthermore, nurses also 
explain that experience is important in terms of identifying and solving problems. Nurses know from 
experience which elements are important to get a good picture of what is normal (what fits with the 
picture) and what is not (what does not fit with the picture). Additionally, they know from experience 
how to deal with a specific problem within a specific context in an efficient and effective manner. 
The second facilitator concerns the relationship between the nurse, the patient, his/her 
family members and his/her colleagues. Nurses use their relationships with the patient, family 
members and colleagues to obtain the information they need in order to do what needs to be done. 
The nurse is in control of the interaction within these relationships. As a result, the relationships are 
nurse-centred, functional and task-oriented.  
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Nurses use this process, as described above, to evaluate their work. If they feel like they have 
kept control and dealt with problems, or in other words, if the care has gone according to plan and if 
they feel like there are no longer any problems for which they feel responsible, they can be satisfied 
and feel like they have done a good job. The provision of extras is not a necessity, but a bonus as 
regards the feeling of having done a good job. External confirmation, through their relationships with 
the patient, family members and/or colleagues, is important too. When assessing whether or not they 
have done a good job, nurses often seek expressions of gratitude and recognition. A nurse’s own 
satisfaction (I did a good job) and the external confirmation (you did a good job) have to be 
adequately present in order to feel good.  
Nurses indicate that this feeling of ‘feeling good’ makes sure that they are able to carry on 
their work. Both feeling good and being able to carry on directly influence the further realisation of 
‘providing good care’.   
  
 
Figure 1. Conceptual framework of the nursing process of providing care to older palliative 
cancer patients  
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DISCUSSION 
The present study explored how nurses provide care for older palliative cancer patients. The 
study reveals an interaction between different components which explain the process of nursing care 
for older palliative cancer patients. The findings highlight that nurses define their provision of care as 
‘doing what needs to be done’. The focus on doing, on tasks and activities is in line with the literature, 
which indicates that the fundamental values of nursing, such as compassion and caring, are more and 
more becoming lost because of an increased focus on acting (Maben, Adams, Peccei, Murrells, & 
Robert, 2012; Maben & Griffiths, 2008). This is introduced by rapid progress in technology which has 
changed the role of nurses (Maben et al., 2012; Maben & Griffiths, 2008). Nurses are confronted with 
increasing complexity of care in which there is little opportunity to reflect (Bail & Grealish, 2016; 
Ebright, Patterson, Chalko, & Render, 2003). As regards setting priorities within this increased 
complexity, literature reports that, regardless of the type of patient, nurses give the highest priority 
to those aspects that have a direct visual/measurable effect on the patient, that are less time 
consuming, and more likely to be audited (Jones, Hamilton, & Murry, 2015), which is similar to our 
findings. The lowest priority is given to educational, emotional, and psychological needs (Jones et al., 
2015). Studies have reported that nurses working in a variety of settings have learned over the years 
of working in clinical practice to become less compassionate (Maben, Latter, & Clark, 2007; Sheldon, 
Barrett, & Ellington, 2006). The nurses in our study consider compassion and participation as 
important, but not vital in order to comply with their image of what should be done. Nurses consider 
these things as ‘extras’ which they will provide only if it does not interfere with what should be done 
(keeping control and managing problems). Pearcey (2010) who reported that nurses consider ‘caring’ 
(e.g. listening to patients, being interested in patients as person, and addressing patients’ needs) as 
an extra, described that nurses know how to be caring, but that they express to have no time for it. 
They attribute this issue to the focus of organisations on quick-fix-solutions (Pearcey, 2010).   
Our study also highlights the fact that nurses identify problems based on a mental picture 
of the patient which they use as a reference to label something as normal (fits within the picture) or 
problematic (does not fit within the picture). Something that is labelled as problematic demands a 
quick, efficient, and effective solution. Care is provided according to what nurses assume is a problem 
and which solution is most suitable. They do this based on their experience. This is in line with Benner 
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(1984) who described that expert nurses have an intuitive grasp of the situation to which they 
respond. Nevertheless, Benner, Tanner, and Chesla (2009) also report that nurses come to engage in 
care with a fundamental disposition of what is right and wrong. Nurses adopt a problem-focused 
approach. However, such an approach might not always be the most appropriate one despite its 
relevance in some situations (McAllister, 2003). Literature indicates two cognitive tendencies which 
interfere with problem-solving: confirmation bias and fixation interference (McAllister, 2003). This was 
also apparent from our study. Nurses search for information that reinforces their idea on which they 
fixate. McAllister (2003) also argues that a problem-focused approach supports the paternalistic care 
model in which the healthcare professional is omniscient. In this paternalistic care model, a patients’ 
power and participation are reduced. This care model - which was renown between the 1940s and 
the 1960s (Tiedeman & Lookinland, 2004) - is in contrast with the widely advocated principles of 
integrating nursing (Grypdonck, Koene, Rodenbach, Windey, & Blanpain, 1979) and patient/person-
centred care (Kitson, Marshall, Bassett, & Zeitz, 2013; McCormack & McCance, 2006). These principles 
emphasise the importance of seeing the patient as a person which is vital as regards his care. Nurse 
experience has its merits in care, but reflection is needed to achieve integrated nursing and person-
centred care (McCormack, Dewing, & McCance, 2011). Indeed, reflection encourages nurses to 
acknowledge different values and perspectives such as the perspectives of patients, families and 
colleagues, which in turn will help them to understand and see problems differently. Organisations 
could achieve this by implementing reflective practices. Reflective practices involve critical reflection, 
learning from oneself and others, sharing and discussing experience (McCormack et al., 2011). 
Finally, the findings of this study indicate that nurses evaluate the care they provide based 
on their image of what care should be like (‘doing’, keeping control, managing problems). When the 
care they provided matches that image, they feel good. The image is adapted to what they can realise. 
Problems that cannot be solved are no longer considered problems and they focus on what can be 
solved. They need to feel they have ‘helped’ their patients. Crocker and Knight (2005) argue that 
people need to experience success and not failure to believe they are worthy as a person. The need 
to feel worthy drives people to behave in a certain way. They will generally pursue something 
guarantees them success and avoid what could result in failure rather than suffer a loss of self-worth 
(Crocker & Knight, 2005). Also, in order to feel good, nurses avoid being confronted with feelings of 
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distress. They organise and define care accordingly. This is in line with the literature which reports 
that nurses use avoidance as coping strategy to protect themselves from emotional situations 
(Mackintosh, 2007; Sandgren, Thulesius, Fridlund, & Petersson, 2006). On the other hand, literature 
also shows that distress is related to avoidance of emotional situations (Garrosa, Rainho, Moreno-
Jimenez, & Monteiro, 2010; Goodman & Schorling, 2012), and that emotion-oriented care has a 
positive influence on job satisfaction (Pol‐Grevelink, Jukema, & Smits, 2012). Furthermore, nurses rely 
on patients’ the expression of gratitude to evaluate their care as “good”. However, literature indicates 
that patients adapt to the context of care and that gratitude is therefore not a reliable criterion of 
providing good care (Vandecasteele et al., 2015). Clinical practice should support nurses in coping 
with distress and in finding appropriate ways to evaluate their care. 
Strengths and limitations 
The study has several strengths and limitations. Much attention was given to the recruitment 
and selection of nurses to participate in the study. However, the researcher had to rely on the head 
nurses who were informed about the inclusion criteria for the referral of nurses to participate in the 
study. Consequently, it remains difficult to determine how the head nurses controlled the selection 
of participants. Nevertheless, saturation was obtained for the majority of the results.  
The results may also reflect a more generalised pattern of care. It became clear during the 
interviews that nurses were speaking from a broader perspective than only their own, or how they 
provide care for older palliative cancer patients. However, this remains to be confirmed in further 
research.  Further research is also needed to confirm the results in other settings, such as home care 
or in other countries. 
The trustworthiness of the study was enhanced through different strategies to obtain rich 
data. The involvement of multiple researchers (researcher triangulation) minimised the risk of being 
stuck in certain concepts during analysis. Also, the primary researcher used peer review, memo writing 
and documentation on the process of requirement and her impressions, ideas and reflections on the 
participants and the obtained data to improve the trustworthiness of the findings. In addition, the 
interviewer had no a priori relationship with the participants nor the hospitals, which probably 
minimised the risk of social desirability answers. 
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CONCLUSION 
This study was one of the first to explore how nurses provide care for elderly palliative cancer 
patients. Nurses want to provide patients with good quality care. They define providing good quality 
care as doing what needs to be done, which is keeping control and managing problems. To 
accomplish this, nurses use their experience and relationships with others. These relationships are 
functional, task-oriented and nurse-centred. The focus is on the nurse being omniscient, and aspects 
such as compassion and participation are considered as an ‘extra’. Nurses need confirmation 
(internally and externally) that they are doing a good job. In this respect, gratitude from patients is 
an important element. Confirmation makes them feel good, which is what they need to be able to 
carry on. More attention should be given, however, to the education and clinical practice of nurses in 
terms of providing patient-centred care and engaging in reflective practice.
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The overall aim of this thesis was to gain insight into which symptoms are experienced by 
older palliative cancer patients and which interventions were performed, and more specifically how 
nurses provide care for older palliative cancer patients.  
In this general discussion, the key findings and methodological considerations of this thesis 
will be addressed. Finally, recommendations for clinical practice, education, institutions and policy, 
and further research will be outlined. 
 
KEY FINDINGS 
Symptoms in older palliative cancer patients 
This thesis started by searching the literature to identify which symptoms were experienced 
by older palliative cancer patients and with which prevalence. The systematic literature review, 
presented in Chapter II, revealed a total of 32 symptoms with a pooled prevalence ranging between 
3.5% and 77.8%. Most research focused on physical symptoms and no studies evaluating social and 
existential symptoms were identified. Based on the findings of this literature search, we were not able 
to make valid conclusions on the experience of the complete range of symptoms in the target 
population. This due to the use of small sample sizes, high heterogeneity between the studies and 
the limited validation of the used instruments in the identified studies. Consequently, more research 
was needed to detect the symptoms experienced by older palliative cancer patients.  
Therefore, we decided to develop and validate a new comprehensive instrument to collect 
data on symptoms in older palliative cancer patients. This instrument included 40 symptoms on 
multiple domains (physical, psychological, functional, social, and existential). The rigorous process of 
development and validation is presented in Chapter III. 
The validated instrument was used to obtain information about the experience of symptoms 
in older palliative cancer patients. A total of 400 hospitalised palliative cancer patients aged 65 years 
and older were questioned (Chapter IV). On average patients reported 13.85 symptoms (range 1-31). 
The prevalence of the symptoms ranged from 7.3% to 77.0% and the highest prevalence was found 
for physical symptoms. However, higher severity was identified for psychological symptoms. Also, two 
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third of the patients reported problems with functionality and one third of the patients reported 
problems with their social life and experiencing life as meaningful. The most prevalent and severe 
symptoms are presented in Table 1. 
 
Table 1. Most prevalent and severe symptoms 
Prevalent symptoms Severe symptoms* 
Dry mouth 
Physical fatigue 
Lack of energy 
Lack of appetite 
Difficulties with moving 
outside 
Shortness of breath 
Difficulties with self-care 
Brooding 
Physical pain 
Psychological fatigue 
77.0% 
69.3% 
65.8% 
58.0% 
55.8% 
 
53.3% 
52.0% 
51.8% 
49.3% 
46.0% 
Psychological pain 
Psychological fatigue 
Lack of willpower 
Lack of energy 
Physical fatigue 
Physical pain 
Depressed mood 
Brooding 
92.4% 
90.1% 
89.4% 
87.3% 
85.1% 
83.5% 
81.3% 
80.5% 
* Symptom being reported as moderate to severe - in more than 80% of the patients reporting the symptom 
 
By reviewing the symptoms reported in research literature in a younger population, there 
might be some indication that older palliative cancer patients experience a higher prevalence of 
symptoms compared to younger palliative cancer patients. Teunissen et al. (2007) systematically 
reviewed the prevalence of symptoms in adults with incurable cancer. The prevalence of twenty-one 
symptoms were collected in both the review of Teunissen et al. (2007) and our study, of which ten 
symptoms were almost identical (< 5% difference) in both populations, one symptom (physical pain) 
was higher in the younger population, and ten symptoms were higher in the older population. In a 
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more recent study, Moens et al. (2014) reported the minimum and maximum prevalence of symptoms 
in advanced cancer patients based on a review of the literature. Ten symptoms were reported in both 
the review of Moens et al. (2014) and our study of which five (fatigue, pain, shortness of breath, 
sleeplessness and diarrhoea) seemed to be higher in our study as opposed to the studies included in 
the review of Moens et al. (2014). However, to provide more conclusive evidence on the difference in 
symptomatology between age-groups, studies including an adequate sample of palliative cancer 
patients within the different age-groups and using a validated instrument to collect the data should 
be performed.   
Factors associated with symptom occurrence in older palliative cancer patients 
We also looked at factors associated with the occurrence of the five most prevalent and 
bothersome symptoms (lack of energy, physical fatigue, physical pain, having psychological problems, 
and experiencing functional dependence). Experiencing psychological symptoms was associated with 
having metastasis and physical pain was negatively associated with age. The literature is inconclusive 
about whether older patients experience more or less pain than their younger opponents. Some 
studies report a decrease in pain sensitivity in older patients (Gibson & Helme, 2001), while others 
state that older patients have a higher sensitivity to pain (Krok, Baker, & McMillan, 2013; Wandner, 
Scipio, Hirsh, Torres, & Robinson, 2012). Functional dependence was associated with age, limited 
prognosis, and having a geriatric risk profile. This is in line with the literature which reports that the 
functionality of older persons steadily decreases as death approaches (Chen, Chan, Kiely, Morris, & 
Mitchell, 2007; Covinsky, Eng, Lui, Sands, & Yaffe, 2003; Gill, Gahbauer, Han, & Allore, 2010). In 
addition to functional dependence, a lack of energy and physical fatigue were also associated with 
having a geriatric risk profile. The association between symptoms and having a geriatric risk profile is 
in line with the hypothesis that the aging process and the higher risk of multimorbidity increase the 
likelihood of experiencing multiple symptoms and functional decline (Banerjee, 2015; Depp & Jeste, 
2006). Furthermore, our analysis indicated that patients receiving chemotherapy were less likely to be 
functionally dependent (odd ratio 0.40). In contrast, patients receiving radiotherapy were 2.71 times 
more likely to be functionally dependent. This could be due to the fact that treatment decisions as 
chemotherapy are often based on age, functionality, and comorbidity (Decoster et al., 2013). 
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Radiotherapy is more likely to be given to patients in the more advanced stage of their illness. because 
of its lower intrusiveness for patients compared to chemotherapy in terms of toxicity and side effects 
(Chow et al., 2007).  
Clustering of symptoms in older palliative cancer patients 
Five groups of symptom clusters could be defined: (1) urological and gastrointestinal 
symptoms, and their treatment complications, (2) psychological and existential symptoms, (3) pain, 
constipation, sleeplessness and airway problems, (4) functionality problems, and (5) fatigue-related 
symptoms. The second cluster indicates a connection between being confronted with psychological 
symptoms and experiencing life as not meaningful. Also, the clustering of the psychological 
symptoms indicates a possible relationship between the different psychological symptoms and their 
negative impact on experiencing life as meaningful. Previous research showed similarities and 
differences. Walsh and Rybicki (2006) measuring symptom clustering in adults of all ages with 
advanced cancer also observed the clustering of fatigue, lack of energy, lack of appetite, and dry 
mouth, and constipation with pain. However, contradictory findings were also present such as the 
absence of the clustering of the psychological symptoms in the study of Walsh and Rybicki (2006). In 
addition, previous research performed in a younger population suggested the clustering of pain, 
fatigue, depression and sleeplessness which we could not observe (Aktas et al., 2010; Kirkova et al., 
2011; Miaskowski et al., 2006). Possible explanations for the contradictory findings are that the 
selection of symptoms to be included in the cluster analysis was different across the studies, and that 
we made, in contrast to previous research, a distinction between physical and psychological pain and 
fatigue. Other explanations are that previous research is mainly based on expert opinions or the 
results of a small sample size study. All these aspects makes comparison across studies more difficult. 
Nonetheless, it is possible that symptoms cluster differently in an older palliative cancer population 
as opposed to a younger population. Further, our analysis of patient groups revealed three groups: 
(1) group of patients who were symptom free, (2) group of patients who experienced physical 
discomfort, and (3) groups of patients who experienced physical and psychological discomfort. In the 
last group, significantly more patients had a geriatric risk profile, were more often functionally 
dependent and experienced their life as not meaningful. The finding that patients with a geriatric risk 
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profile are more likely to experience physical and psychological discomfort is, as already mentioned, 
in line with the hypothesis that being confronted with multimorbidity increases the likelihood of 
experiencing multiple symptoms and functional decline (Banerjee, 2015; Depp & Jeste, 2006).    
Symptoms in older palliative cancer versus non-cancer patients 
Originally palliative care was only focused on the care of the dying patient with cancer. Over 
the years, it has been advocated to also provide palliative care to patients facing chronic illnesses 
(Zheng et al., 2013). We wanted to explore if there was a difference in symptomatology between older 
palliative patients with cancer and patients with a chronic illness (Chapter VI). In total, 100 patients of 
65 years and older with heart failure, obstructive lung disease, renal failure, and/or liver failure were 
questioned. Similarities were found when ranking the symptoms from highest to lowest frequency 
and intensity. Similarities in symptom patterns were also observed in the systematic reviews of Solano 
et al. (2006) and Moens et al. (2014) which evaluated the difference in symptom prevalence between 
adults with different advanced staged diseases. Despite these similarities, also differences could be 
observed. Non-cancer patients experienced significantly more physical symptoms and more non-
cancer patients were functionally dependent compared to cancer patients. In contrast, cancer patients 
appeared to experience a higher frequency and intensity of psychological symptoms. A possible 
explanation is that older people with a chronic illness as opposed to people with cancer have had a 
longer time to adjust and learn to cope with their illness and that a chronic illness is characterised by 
a gradual deterioration due to organ failures over time (Murray, Kendall, Boyd, & Sheikh, 2005). 
Another explanation is that non-cancer patients might not or do not want to be aware of the life-
threatening condition of their chronic illness as opposed to cancer patients (Barclay, Momen, Case-
Upton, Kuhn, & Smith, 2011; Pinnock et al., 2011).  
Interventions in older palliative cancer patients 
Older palliative cancer patients received a variety of interventions for treating their 
symptoms (Chapter IV). The data provided some indication that much attention was given to physical 
pain. This can be assumed by the lower prevalence of pain compared to figures in the literature 
(Chapter II) and the prescription of analgesics in two-thirds of the sample. One-third of the patients 
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received chemotherapy and 10% received radiotherapy in the period of symptom assessment. 
Multiple disciplines were involved in the care of older palliative cancer patients. On average five 
disciplines were involved. The type of disciplines involved seems to indicate that the medical and 
social aspects are the main focus in care. All patients were cared for by a nurse and an oncologist. In 
a lesser extent, other disciplines such as a dietician, social worker, or physical therapist were involved. 
The physical focus was confirmed in Chapter VIII, which revealed that nurses primarily focus on the 
physical aspects of care. Despite the fact that great attention was given to physical symptoms, 
approximately 30% of the patients reporting physical pain did not receive analgesics. Few patients 
were seen by a psychologist (17.5%) or spiritual consultant (16.0%), and this despite the fact that 
psychological symptoms were reported as highly prevalent and bothersome. Possible reasons could 
be that older cancer patients do not want to talk to these healthcare professionals because they need 
to stay hopeful, more often use avoidance coping strategies, and do not want to be a burden to 
others (Aarts et al., 2015; McPherson et al., 2007). Other explanations might be a negative attitude 
and/or lack of knowledge in healthcare professionals regarding the need of patients to be supported 
psychologically and spiritually (Dilworth et al., 2014). In our interviews with nurses (Chapter VIII), we 
observed that nurses are the ones to decide when to contact a psychologist, and this was often done 
when they lacked the time to listen to the patient. Also, before a referral to a psychologist, the nurse 
needs to be able to recognise the psychological distress in patients first.  
The palliative support team was consulted for a limited number of patients (26.3%). This is 
in line with the literature, which indicated that palliative care is often only provided in the terminal 
phase of illness (Bruera & Hui, 2010). In addition, the literature has reported that older people are less 
often referred to palliative care in comparison to those who are younger (Burt & Raine, 2006).  
Role of the nurse in symptom assessment and management 
In symptom assessment, patients’ self-report is seen as the gold standard. We explored the 
agreement in symptom assessment between nurses, patients and their proxies (Chapter VII). The 
results indicated that nurses and patient proxies tend to underestimate physical and social symptoms 
and overestimate psychological, functional, and existential symptoms. The agreement of the 
frequency of symptoms between patients and proxies was better than the agreement between 
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patients and nurses. The agreement between the intensity assessment of symptoms was poor to fair 
between patients and nurses and patients and proxies. Differences in scores might be the result of 
patient - or nurse factors. We considered the assessment of symptoms by patients as the gold 
standard. However, one could question if patients truly express their experience. Literature suggests 
that patients, particularly older adult patients, sometimes minimise their symptoms for a variety of 
reasons, such as not wanting to be a burden to others (McPherson, Wilson, Chyurlia, & Leclerc, 2010; 
McPherson, Wilson, & Murray, 2007), seeing symptoms as part of aging (Kaye et al., 2010), and 
denying symptoms as coping mechanism (Arraras, Wright, Jusue, Tejedor, & Calvo, 2002; Hauer et al., 
2009). In contrast, the experience of the patient might be a true representation, but the nurse might 
not be able to adequately evaluate this experience (Chapter VIII).  
To have a better understanding on how nurses care for older palliative cancer patients, we 
interviewed 17 nurses about how they provide care to the target population (Chapter VIII). A 
conceptual framework could be developed explaining interactions in the nursing process of providing 
care to older palliative cancer patients. Nurses want to provide good care to patients, which they 
define as doing what needs to be done. It is like a preconceived mental image to which they respond 
by keeping control and managing problems. Aspects such as caring and participating are seen as 
extras which they will provide under the condition that it does not interfere with their preconceived 
image. In identifying problems, nurses in our study rely on a mental picture. They use this mental 
picture as a reference to label their observation as normal (fits with the picture) or problematic (does 
not fit with the picture). Something that is labelled as problematic demands a quick, efficient, and 
effective solution. The identification of problems is influenced by the nurses’ perception of what fits 
with their mental picture and their ability to solve the problem. These findings might provide some 
explanation of our findings in Chapter VII. The level of agreement in symptoms assessment between 
patients and nurses was low for symptoms which nurses are more likely evaluate as subjective, normal, 
and/or unsolvable. Higher levels of agreement in symptom assessment between patients and nurses 
were observed for symptoms which nurses are more likely evaluate as observable and problematic. 
This is in line with literature which reports that healthcare professionals give highest priority to those 
aspects which have a direct visual/measurable effect on the patient, are less time consuming, and 
more likely to be audited (Jones, Hamilton, & Murry, 2015). In addition, nurses in our study use their 
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experience and relationship with others which is a functional, task-oriented, and nurse-centred 
relation to keep control and manage problems. Nurses’ experience has it’s merit in care, but the 
findings indicate that nurses use a problem-focused approach which supports the paternalistic care 
model as healthcare professionals being omniscient. Furthermore, nurses evaluate the care they 
provided in terms of their ability to keep control and manage problems. When they feel they 
succeeded, they feel good. Nurses express to need to feel good, to continue doing their job. 
Therefore, their preconceived image is adapted to what they can realise. Crocker and Knight (2005) 
argue that people need to feel success and not failure, to believe they are worthy as a professional. 
Literature also indicates that nurses use avoidance strategies to protect themselves from emotional 
distress (Mackintosh, 2007; Sandgren, Thulesius, Fridlund, & Petersson, 2006). However, literature 
shows that distress is related to avoidance of emotional situations (Garrosa, Rainho, Moreno-Jimenez, 
& Monteiro, 2010; Goodman & Schorling, 2012), and that emotion-oriented care has a positive 
influence on job satisfaction (Pol‐Grevelink, Jukema, & Smits, 2012). Nurses in our study rely highly 
on the gratitude from patients. However, literature indicates that patients adapt to the context of care 
and that gratitude is therefore not a reliable criterion (Vandecasteele et al., 2015). 
     
METHODOLOGICAL CONSIDERATIONS 
Defining the older patient  
In defining the population in this thesis, a reflection is needed on who the older patient is as 
opposed to the geriatric patient. The older patient in this thesis was defined by its age which was in 
accordance with other research in older patients. In our analyses, we looked at the contribution of 
age as a factor in the experience of symptoms, and agreement of symptom assessment. For the 
experience of symptoms, we found that of the five symptoms included in a multivariate analysis, two 
indicated that age was a contributing factor. Age was negatively associated with physical pain and 
positively associated with functional limitations. Nevertheless, age is often used as criterion to define 
the older persons, but age does not allow to evaluate if an older patient has a geriatric profile. An 
older patient can be defined as a geriatric patient when confronted with a complex interplay of 
comorbidities, polypharmacy, functional decline, psychosocial problems and cognitive impairment as 
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a result of the ageing process (Depp & Jeste, 2006). To identify the geriatric patient in this thesis, we 
measured the geriatric risk profile of the included patients. This risk profile measures the increased 
likelihood of a patient of experiencing adverse events and a geriatric syndrome (e.g. fall, functional 
decline, delirium). Our analysis indicated that patients with a geriatric risk profile experienced 
significantly more physical and psychological discomfort and were at higher risk of functional 
limitations. These findings indicate that age, and especially having a geriatric profile are important 
factors in symptom experience and need attention in clinical practice. Further research might focus 
more on the persons aged 75 years and older and/or use another criterion than age to identify the 
geriatric patient. Having multiple comorbidities is another common factor in geriatric patients. In our 
analysis, we looked at the contribution of number of comorbidities as an influencing factor for 
experiencing symptoms. The multivariate analyses indicate that the number of comorbidities was not 
associated with experiencing symptoms. Symptoms can very often not be attributed to one condition, 
but are rather the result of an interaction between different conditions (Schäfer et al., 2010). Further 
research could investigate an interaction effect of comorbidities with other conditions. 
Universal definition of the palliative patient in research 
The lack of a universal definition on who the palliative patient is, demanded that we 
operationalised this definition for this thesis to ensure the validity of our findings. A definition on the 
older palliative cancer patient was obtained by consulting a panel of experts with clinical expertise in 
oncology, palliative care and/or geriatric care. The criteria were built on the concept of palliative care 
of the World Health Organisation and the definition of the palliative patient proposed by the Belgian 
Health Care Knowledge Centre. These organisation advice to integrate palliative care early in the 
course of illness based on the needs of the patient rather than the prognosis (Davies & Higginson, 
2004; Keirse et al., 2009). This resulted the following definition: “A patients with cancer who is no 
longer curable as a result of a lack of treatment options or for whom curative treatment is not/no 
longer recommended as a result of a weak general condition, multipathology and/or preference of 
the patient to discontinue treatment. In contrast to healing, stabilisation of the cancer is possible.” 
In Chapter II, we used a broader definition given the lack of a universal definition on the 
palliative patient and the understanding that different criteria are used across studies. The study in 
GENERAL DISCUSSION 
 
219 
 
Chapter VII was performed prior to the operationalisation of the definition of the palliative patient 
used in the other studies. The definition of Desmedt et al. (2011) was used in Chapter VII: “A patient 
suffering from an incurable, progressive, life-threatening disease, with no possibility of obtaining 
remission, stabilisation or improvement of this illness". In this definition, an estimation of life 
expectancy was purposefully omitted to highlight the importance of palliative care based on needs 
rather than prognosis (Desmedt et al. 2011) which complies with our definition of the palliative 
patient. The major difference with our overall definition used in the other chapters is that the 
definition of Desmedt et al. (2011) does not allow stabilisation of the disease. Consequently, the 
population in Chapter VII could be seen as a subset of our overall population. The population in 
Chapter VII also complies with our definition used in the other chapters in that the patients were also 
recruited on non-palliative care units and through the physician instead of the palliative support team 
and patients in a terminal phase were excluded from the study. In Chapter VIII, we used an exemplary 
case of an older palliative cancer women in our interviews with nurses. The exemplary case was built 
based on our criteria of the palliative patient. The word ‘palliative’ was purposefully omitted from the 
case because palliative care remains linked to care for the dying patients and we wanted to avoid that 
nurses told us about their care for terminal patients.  
Development of a new instrument to assess symptoms 
A profound process of instrument development and validation was performed to obtain a 
new comprehensive assessment to collect data on the frequency and intensity of symptoms in older 
palliative cancer patients. We developed a new instrument, because we wanted to collect data on 
multiple symptoms in various domains (physical, psychological, functional, social, and existential). We 
judged it necessary to develop a new instrument because the current available instruments measuring 
symptoms in palliative or older patients merely cover a limited number of symptoms and domains. 
The focus was on obtaining one comprehensive, disease and population specific instrument which 
measures symptoms in multiple domains. We opted for one assessment instrument in order to reduce 
the burden for the patient of having to complete long instruments measuring different symptoms 
with a possibility for duplication of certain symptoms. We also judged that the instrument should be 
disease- and population specific to be able to capture those symptoms which are characteristic for 
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the older palliative cancer patient. To ensure that the most important symptoms experienced by the 
target population were included in the instrument, the content validity of the instrument was 
assessment. Nevertheless, we are aware that our target population remains very heterogeneous due 
to differences in cancer types, comorbidities, illness trajectory and perception of the illness. Therefore, 
some very  specific symptoms such as hoarseness in patients with laryngeal cancer might have been 
missed.  
Our new instrument was also used in the data collection of symptoms in older palliative non-
cancer patients. In these patients, an adapted version of the instrument was used. The instrument was 
adapted based on a review of the literature on symptoms in non-cancer patients. However, in 
comparing the group of older palliative patients with and without cancer, only those symptoms 
included in our initial instrument could be incorporated in the analysis. We are aware that some non-
cancer specific symptoms such as weight gain (symptom in patients with heart failure), and restless 
legs (symptom in patients with kidney failure) might have been missed.  
The new instrument was developed mainly for research purposes. We did not evaluate the 
feasibility of the use of the instrument in clinical practice. A 40-item instrument might be judged too 
long for clinical practice. Nevertheless, questioning the older palliative cancer patients using the 
instrument allowed them to tell their story. In line with this, the instrument could be seen as a tool to 
engage in a narrative dialogue with the patient. The added value of this instrument in daily clinical 
practice should be weighed against the feasibility and further investigated. 
Screening of patients with a geriatric risk profile 
A variety of tools exists to assess patients at risk of having a geriatric risk profile (Decoster 
et al., 2015). Examples of internationally used tools are the G8, the fTRST (Flemish Triage Risk 
Screening Tool), the Vulnerable Elders Survey-13 (VES-13), and the Groningen Frailty Indicator (GFI) 
(Decoster et al., 2015). The first three are the most studied tools. In our studies, we chose to use the 
two most often used screening instruments in the Belgian clinical practice, namely the G8, and the 
fTRST (Flemish Triage Risk Screening Tool). Both tools have a high sensitivity but low specificity (Kenis 
et al., 2014). This means that the tools result in few false negative results, but many false positive 
results. Consequently, in our studies patients might have been wrongly classified as having a geriatric 
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risk profile. However, the small confidence intervals and large chi-square values indicated that the 
probability of the differences being due to chance only was small (Pett, 1996) and therefore, our 
findings were considered as valid.  
High quality cohort studies  
The use of a cross-sectional design does not allow to identify causal relationships among 
variables. To measure a causal relationship among variables, a high quality cohort study should be 
performed. In cohort studies, the exposure precedes the outcome, which allows to evaluate the 
causation between the two. In setting up these studies attention should be given to minimise bias 
and confounding. However, performing a cohort study in older palliative patients might be difficult. 
It is time-consuming and a demanding process for a vulnerable population and there is a high risk of 
drop-out which introduces bias in the obtained results.      
Clustering of symptoms 
The clustering of symptoms and patient groups based on the clustering of symptoms in 
older palliative cancer patients was investigated using an agglomerative hierarchical clustering 
analysis. This type of cluster analysis is exploratory in that it allows to identify clustering of symptoms 
without a priori knowledge on the numbers and types of clusters. Given the lack of research on 
symptoms in older palliative cancer patients, this type of analysis was most suitable. However, a 
cluster analysis is mainly a research tool because it is exploratory and descriptive, has strong 
mathematical properties and is strongly influenced by the symptoms included in the cluster analysis 
(Beckstead, 2002). Therefore, a first next step would be to validate the identified clusters in the clinical 
setting. A possible way to clinically validate the results is to evaluate the effect of treatment on the 
different symptoms within a cluster (Beckstead, 2002; Kirkova et al., 2011). If symptoms are clustered, 
the effect of treatment on one symptom should have an impact on the other symptoms within a 
cluster. Another way is to examine the underlying mechanisms such as biological basis behind the 
occurrence of symptoms, which might provide an indication on how to handle symptoms (Beckstead, 
2002; Kirkova et al., 2011). Also, the obtained clusters could be clinically validated by confirming the 
presence of the other symptoms within the cluster when one symptom is observed.   
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RECOMMENDATIONS FOR CLINICAL PRACTICE, EDUCATION AND POLICY 
Several key findings were identified which need attention in clinical practice, education and 
policy. 
Systematic symptom assessment 
Older palliative patients both with and without cancer are confronted with multiple 
symptoms of which psychological symptoms are experienced as severely bothersome. It is 
recommended that healthcare professionals systematically assess symptoms in older palliative cancer 
patients using a validated instrument which measures symptoms in multiple domains (Larkin et al., 
2008; Radbruch et al., 2010; Radbruch et al., 2008; Rayner et al., 2011; Ripamonti et al., 2001; World 
Health Organisation, 2002). The literature indicates that more symptoms are reported following 
systematic assessment of symptoms (Homsi et al., 2006). A study examining the impact of systematic 
symptom assessment versus spontaneous reporting of symptoms found a higher quality of life in the 
systematic assessment group (Velikova et al., 2004). Also, the systematic assessment of symptoms 
allows to question symptoms which are more difficult to talk about such as psychological symptoms 
and this for both the patient and the healthcare professional. The primary researcher of this thesis 
experienced that in questioning the 400 older palliative cancer patients with the validated instrument 
many of them were happy to talk and needed to share their experience and feelings. These aspects 
indicate that the patients have a need to tell their experience. This is in line with previous research, 
which stressed the importance of listening to the story of the patient (Jonas-Simpson et al., 2006; 
Senden et al., 2015). Therefore, a symptom assessment instrument could be used as a means to 
engage in a narrative interview with patients in clinical practice. Given the fact that our instrument 
might be too long to be used on clinical practice, an adapted version might be more suitable. The 
findings of this thesis indicate that nurses are primarily focused on physical issues. Therefore, it might 
be recommended that the adapted instrument mainly focuses on other aspects such as psychological, 
social and existential issues. Institutions should decide on a way to assess symptoms in, and more 
specifically engage in a narrative interview with patients. However, the findings of this thesis also 
indicate that nurses engage in a task-oriented (‘doing’), nurse-centre (the nurse is omniscient) and 
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functional (the patient is a source of information) relationship with the patient. The question rises if 
nurses would see a symptom assessment instrument as a task or as an aid to understand the true 
experience of patients. This should be investigated in further research.  
Furthermore, the findings indicate that patient proxies were slightly better at estimating the 
frequency and intensity of symptoms compared to nurses. The patient is the gold standard in 
evaluating symptom experience. However, in some cases such as a patient in an acute confusional 
state healthcare professionals could consult a proxy of the patient to have a better understanding of 
which symptoms the patient might experience instead on relying on their own single observation.  
Also, healthcare professionals should be informed about the experience of multiple 
symptoms by older palliative cancer patients and their need to be listened to. Furthermore, they 
should be instructed on how to assess symptoms. This can be achieved through training consisting 
of lectures, workshops, and role plays, which can be provided by institutions and educational 
organisations. Further, methods of research translating might be needed such as a culture of striving 
to deliver evidence-based care and questioning the clinical practice, role models, time to learn, and 
discussion groups in order to increase awareness and skills on symptom management in older 
palliative cancer patients (Glacken & Chaney, 2004; Hutchinson & Johnston, 2004). Institutions should 
support healthcare professionals to make these aspects part of daily practice. 
Attention for patients with a geriatric risk profile    
Healthcare professionals should be alert for patients with a geriatric risk profile. Our studies 
revealed that those patients were at higher risk of experiencing symptoms and functional decline. 
Also, those patients were more likely to experience both physical and psychological symptoms which 
negatively impacted functionality and experiencing life as meaningful. As already mentioned, 
different screening instruments exist to identify patients with a geriatric risk profile in clinical practice. 
Each institution should decide on one screening instrument to use to guarantee uniformity and 
understanding across the whole institution. The screening might support healthcare professionals to 
be alert to different needs in care for patients with a geriatric risk profile. Nevertheless, healthcare 
professionals should realise that is a first step in optimising care but that an individual approach is 
the cornerstone of person-centred care.  
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Specialised geriatric and palliative care 
The treatment of older palliative cancer patients should be based on the patients’ needs and 
the treatment goals. In hospitals, it is estimated that approximately one third of the hospitalised 
patients are 65 years and older and this proportion will rise in the following years and decade 
(Deschodt et al., 2015) and approximately one in five patients are palliative (Desmedt, 2016). 
Consequently, every hospital nurse will at some point need to care for an older and/or palliative 
patient. A combined palliative and geriatric approach could be beneficial for the older palliative 
cancer patient (Pautex et al., 2010). Educating healthcare professionals about the complexity and basic 
skills of geriatric and palliative care is recommended. This should be part of every nursing education 
program and internship. Basic skills in geriatric care involve the recognition of the physiological 
changes associated with age, the psychological, social, functional and existential impact of the disease 
and the hospitalisation, and the complexity of the interaction of multiple conditions and knowledge 
on the management of geriatric syndromes (Boltz et al., 2008; Parke & Brand, 2004). Also, every 
hospital nurse should be able to adequately assess the cognitive function and care participation of 
the patient, and evaluate the risk of poor discharge outcomes (Boltz et al., 2008; Parke & Brand, 2004). 
Basic skills in palliative care involve adequate communication skills to talk about advanced care 
planning and death, symptom assessment skills and knowledge on basic comfort care interventions 
(Gamondi, Larkin, & Payne, 2013). However, when the basic skills do not suffice, healthcare 
professional should consult or refer to specialised care. Reflections and discussions within the care 
team and with the patient might be beneficial in identifying the need to refer patients to specialised 
care. Also, a geriatric screening tool could be used to identify the older palliative cancer patient with 
a geriatric profile and the need for referral or co-management by a specialised care team (Decoster 
et al., 2015). If an older palliative cancer patient has a symptom that is deemed reversible such as a 
decrease in functionally a geriatric approach might be recommended (Baztán, Suárez-García, López-
Arrieta, Rodríguez-Mañas, & Rodríguez-Artalejo, 2009; Fox et al., 2012). Specialised geriatric care is 
known to be beneficial in improving physical, mental and social functioning, reducing the length of 
hospital stay and readmissions, and reducing the risk of placement in long-term care (Baztán, et al., 
2009; Fox et al., 2012). If an older patient is confronted with complex symptom burden from a life-
threatening disease and the goal is to alleviate the suffering, the patient might benefit from a referral 
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to a specialised palliative care team (Higginson et al., 2002; Radbruch & Payne, 2004). The findings of 
this thesis indicate that few patients were referred to a palliative support team. Possible reasons for 
the fact that the referral remains mainly prognosis-based might be that healthcare professionals lack 
the knowledge on what palliative care comprises and what the added value might be for the patient 
(Beernaert et al., 2015). Also, the focus on curative care makes it difficult, especially for physicians, to 
see palliative care as an added value rather than ‘giving up’ on patients (Gardiner, Cobb, Gott, & 
Ingleton, 2011). Patient could also be referred to a psychologist or spiritual counsellor if the 
psychological and/or existential burden is too severe and complex for everyday nurses to handle 
(Daem et al., 2013). In Belgium, a psychologist is a team member of specialised palliative care (KB 
15.07.1997). However, this is not true for all countries and in some cases it can be considered better 
to refer the patients to a psychologist or spiritual counsellor instead of specialised palliative care. For 
instance if a patient does not want to be confronted with palliative care (Zimmermann et al., 2016).  
Person-centred and compassionate care 
Given that the number of older patients, and especially patients with a complex profile will 
increase over the years, attention needs to be given to this population (Banerjee, 2015). The care for 
this population is complex and challenging. Nevertheless, the needs of the older patients should be 
at the basis of this care. The findings of this thesis indicate that more attention should be given to 
the principles of person-centred care during clinical practice/internship. McCormack and McCance 
(2006) developed a framework for person-centred nursing in older persons, which was based on 
existing evidence on a therapeutic relationship and caring, a critical dialogue, and focus groups with 
practitioners and researchers. The framework comprises of three components which need to be 
considered to obtain person-centred care: (1) attributes of the nurse (professional competences, 
being committed, clear values and beliefs, interpersonal skills, and knowing oneself), (2) the care 
environment (supportive organisation, appropriate skill mix), and (3) a person-centred process 
(working with patients’ beliefs and values, engagement in the nurse-patient relationship, shared 
decision making, recognizing the uniqueness and value of the individual, and providing for psychical 
needs). Without compassion, care could never really be person-centred. In compassionate care, the 
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relationship is based on empathy, emotional support, and effort to understand the distress of the 
patient (Dewar & Nolan, 2013).  
To optimise care, a learning culture is needed. In this learning culture, training and reflective 
learning might be strategies to obtain person-centred and compassionate care (McCormack, Dewing, 
& McCance, 2011). Training is a first part, in which healthcare professionals/students are instructed 
about the complexity of caring for older palliative cancer patients, and the principals of patient-
centred and compassionate care. Training might take the form of a lecture, alongside workshops, 
debates, simulation, and role play (Simpson & Courtney, 2002). Nevertheless, training which enhances 
knowledge and skills alone might not be sufficient. Reflective practices might be a second strategy. 
Especially, given the fact that nurses rely on what they identify as a problem and solution for a 
patients’ problem, rather than relying on the patients’ input. Reflective practices involve critical 
reflection, learning from oneself and others, sharing and discussing experience (McCormack et al., 
2011). Reflection also encourages nurses and nursing students to acknowledge different values and 
perspectives such as patients’, families’ and colleagues’ perspective, to understand problems 
differently. Reflection should not only focus on the product (the outcome), but also on the process. 
In reflecting on the process, nurses and nursing students could be encouraged to look at how they 
engaged with the patient and how they involved the patient in his care. The emphasis lies on what 
works for this particular patient. These reflective practices might take the form of a reflective dialogue, 
in which healthcare professionals and students discuss with one another, the form of video-analysis 
in which interaction are recorded and subsequently discussed or could be achieved through journal 
writing in which writing is used as a means to reflect (Caris-Verhallen, Kerkstra, Bensing, & Grypdonck, 
2000; Dubé & Ducharme, 2015). Another often mentioned strategy in reflective practices is having 
role models who engage in person-centred and compassionate care present in clinical practice and 
internship (Maben, Latter, & Clark, 2007). Being more person-centred and compassionate could result 
in being confronted with more difficult situations such as distress of patients (Maben et al., 2007; 
Sheldon, Barrett, & Ellington, 2006). In these reflection practices, healthcare professionals and 
students should be supported and allowed to be open and share their feelings to help them cope 
with distressing situations (Hockley, 2014). This requires a culture of openness, honesty and trust is 
required because healthcare professionals and students show their vulnerability. Institutions should 
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support the implementation of reflective practices in daily care. Attention should been given to the 
barriers and facilitators of implementing such practices and how these can be addressed. Further, 
institutions should provide the necessary resources such as educators to teach healthcare 
professionals to reflect, time to reflect, and rewards for reflective behaviour. Other aspects which have 
proven to be associated with positive change toward person-centred care are strong, supportive, and 
visible nurse leadership with a possibility for open communication with management, and recognition 
of nursing excellence (Bail & Grealish, 2016). The recommended changes require resources and time 
which are scarce in today’s clinical practices. Nevertheless, person-centred care is a key indicator of 
quality of care (Institute of Medicine Committee on Quality of Health Care in, 2001). Many researchers 
and experts in the field of care for the older person have advocate the focus on person-centered care, 
but the challenge as stated by Richards et al. (2015) remains to “overcoming ‘system’ inertia and 
paternalism” ((Institute of Medicine Committee on Quality of Health Care in, 2001; McCormack, 
Roberts, Meyer, Morgan, & Boscart, 2012; Richards, Coulter, & Wicks, 2015). It required a change in 
mindset and culture of healthcare professionals, institution, and policy (McCormack, Roberts, Meyer, 
Morgan, & Boscart, 2012). But the evidence shows that engaging in person-centred care is valuable 
for both patients and healthcare professionals. Patient cared for in a person-centred manner indicate 
higher rates of satisfaction with care, and empowerment (Olsson, Jakobsson Ung, Swedberg, & 
Ekman, 2013; Richards et al., 2015). In healthcare professionals, engaging in person-centred care is 
shown to improve job satisfaction, and decrease the intention to leave the job and burnout 
(McCormack et al., 2010; Pol‐ Grevelink, Jukema, & Smits, 2012). These aspects emphasise that 
investing both in time and resources might be beneficial in the long-term.  
RECOMMENDATIONS FOR FURTHER RESEARCH 
Improve the care for older palliative cancer patients 
The first step in developing an intervention to improve care for older palliative cancer 
patients, is to analyse the current practice and identify the problem areas (van Meijel, Gamel, van 
Swieten‐Duijfjes, & Grypdonck, 2004). This thesis highlights the importance of symptoms assessment 
with attention to patients with a geriatric risk profile, and the need for person-centred and 
compassionate care which can be facilitated through reflective practices. Further steps in the 
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improvement of  care might be achieved through action research (McCormack, Manley, Kitson, 
Titchen, & Harvey, 1999). In action research, the emphasis lies on generating change by engaging 
healthcare professionals in de development and implementation of strategies to obtain change 
(McCormack, Manley, Kitson, Titchen, & Harvey, 1999). A pre-existing care model can be used as a 
guidance to facilitate the development of a change. Herein, the framework of person-centred and 
compassionate care developed by McCormack and McCance, 2006  and Dewar & Nolan, 2013 
respectively might be recommended.   
A narrative dialogue to assess symptoms in multiple domains 
We already mentioned that the use of a symptom assessment instrument allowed the patient 
to tell their story which they seemed to value. Further research could evaluate the effectiveness of an 
adapted version of our symptom assessment instrument as a means to engage in a conversation with 
patients and allow them to talk openly. The adapted version could mainly focus on psychological, 
social and existential issues. The effectiveness could be evaluated by implementing the use of the 
adapted assessment instrument in daily practice and evaluate the effect on patient-outcomes such a 
decrease in symptom experience, and having a feeling to be able to openly talk about their experience 
and nurse-outcomes such as improvement in communication skills, and decrease in task-oriented 
and nurse-centred care.  
Palliative care for older palliative patients with a non-cancer diagnosis 
In recent years, more attention has been given to palliative care for patients with a life-
threatening condition other than cancer. We explored the difference in symptomatology between 
older palliative patients with and without cancer. We observed some similarities but also differences. 
Nevertheless, our group of non-cancer patients was rather small. To accurately measure a prevalence 
of 50% which is the worst-case scenario, a sample size of 400 patients is required. More research on 
symptoms and treatment interventions is needed in this target population. 
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SUMMARY 
Ageing is a fundamental risk factor in the development of cancer. Older patients are not 
always treated for their cancer for a variety of reasons. This leads to a higher risk of advanced stage 
cancer in older people. For those patients, palliative care might be beneficial. Palliative care is 
characterised by its focus on improving the quality of life of persons with life-threatening diseases 
through adequate assessment and treatment of suffering. Nurses play an important role in both 
assessment and treatment of symptoms, because they are most often involved with patients. 
Therefore, this thesis aims to provide insight into which symptoms are experienced by and which 
treatment is provided to older palliative cancer patients, and more specifically how nurses provide 
care for these patients. The insights were gained through seven studies. 
First, a systematic literature review was conducted to identify which symptoms were 
experienced by older palliative cancer patients and with which prevalence. Seventeen studies were 
included and a meta-analysis was performed. A total of 32 symptoms with a pooled prevalence 
ranging between 3.5% and 77.8% were identified. Most research focused on physical symptoms and 
no studies evaluated social and existential symptoms. There was a need for studies with an adequate 
sample size and use of a validated symptom assessment instrument to be able to adequately evaluate 
the symptoms experienced by older palliative cancer patients.  
Second, given the lack of a valid and comprehensive instrument to assess symptoms in older 
palliative cancer patients, a new instrument was developed and validated. This was done through a 
rigorous process including a literature review, Delphi-procedure, cognitive interviewing and test-
retest. These steps led to a well-designed, content validated and reliable instrument which included 
40-items and consisted of 24 physical, 10 psychological, and 3 functional symptoms, and 2 items in 
the social and 1 item in the spiritual domain. Both frequency and intensity were measured. 
Third, a cross-sectional study in 400 hospitalised palliative cancer patients aged 65 years and 
older was performed using the newly developed instrument. The prevalence of the symptoms ranged 
from 7.3% to 77.0% and patients reported 13.85 symptoms on average (range 1-31). The highest 
prevalence was found for physical symptoms, but higher severity was identified for psychological 
symptoms. Also, two third of the patients reported problems with functionality and one third of the 
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patients reported problems with their social life and experiencing life as meaningful. The analysis on 
the association between symptoms and demographic, and clinical variables revealed that 
experiencing psychological symptoms was associated with having metastasis and physical pain was 
negatively associated with age. Functional dependence was associated with age, limited prognosis, 
and having a geriatric risk profile. In addition to functional dependence, a lack of energy and physical 
fatigue were also associated with having a geriatric risk profile. In looking at the clustering of 
symptoms in older palliative cancer patients, five groups of symptoms were identified: (1) urological 
and gastrointestinal symptoms, and their treatment complications, (2) psychological and existential 
symptoms, (3) pain, constipation, sleeplessness and airway problems, (4) functionality problems, and 
(5) fatigue-related symptoms. The analysis of patient groups based on the clustering of symptoms 
revealed three distinct groups: (1) group of patients who were symptom free, (2) group of patients 
who experienced physical discomfort, and (3) groups of patients who experienced physical and 
psychological discomfort. In the last group, significantly more patients had a geriatric risk profile, 
were more often functionally dependent and experienced their life as not meaningful.  
Fourth, a cross-sectional study with hospitalised older palliative cancer (n=100), and non-
cancer patients was performed to evaluate the difference in symptomatology between both groups 
of patients. Similarities were found when ranking the symptoms from highest to lowest frequency 
and intensity. Despite these similarities, cancer patients reported significantly less symptoms than 
non-cancer patients. Non-cancer patients experienced significantly more physical symptoms and 
functional dependence compared to cancer patients. In contrast, cancer patients appeared to 
experience a higher frequency and intensity of psychological symptoms. 
Fifth, the interventions employed in the care for hospitalised older palliative cancer patients 
(n=400) were investigated. One-third of the patients received chemotherapy and 10% received 
radiotherapy in the period of symptom assessment. The data provided some indication that much 
attention was given to physical pain. Despite the fact that great attention was given to physical pain, 
approximately 30% of the patients reporting physical pain did not receive analgesics. Multiple 
disciplines were involved in the care of the patients. Few patients were referred to a palliative support 
team (26.3%), or were followed up by a spiritual consultant (16.0%) or psychologist (17.5%). 
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Sixth, a cross-sectional study was performed to evaluate the agreement in symptom 
assessment between nurses, older palliative cancer patients and their proxies. The results indicated 
that nurses and patient proxies tend to underestimate physical and social symptoms and overestimate 
psychological, functional, and existential symptoms. The agreement of the frequency of symptoms 
between patients and proxies was better than the agreement between patients and nurses. The agree-
ment between the intensity assessment of symptoms was poor to fair between patients and nurses 
and patients and proxies. Agreement was associated with multiple demographic and clinical factors 
such as gender and the presence of metastases. 
Last, a qualitative study was conducted to have a better understanding on how nurses care 
for older palliative cancer patients. Semi-structured interviews were held with 17 nurses who care for 
hospitalised older palliative cancer patients. At the start of the interviews, participants received an 
exemplary case of an older women with metastatic cancer. The results indicated that nurses want to 
provide good care which they translate to doing what needs to be done. Nurses accomplish ‘doing 
what needs to be done’ by keeping control and managing problems. Nurses keep control by keeping 
the organisation running and avoiding problems. Nurses identify problems based on their feeling of 
something not being right, which is based on mental image they have of the patient. Following the 
identification, problems are solved quickly, efficiently, and preferable with a measurable effect. Nurses 
use their experience and relationship with others as facilitators for keeping control and manage 
problems. Nurses search for confirmation (internally and externally) that they do a good job. In this, 
gratitude from patients is an important element. Confirmations help them to feel good which is what 
they need to be able to keep going. Consequently, nurses continue to realise care as doing what 
needs to be done.  
Taken together, improvements are needed in the care for older palliative cancer patients. 
Attention should be given to the systematic assessment of symptoms in older palliative cancer 
patients, and especially in those patients with a geriatric risk profile. Furthermore, making a priority 
of person-centred and compassionate care is highly recommended. This can be achieved through 
training and the implementation of reflective practices. Additionally, the care for older palliative 
cancer patients should be based on the needs of the patient and if needed a referral to a specialised 
care team might be considered.  
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SAMENVATTING 
Ouderdom is een fundamentele risicofactor in de ontwikkeling van kanker. Oudere patiënten 
worden, omwille van een verscheidenheid aan redenen, niet altijd behandeld voor kanker. Dit leidt 
tot een verhoogd risico op vergevorderde kanker bij ouderen. Voor deze patiënten kan palliatieve 
zorg een meerwaarde bieden. Palliatieve zorg wordt gekenmerkt door haar focus op het verbeteren 
van de kwaliteit van leven van mensen met levensbedreigende ziekten door middel van adequate 
beoordeling en behandeling van symptomen. Verpleegkundigen spelen een belangrijke rol bij zowel 
de beoordeling als de behandeling van symptomen, omdat zij het meest betrokken zijn bij de zorg 
voor patiënten. Dit proefschrift heeft als doel inzicht te krijgen in welke symptomen worden ervaren 
door en behandeling wordt geboden aan oudere palliatieve kankerpatiënten. Meer in het bijzonder 
tracht dit proefschrift inzicht te krijgen in hoe verpleegkundigen zorg opnemen voor oudere 
palliatieve kankerpatiënten. De inzichten worden verkregen door middel van zeven studies.  
Ten eerste werd een systematisch literatuuronderzoek uitgevoerd om te bepalen welke 
symptomen worden ervaren door oudere palliatieve kankerpatiënten en met welke prevalentie. 
Zeventien studies werden opgenomen in deze studie en een meta-analyse werd uitgevoerd. In totaal 
werden 32 symptomen met een gepoolde prevalentie variërend tussen 3.5% en 77.8% 
geïdentificeerd. De geïncludeerde studies richtten zich voornamelijk op fysieke symptomen; er 
werden geen studies geïdentificeerd die sociale en existentiële symptomen evalueerden. De studie 
toont aan dat er nood is aan verder onderzoek, gebruik makende van een adequate steekproef en 
een gevalideerde symptoom instrument, om accuraat symptomen bij oudere palliatieve 
kankerpatiënten te evalueren. 
Ten tweede werd, gezien het ontbreken van een gevalideerd instrument om de symptomen 
bij oudere palliatieve patiënten met kanker te beoordelen, een nieuw instrument ontwikkeld en 
gevalideerd. Hiervoor werd een rigoureus proces bestaande uit een literatuurstudie, Delphi-
procedure, cognitieve interviews en test-hertest toegepast. Dit proces heeft geleid tot een goed 
ontworpen, inhoudsvalide en betrouwbaar instrument bestaande uit 40-items waarvan 24 fysieke, 10 
psychische en 3 functionele symptomen en 2 items in de sociale en 1 item in het spirituele domein. 
Zowel de frequentie en de intensiteit werden gemeten. 
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Ten derde werd een cross-sectionele studie uitgevoerd bij 400 gehospitaliseerde palliatieve 
kankerpatiënten van 65 jaar en ouder gebruik makende van het nieuw ontwikkeld instrument. De 
prevalentie van de symptomen varieerde van 7.3% tot 77.0% en patiënten rapporteerden gemiddeld 
13.85 symptomen (bereik 1-31). De hoogste prevalentie werd gevonden voor fysieke symptomen, 
maar hogere ernst werd geïdentificeerd voor psychische symptomen. Twee derde van de patiënten 
rapporteerden problemen met functionaliteit en een derde van de patiënten meldden problemen 
met hun sociale leven en het leven als zinvol ervaren. Er werd een verband vastgesteld tussen het 
ervaren van psychologische symptomen en het hebben van metastasen en fysieke pijn was negatief 
geassocieerd met toenemende leeftijd. Functionele afhankelijkheid was geassocieerd met leeftijd, 
beperkte prognose en  het hebben van een geriatrisch risico profile. Naast functionele afhankelijkheid 
waren gebrek aan energie en fysieke vermoeidheid ook geassocieerd met het hebben van een 
geriatrisch risico profiel. Bij het bestuderen van de clustering van symptomen bij oudere palliatieve 
kankerpatiënten, werden vijf groepen van symptomen geïdentificeerd: (1) urologische en gastro-
intestinale symptomen en behandeling complicaties (2) psychologische en existentiële symptomen, 
(3) pijn, constipatie, slapeloosheid en luchtweg problemen, (4) problemen met functionaliteit, en (5) 
vermoeidheid-gerelateerde symptomen. De analyse van patiëntengroepen gebaseerd op de 
clustering van symptomen toonde drie te onderscheiden groepen: (1) patiënten vrij van symptomen, 
(2) patiënten met fysiek ongemak, en (3) patiënten met fysiek en psychologisch ongemak. In de laatste 
groep hadden significant meer patiënten een geriatrisch risicoprofiel, waren significant meer 
patiënten functioneel afhankelijk en ervaarden significant meer patiënten hun leven als niet zinvol.  
Ten vierde werd een cross-sectionele studie uitgevoerd bij gehospitaliseerde oudere 
palliatieve (n = 100), en niet-kankerpatiënten om de overeenkomst in symptomatologie tussen beide 
patiëntengroepen te evalueren. Gelijkenissen werden gevonden wanneer symptomen gerangschikt 
werden van hoogste naar de laagste frequentie en intensiteit. Desondanks deze overeenkomsten, 
werden ook verschillen waargenomen. Kankerpatiënten ervaarden aanzienlijk minder symptomen 
dan niet- kankerpatiënten. Niet-kankerpatiënten ervaarden significant meer fysieke symptomen en 
functionele afhankelijkheid dan kankerpatiënten. Daarentegen ervaarden kankerpatiënten hogere 
frequentie en intensiteit voor psychische symptomen. 
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Ten vijfde werd er gekeken naar de behandeling bij gehospitaliseerde oudere patiënten 
palliatieve kanker (n = 400). Een derde van de patiënten kreeg palliatieve chemotherapie en 10% van 
de patiënten kreeg palliatieve radiotherapie in de periode van de symptoom beoordeling. De 
bevindingen toonden aan dat er veel aandacht besteed werd aan fysieke pijn. Desondanks deze 
bevinding, kreeg ongeveer 30% van de patiënten geen analgetica. Gemiddeld waren per patiënt vijf 
disciplines betrokken in de zorg. Weinig patiënten werden doorverwezen naar een palliatief support 
team (26.3%), of gevolgd door een spiritueel adviseur (16.0%) of een psycholoog (17.5%).  
Ten zesde werd een cross-sectionele studie uitgevoerd om de overeenkomst in symptoom 
beoordeling tussen verpleegkundigen, oudere patiënten palliatieve kanker en hun naasten te 
evalueren. De resultaten toonden aan dat verpleegkundigen en de naasten van de patiënten de 
neiging hadden om fysieke en sociale symptomen te onderschatten en psychologisch, functioneel, 
en existentiële symptomen te overschatten. De overeenkomst in de frequentie van symptomen was 
beter tussen patiënten en hun naasten dan tussen patiënten en de verpleegkundigen. De 
overeenkomst in de intensiteit van symptomen tussen patiënten en verpleegkundigen en patiënten 
en hun naasten was zwak. De onder- en overbeoordeling was geassocieerd met verschillende 
demografische en klinische factoren zoals geslacht en de aanwezigheid of afwezigheid van 
metastasen. 
Tot slot werd een kwalitatieve studie uitgevoerd om zicht te krijgen op hoe 
verpleegkundigen zorg opnemen voor oudere palliatieve kankerpatiënten. Semi-gestructureerde 
interviews werden gehouden met 17 verpleegkundigen die zorgen voor gehospitaliseerde oudere 
palliatieve kankerpatiënten. De interviews startten met het voorleggen van een casus van een oudere 
vrouw met gemetastaseerde kanker. De resultaten toonden aan dat verpleegkundigen goede zorg 
willen geven aan patiënten. Verpleegkundigen vullen dit in door te ‘doen’ wat gedaan moet worden. 
Verpleegkundigen verwezenlijken dit door controle te behouden en problemen te managen. In het 
managen van problemen geven verpleegkundigen aan dat ze aanvoelen wanneer er iets niet klopt. 
Dit aanvoelen is gebaseerd is op een mentaal beeld dat ze hebben van de patiënt. Om controle te 
behouden en problemen te managen gebruiken verpleegkundigen twee facilitatoren, met name de 
relatie met de ander en hun ervaring. Verpleegkundigen zoeken naar bevestiging (intern en extern) 
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dat ze goed werk doen. Deze bevestiging dient aanwezig te zijn om zich goed te voelen. 
Verpleegkundigen geven aan dat dit ‘goed voelen’ er voor zorgt dat ze hun werk kunnen volhouden.  
De bevindingen in dit proefschrift tonen aan dat de zorg aan oudere palliatieve 
kankerpatiënten kan verbeterd worden. Er dient aandacht besteed te worden aan de systematische 
beoordeling van de symptomen bij oudere palliatieve kankerpatiënten met een specifiek aandacht 
voor patiënten met een geriatrisch risicoprofiel. Bijkomend is het ten zeerste aanbevolen om een 
prioriteit te maken van persoon-gerichte zorg en compassie in de zorg. Dit kan verwezenlijkt worden 
door middel van training en de implementatie van reflecterende praktijken. Verder dienen de noden 
van de oudere palliatieve kankerpatiënt het uitgangspunt te zijn van de beslissingen in de zorg 
waarbij indien nodig de patiënt wordt doorverwezen naar gespecialiseerde zorg.
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zijn. Jullie onvoorwaardelijke vriendschap is een geschenk dat ik elke dag koester. Ik geniet steeds 
opnieuw van de momenten die we samen doorbrengen.  
Aan Aurélie en Magali, drie jaar samenwonen dat brengt de mensen dichterbij. Dank jullie wel voor 
deze fijne tijd en ook voor de momenten die we nog steeds samen doorbrengen. 
Aan Anne-Catherine, bedankt om me nieuwe dingen te leren kennen en te doen geloven dat het kan.  
  
258 
 
Een speciale dank aan mijn zus Delphine en mijn broer William, mijn schoonzus Valerie en mijn 
schoonbroer Bram voor de vele fijne momenten die we samen doorbrengen als familie.  
Ook een woordje van dank aan mijn grootouders. Aan mijn grootvader Van Lancker. Papy, in deze 
wat moeilijkere tijden liet je me toe jouw handen te fotograferen voor het ontwerp van de cover. 
Dank je wel hiervoor. Mijn grootouder Debandt, bon-papa en grand-maman, jullie zijn een bron van 
inspiratie, een bron van warmte. Dank jullie wel voor de mooie en diepgaande momenten samen. 
En dan last but definitely not least, mama en papa. Om jullie te bedanken kom ik pagina’s te kort. 
Dankzij jullie steun, zeker dit laatste jaar, heb ik dit doctoraat kunnen afleggen. Jullie geloof in mijn 
kunnen en jullie aanwezigheid in mooie, maar ook moeilijke momenten, zijn van ontelbare waarde. 
Enorm bedankt hiervoor.      
 
 
